Me ya sa waɗannan alamun suke faruwa?
Kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar, musamman a shekarunku.
Kuma tare da zazzabi
Hakanan za a duba hawan jini da kuma yawan cholesterol.
Kuma kuna da ciwon kirji a yanzu?
Kuma kuna da wannan ciwon na kirji a yanzu?
Kuma, shin kuna da matsalar numfashi?
Kuma za ku iya gaya mani menene alamun da kuke da shi?
Kuma zafin jikinku ya daɗe.
Kuma ina yin zurfi.
Kuma ina da ƙananan faduwa da kuma rashin ƙarfi.
Kuma a yau ina da ciwo mai tsanani a cikin ƙirjina.
Kuma shin lokaci ne da za ku yi amfani da wannan maganin rigakafi?
Kuma yana haifar da ciwon ciki.
Kuma ina ganin ina da zazzabi.
Kuma ina so ku bayyana yanayin ciwon kirji.
Kuma suna da zazzabi.
kuma tare da tarihin ciwon sukari
Kuma, ka sani, ina jin kamar na yi burgewa.
Kuma ka sani mutane suna yi mini baƙar magana.
Kuma ƙirjinka yana ciwo.
Kuma kun ce, "Wannan ya kasance a kan ƙirjinku".
Wani daga cikin dangin yana da cututtukan zuciya, cututtukan zuciya, bugun zuciya, yawan cholesterol, hawan jini
Waɗanne alamomi ko matsaloli ne ka lura da su a cikin ciwon tsoka?
Shin akwai wasu mutane a cikin gida da ke fama da irin wannan alamun?
Shin kana da wasu alamun cutar?
Shin kuna da numfashi mai wuya?
Shin kuna da ciwon kirji a cikin kwandon kirji?
Domin yanzu lokaci ne na mura.
Shin, ba za mu manta da ciwon kirji ba, wanda ya zo daga zuciya?
Amma matsalar da ta fi muhimmanci a yanzu ita ce ciwon kirji.
Amma ina da matsala wajen numfashi.
Amma na san cewa mutane da yawa za su gane ni.
Amma dole ne mu kula da kowace ciwon kirji da tsanani.
Amma yanzu tana numfashi sosai, ko ba haka ba?
Na manta da shi gaba daya saboda ciwon kirji.
Kana jin kamar wani yana matsa maka a kirji
Har yanzu kuna jin kunyar numfashi.
Shin suna fama da irin wannan cuta?
Shin kana da wata matsala ta kullum, kamar hawan jini ko kuma irin wannan matsalar?
Shin kuna da wata cuta ko wata cuta ta kullum kamar ciwon sukari?
Shin kuna da ciwon kirji tare da numfashi mai wuya?
Kana da hawan jini?
Shin kuna da damuwa da wannan numfashi?
Ka san abin da ya faru da shi?
Kuna ganin hoton?
Ka sha ruwa mai yawa a yau.
Ina yin gwajin ciwon sukari, duk da haka.
Duk da haka, yana da alamun da suka yi kama da na.
Yaya zafin zafin jikinka yake?
Yaya hawan jini yake?
Idan zafin jikinka ya ci gaba da ƙaruwa,
Idan zazzabinku ya yi ɗari biyu ko fiye,
Idan kana ganin alamun ka ko kuma matsalolin ka na bukatar a duba su sosai
Na kamu da zazzabi a jiya.
Ina da zazzabin zazzabi.
Na kamu da zazzabi a jiya.
Ina jin zafi sosai a cikin kwandon kwandon.
Ni ma ina da matsalar numfashi.
Zan aika muku da hoto.
A yau ina jin zafi a kirjina.
Ina da ɗan ciwon kai da zazzabi a yau.
Ina ganin yana da mura.
Ina ganin wannan wani abu ne mai sauƙi.
Yana kama da mutum mai nauyi yana zaune a kirjinka?
Dukkanin ya fara ne tare da ciwon kai da zazzabi a lokaci guda.
Yana cikin ƙirjina.
Matsin lamba yana kama da ciwon kirji.
Ina ciwo a ƙirjina.
Yana tsakiyar ƙirjina.
Yana tsakiyar ƙirjina.
Na ji zafi a cikin ƙirjina.
Ina matukar damuwa game da ciwon kirji.
Ina so ku gaya mani lokacin da kuke kwatanta wannan ciwon na ƙirjin.
irin su hawan jini ko ciwon sukari
Yana cikin ƙirjina.
Yanzu za ku iya amfani da ita don zazzabin sukari na takapirina
Da kyau, Mary, ka yi kwanaki da yawa kana da waɗannan alamun.
Yanzu kun ce kuna da ciwon kirji.
Wani lokaci ina jin zafi a cikin ƙirjina.
Da kyau, shin kuna da wasu alamun bayyanar cututtuka a wajen ciwo?
Ko kuwa wani yana zaune a ƙirjinku?
Zazzabi da tari, ciwon kai da ciwon tsoka, duk kusan haka ne.
Yana cikin ƙirjina.
A wannan hoton, nuna mini inda za ka ji zafi.
Domin kuna da zazzabi.
Shin kana ganin wasu daga cikin wadannan alamun na iya kasancewa na ciki ne?
Shin yaranku suna da irin waɗannan alamun?
Ka bayyana mini abin da ke damun kai.
Zazzabi yana tashi da dare.
Na samu wani abu mai kama da taba kwana biyu da suka wuce.
A daren jiya, zazzabin ya kara tsanani.
Shi ne Dr. Porter a cikin ɗakin gaggawa na Triangle.
Za ka iya gaya mini ƙarin game da ciwon kirjinka?
Ina jin zafi a gaban kaina a cikin kwandon ƙirjina.
Na yi rashin lafiya a cikin kwandon a cikin dogon lokaci.
Da kyau, lokacin da nake da wannan ciwon a cikin kwandon.
Wane irin ciwo kake da shi a cikin kurkuku?
Yaushe ne wannan ciwon ya fara?
A wace sassa na kanka kake jin zafi?
A ina kake jin wannan ciwon kirji?
Kuna jin kunyar a cikin kwandon kai.
Ka san cewa ina da ciwon sukari da sauran matsaloli.
Ka ce kana da ciwon kirji.
Kasancewar cutar coronavirus (COVID-19) da ke tasowa a cikin EU/Turai da Birtaniya, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Kasancewar cutar ta Coronavirus (COVID-19) ta karuwa, irin wannan yanayin a cikin kasashen EU/Yankin Tattalin Arzikin Turai da Ingila ya nuna cewa ko da yake cutar ta yadu a cikin ƙasashe daban-daban a matakai daban-daban, cutar ta COVID-19 tana yaduwa cikin sauri a duk ƙasashe.
Bisa ga kwarewar da aka samu daga cutar a Italiya, ƙasashe, asibitoci da garuruwan kulawa ta musamman suna bukatar su kara kasancewa a shirye don manyan magungunan marasa lafiya na COVID-19 da ke buƙatar kula da lafiya, musamman kulawa ta musamman.
A ranar 31 ga Disamba, 2020, an samu rahoton wani rukuni na marasa lafiya na cutar sankara da ba a san dalilinsa ba a Wuhan, lardin Hubei na kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar China ta ba da rahoton cewa cutar ta haifar da wani sabon nau'in coronavirus wanda daga yanzu ake kira cutar ta Coronavirus 2 ta hanyar cutar ta numfashi mai tsanani ko kuma ta hanyar taƙaitaccen SARS-CoV-2.
Tun daga wannan lokacin, rashin lafiyar da aka samu daga kamuwa da SARS-CoV-2 an kira shi cutar coronavirus (COVID-19).
Bayanai da aka samu sun nuna cewa kusan kashi 80 cikin dari na mutanen da suka kamu da COVID-19 suna kamuwa da cutar ta hanyar numfashi tare da ko ba tare da cutar huhu ba, kuma yawancin su sun warke.
A cikin kashi 14 cikin dari na al'ummomin, COVID-19 ya zama mummunan cuta wanda ya sa marasa lafiya suka shiga asibiti, yayin da kashi 6 cikin dari na sauran al'ummomin da suka kamu da mummunan cuta suka shiga cikin kulawa ta musamman.
Yawan mutuwar marasa lafiya da aka kwantar da su daga COVID-19 ya kai kusan 4%.
A cikin wannan binciken, mun kimanta yanayin kamuwa da cutar COVID-19 a kowace ƙasa ta EU/kasashen tattalin arziki na Turai da Ingila, kuma mun kwatanta shi da yanayin a lardin Hubei na kasar Sin.
Muna kuma kwatanta yawan mutanen da ke kamuwa da COVID-19 a cikin EU/Yankin Tattalin Arzikin Turai da Ingila da waɗanda ke kamuwa da cutar a Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Cutar COVID-19 a cikin ƙasashen EU / EU da Ingila
Bayan haka, COVID-19 ya bazu zuwa wasu yankuna na duniya, kuma halin da cutar ta COVID-19 ke ciki a sauran sassan duniya yana bin irin wannan yanayin a kasar.
A ranar 11 ga watan Maris, Sakataren Janar na Hukumar Lafiya ta Duniya (WHO) ya sanar da barkewar cutar COVID-19.
A cikin wata mujallar Eurosurveillance ta 5 ga Maris 2020, Spiteri da abokan aikinsa sun ba da rahoton farkon kamuwa da cutar coronavirus a Turai bisa ga ma'anar Hukumar Lafiya ta Duniya.
A cikin EU/Economic Region, an samu kamuwa da cutar ta farko a ranar 24 ga Janairu 2020 a Faransa tsakanin fasinjojin da suka dawo daga Wuhan, lardin Hubei na kasar Sin.
A ranar 15 ga Maris, 2020, an gano mutane masu kamuwa da COVID-19 a duk ƙasashen 30 na EU / Yankin Tattalin Arzikin Turai da Ingila (UK), wanda ya ba da rahoton kamuwa da cutar 39,768 da kamuwa da cutar 1,727 a tsakanin 31 ga Disamba, 2019 zuwa ƙarshen wannan kwanan wata, inda Italiya kadai ta sami kamuwa da cutar 1,7750 da mutuwar 1,441.
Samun adadi da kuma samun adadin masu kamuwa da cutar COVID-19
A Cibiyar Kula da Cututtuka ta Turai (ECDC), ana samun lambobin marasa lafiya na COVID-19 da aka tabbatar a kowace ƙasa a kowace rana daga kafofin hukuma kamar Ma'aikatar Lafiya, hukumomin kiwon lafiya na ƙasa da na yanki a waɗannan ƙasashe da kuma Hukumar Lafiya ta Duniya, kuma ana sabunta su da karfe 8:00 na safe.
An yi amfani da wannan bayanan don kimanta yanayin COVID-19 a cikin ƙasashen EU / EU da Ingila da kuma kwatanta su da Italiya.
A matsayin tushen ƙayyade yaduwar cutar COVID-19, mun ƙayyade tsawon lokacin da aka rage yawan kwanaki 14 na kamuwa da cutar COVID-19, don haka an yi la'akari da lokacin COVID-19 na al'ada, a kowace ƙasa memba na EU / EU da Ingila, a cikin lokacin Janairu 1 zuwa Maris 15, 2020.
An kuma kwatanta yawan marasa lafiya a kowace ƙasa a cikin jimlar Janairu 31 zuwa Maris 15, 2020, kamar yadda aka nuna a karfe 8:00 na safe na ranar 15 ga Maris, 2020.
Kasancewar kamuwa da COVID-19 a cikin EU / EU da Ingila
Hanyoyin da aka lura a cikin rage yawan kwanaki 14 na COVID-19 a cikin ƙasashen EU / EU da Ingila sun dace da yanayin da aka ambata a cikin lardin Hubei (China) (Figure 1).
A cikin duka, a cikin EU / EU da Ingila, an fara samun COVID-19 a cikin ƙasashen da ke cikin EU / EU da kuma Ingila a ranar 21 ga Fabrairu, sannan kuma a ranar 28 ga Fabrairu, 2020 (abun da aka haɗa).
Wannan ya faru ne saboda yawan adadin marasa lafiya da aka samu daga Italiya, amma duk sauran ƙasashen EU/Economic Union da Birtaniya sun nuna irin wannan karuwa a cikin COVID-19 (ƙididdiga sun haɗa).
Shafi na 2 ya kwatanta yawan adadin mutanen da suka kamu da COVID-19 a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai da Ingila da waɗanda suka kamu da cutar a Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya bayyana cewa, a karfe 8:00 na safe, 15 ga Maris, wasu kasashe 15 na EU / EU da Birtaniya sun ba da rahoton yawan adadin kamuwa da cutar, wanda ya yi daidai da na Italiya a cikin makonni 3 ko ƙasa da haka.
Sakamakonmu ya nuna cewa yawan marasa lafiya na COVID-19 na ƙaruwa cikin sauri a cikin ƙasashen EU / EU da Ingila.
Hanyoyin da aka lura da tarin COVID-19 sun nuna cewa cutar za ta yadu da irin wannan saurin a duk ƙasashe.
Duk da cewa ƙasashe suna fuskantar matakai daban-daban na yaduwar cutar, akwai bambance-bambance a cikin yadda hukumomin kiwon lafiya na ƙasashe ke amsawa, kuma a ƙasashe daban-daban, ana amfani da ƙa'idodi daban-daban don mutanen da ke buƙatar yin gwajin tabbatarwa ko ƙarin gwajin COVID-19.
A farkon Maris 2020, likitoci a yankunan da ke da cutar ta Italiya sun ba da rahoton halin da ake ciki inda kusan kashi 10% na marasa lafiya da ke da cutar COVID-19 ke buƙatar kulawa ta musamman, kuma kafofin watsa labarai sun ba da rahoton cewa an riga an kammala babban ƙarfin asibitoci da sassan kulawa na musamman a waɗannan yankuna.
A halin yanzu, a cikin ƙasashen EU / Yankin Tattalin Arzikin Turai, kashi 6% da 1% na kasashe ne kawai ke da bayanai game da karɓar marasa lafiya COVID-19 a asibiti da/ko shiga cikin kulawa ta musamman (ba a nuna bayanai ba).
Duk da haka, dole ne a tattara su cikin tsari don amfani da su a matsayin ƙarin bayanan kulawa na yanzu kuma a mayar da hankali kan wasu ɓangarorin da aka ruwaito da kuma ɓangarorin mutuwa.
Wani bincike da aka gudanar a tsakanin 11 zuwa 2010 ya nuna bambanci mai yawa a cikin samun damar zuwa asibitocin kulawa na musamman da matsakaici a Turai, inda ya bambanta daga 29.2 a Jamus zuwa 4.2 a Portugal ga kowane 100,000 mutane.
Wannan yana nufin cewa waɗannan ƙasashe suna da albarkatu fiye da Italiya (mafi yawan wuraren kulawa na musamman da matsakaici 12.5 a kowace 100,000 mutane a shekara ta 2011-2010).
An gabatar da yanayin tsarawa dangane da wadatar da damar kiwon lafiya da magani tare da kimantawa ga kowace ƙasa ta EU / EU da Burtaniya game da yawan marasa lafiya COVID-19 da ke da haɗarin > 90% fiye da ƙarfin wuraren kula da lafiya na musamman a cikin tsarin ECDC na shida na kimanta haɗarin COVID-19.
Tun da an riga an lura da cututtukan cututtuka a wasu yankuna a cikin ƙasashen EU / EU da Ingila, kuma asibitoci da wuraren kulawa na musamman suna ba da sabis ga yawan jama'a na yanki, dole ne a ba da bayanai game da cututtuka da wuraren kulawa na musamman a cikin tsari na Ƙungiyoyin Ƙungiyoyi don Matsayi na 2 (NUTS-2).
Kwarewar cutar a Italiya da kuma abubuwan da ke faruwa a yanzu a wasu ƙasashe sun nuna cewa annobar COVID-19 tana yaduwa cikin sauri a cikin ƙasashen EU / EU da Ingila.
Saboda haka, dole ne kasashe, asibitoci da kuma wuraren kulawa na musamman su shirya kansu don magance yanayin ci gaba da yaduwar cutar SARS-CoV-2 da kuma samar da shirye-shirye don karɓar marasa lafiya da ke fama da COVID-19, musamman a cikin wuraren kulawa na musamman, kamar yadda ya faru a yankunan da aka kamu da cutar a Italiya.
Kamar yadda aka bayyana a cikin ƙididdigar haɗarin ECDC na kwanan nan, yana da mahimmanci don jinkirta yaduwar SARS-CoV-2 zuwa hanzari, gaba da yaduwa da kuma daidaitaccen tsarin aiki tare da sauya ra'ayi daga ƙuntatawa zuwa rage saurin annobar, saboda idan ba a ɗauki matakan da suka dace ba, ƙimar da ake tsammani na masu kamuwa da cutar ba za ta sami damar da za a ba hukumomin yanke shawara da asibitoci don ganowa, karɓa da aiwatar da martani mai kyau ba.
Har ila yau, kimantaccen haɗari na sauri ya lissafa matakan kiwon lafiyar jama'a don rage tasirin cutar.
Kasashe suna da ɗan gajeren lokaci don ƙarfafa ƙoƙarin sarrafa su da rage saurin yaduwar SARS-CoV-2 don haka rage matsin lamba akan tsarin kiwon lafiya da magani.
Idan ba a iya yin haka ba, tsarin kula da lafiya na sauran EU / EU na iya fuskantar babban adadin marasa lafiya da ke buƙatar kulawa ta musamman a cikin kwanaki ko makonni masu zuwa.
Cutar cutar Coronavirus 2019 (COVID-19), wanda cutar ta Coronavirus 2 (SARS-CoV-2) ta haifar da cutar ta hanyar numfashi mai tsanani (SARS), ta haifar da mutuwar mutane fiye da 3,000 da kamuwa da cutar fiye da 80,000 a China da sauran sassan duniya, kuma a matsayin haka, ta haifar da bala'in ɗan adam.
Hakanan SARS-CoV-2 na iya zama kamar wanda ya haifar da SARS-CoV a cikin dubban mutane a shekara ta 2003, wanda ya kamu da cutar ta hanyar kwayoyin halitta, kuma yana haifar da bayyanar cututtuka iri ɗaya ta hanyar aiwatar da irin wannan tsari.
Koyaya, COVID-19 yana da ƙarancin tsanani da mutuwa fiye da SARS, amma yana da ƙarancin kamuwa da cutar, yana cutar da tsofaffi da maza fiye da matasa da mata.
A cikin martani ga karuwar wallafe-wallafen game da wannan sabon cuta, wannan ya yi ƙoƙari ya ba da cikakken bayani game da bincike mai zurfi.
Za mu samar da bayanai na asali game da cututtukan cututtuka, etiology, virology, ganewa, magani, gargadi da rigakafin cutar.
Ko da yake har yanzu akwai tambayoyi da yawa da ba a amsa ba, ana fatan wannan binciken zai taimaka wajen gano wannan cuta mai haɗari da kuma kawar da ita.
Bikin bazara a ranar 25 ga Janairu 2020 ya zama abin tunawa da ba za a iya mantawa da shi ba ga duk Sinawa da aka nemi su zauna a gida a lokacin hutu da kuma makonni masu yawa bayan barkewar sabuwar cuta ta cutar.
Wannan cutar tana da kamanceceniya da cutar coronavirus (CoV) wanda ya haifar da barkewar cutar ta SARS a shekara ta 2003, saboda haka, a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta zabi sunan SARS-CoV-2 da kuma sunan cutar da ta danganta da ita, CoV Disease-19 (COVID-19) (Covid-19 ko COVID-19).
Cutar ta fara ne a Wuhan, China, kuma ta bazu cikin sauri a duk faɗin ƙasar da kuma wasu ƙasashe 5 a duniya.
Tun daga ranar 2 ga Maris, 2020, cutar ta haifar da kamuwa da cutar ta musamman fiye da 80,000, wanda adadin marasa lafiya da aka sallama ya wuce 40,000, kuma fiye da 3,000 sun mutu.
"Kungiyar lafiya ta duniya ta yi gargadin cewa COVID-19 "mai gaba daya ne mai lamba 1", kuma yana da iko fiye da ta'addanci".
A cikin ƙasa da watanni biyu, fiye da 200 na nazarin kimiyya game da COVID-19 sun fito, wanda ya ƙunshi batutuwa kamar ƙwayoyin cuta, cututtukan cututtuka, etiology, ganewar asali da magani tun lokacin da aka fara rahoton labarin farko a ranar 7 ga Janairu 2020 game da ƙayyade tsarin kwayoyin cuta na cutar da aka zaɓa daga marasa lafiya da yawa.
Wannan binciken na nazari ne wanda ke nufin sake nazarin ci gaban bincike a sababbin fannoni da ake nema.
A cikin sakin layi na biyu, za mu gwada COVID-19 da SARS da sauran cututtukan da ke haifar da cutar coronavirus da ake kira Middle East respiratory syndrome (wanda ya zama sananne a shekara ta 2012).
Za mu tattauna abin da muka koya game da rigakafi da kuma gano cutar, da kuma wasu muhimman tambayoyi.
An yi amfani da coronavirus a matsayin mai cutar da ba ta da cutar a cikin mutane kuma sun kasance sun haifar da kusan 15% na sanyi na yau da kullum.
Koyaya, a cikin karni na yanzu, mun haɗu da ƙwayoyin cuta na mutum sau biyu, SARS-CoV da MERS-CoV, waɗanda suka haifar da farkon annobar cutar a cikin 2003 a China da 2012 a Saudiyya, kuma a cikin ɗan gajeren lokaci sun faɗaɗa zuwa wasu ƙasashe, suna haifar da mummunan cututtuka da mutuwa.
Saboda haka, COVID-19 na yanzu shine annoba ta uku ta coronavirus a tarihin ɗan adam.
Kamar yadda aka nuna a Figure 1, an fara bayar da rahoton tarin cutar sankara da ba a bayyana asalinsa ba daga Wuhan zuwa Hukumar Lafiya ta Kasa ta kasar Sin a ranar 31 ga Disamba, 2019.
Kwanaki bakwai bayan haka, an gano cewa cutar ta kamu da cutar.
A ranar 15 ga Janairu, 2020, an fara samun rahoton wani abu na cutar foti daga Wuhan.
A halin yanzu, cutar ta bazu cikin sauri zuwa garuruwan makwabta, sauran larduna da ƙasashe.
A ranar 20 ga watan Janairu, an bayar da rahoton kamuwa da cutar ga ma'aikatan kiwon lafiya da kiwon lafiya, wanda ya nuna cewa za a iya watsa cutar daga mutum zuwa mutum.
A ranar 23 ga Janairu, an kammala killace birnin Wuhan, kuma an dakatar da zirga-zirgar jama'a a cikinta.
A ranar 24 ga watan Janairu, binciken farko na asibiti game da cutar ya ba da rahoton cewa daga cikin marasa lafiya 40 na musamman, kawai 21 ne suka yi tuntuɓar kai tsaye da kasuwar abincin teku ta Wuhan, inda cutar ta fara daga asalin dabba da ba a san shi ba.
A ranar 30 ga Janairu, Hukumar Lafiya ta Duniya ta bayyana cewa annobar ta zama dokar ta baci ta duniya.
Har zuwa lokacin da aka rubuta wannan rahoton, cutar ta bazu a duk faɗin China da kuma wasu ƙasashe 50 a duniya.
Tun da yanayin yana canzawa cikin sauri, dole ne a ƙayyade girman da kuma matsanancin cutar.
A ranar 11 ga Fabrairu, 2020, wani bincike da cibiyoyin bincike suka gudanar akan marasa lafiya 8,866 da suka kamu da cutar COVID-19 sun hada da marasa lafiya 4,021 da suka kamu da cutar ta COVID-19, sun nuna irin wannan annobar ta fi muni (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane na dukan shekaru, amma ya shafi mutane masu shekaru 65-30.
Kusan rabin (47.7%) na mutanen da suka kamu da cutar sun fi shekaru 50 da haihuwa, kuma kaɗan ne ke ƙarƙashin shekaru 20, kuma mutane 14 ne kawai ke ƙarƙashin shekaru 10.
SARS-CoV-2 ya fi kamuwa da maza (0.31 daga 100,000) fiye da mata (0.27 daga 100,000).
COVID-19 ya bazu a cikin tsari a Hubei da kewaye da shi.
Ana gano COVID-19 a matsakaici kwanaki biyar (kwana 9-2) daga lokacin da aka fara.
Matsakaicin tsawon lokacin da aka samu (7.2-3.0) shine kwanaki 4.8.
Matsakaicin lokacin daga farkon cutar zuwa mutuwa (13-4.8) ya kasance kwanaki 9.5.
Matsayin haɓaka na asali (R<sub>0</sub>) ya yi daidai da 3.77 (tare da iyakar tabbacin: 4.05-3.51) kuma daidaitaccen R<sub>0</sub> ya kasance 4.82-2.23.
Yawan masu kamuwa da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin da yawan fasinjoji ke ƙaruwa kafin bikin bazara a China.
Mutuwar marasa lafiya da aka tabbatar da ita ta kasance 1.44% (tare da tabbacin 95% daidai: 1.86-1.10) da kuma daidaitaccen mutuwar marasa lafiya da aka daidaita a duk marasa lafiya ya kasance 3.06% (tare da tabbacin 95% daidai: 4.59-2.02).
Babban manyan abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (shekaru 60 ko sama da haka) da kuma mummunan pneumonia.
Coronavirus suna cikin manyan ƙananan ƙwayoyin cuta masu ƙunshe da ke ƙunshe da keɓaɓɓen madaidaicin RNA.
An rarraba su cikin nau'i hudu, wato alpha, beta, gamma, da delta, wanda ya haɗa da kwayar cutar Alpha da beta.
Glycoprotein Spike (S) ya shafi ƙwayar cutar SARS-CoV da MERS-CoV, wanda ke haɗuwa da masu karɓar ƙwayoyin halitta da ake kira angiotensin-2 (ACE2) da dipeptideyl peptidase-4 (DPP4) da kuma haɗuwa da membrane na ƙwayoyin halitta.
Ana sakin kwayoyin RNA na kwayar cutar a cikin cytoplasm; bayan an haifi kwayoyin kwayar cutar, RNA na kwayar halitta tare da sutura na glycoproteins da nucleoacid proteins, suna samar da vesicles masu dauke da virion wanda aka haɗa tare da membrane na plasma, yana haifar da sakin sabon kwayar cutar.
An fara samun jerin kwayoyin halitta na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
Binciken ya nuna cewa SARS-CoV-2 wani sabon nau'in beta coronavirus ne wanda samfurori 10 da aka samu daga asalin wurin da aka samu a kasuwar abincin teku ta Hunan a Wuhan, sun yi kama da 99.98%.
Kwayar SARS-CoV-2 tana da kamanceceniya da SARS-CoV fiye da MERS-CoV.
An gano SARS-CoV-2 a cikin ƙananan ƙananan ƙananan epithelium na hanyar iska ta mutum ta hanyar binciken lantarki.
An san mutum ACE2 a matsayin mai karɓar cutar SARS-CoV-2 ko SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana da rauni a cikin haɗin kai zuwa mai karɓar ACE2 na mutum idan aka kwatanta da SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da rauni a cikin cutar idan aka kwatanta da SARS-CoV.
SARS-CoV-2 yana samar da sabon ƙaramin furotin da aka yi amfani da shi ta hanyar orf3b da kuma furotin mai narkewa da aka yi amfani da shi ta hanyar orf8.
Protein orf3b na SARS-CoV-2 yana da tasiri a cikin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
A ranar 18 ga Fabrairu, 2020, Zhou da abokan aikinsa sun ba da rahoton tsarin lantarki na micro-microscope na karɓar ACE2 na mutum tare da ƙuduri na 2.9 angstrom a cikin wani tsari tare da mai ɗaukar amino acid mai suna B0AT1.
Sun gano cewa wannan babban tsari wanda ke da tsari na budewa da rufewa, yana haɗuwa a matsayin dimer kuma za a iya haɗa ACE2-B0AT1 zuwa sunadarai S guda biyu wanda za a iya amfani da shi azaman ma'auni don ganowa da kamuwa da cutar coronavirus.
B0AT1 na iya zama manufa ta magani don tace magunguna don magance kamuwa da cutar SARS-CoV-2.
Tushen da kuma matsakaiciyar mai watsa shiri
An gano cewa SARS-CoV da MERS-CoV sun fito ne daga bats kuma sun kamu da su zuwa mutane ta hanyar cat cat Sanzbad da shitter, bi da bi.
An gabatar da tsutsotsi a matsayin babban mai masaukin SARS-CoV-2 ta hanyar kwatancen kwayoyin halitta na SARS-CoV-2 da sauran ƙwayoyin cuta, saboda sabon ƙwayar cuta ya kasance 96% kama da SARS-like coronavirus biyu daga bats da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, ko wane mai masaukin baki ya taimaka wajen shigar da cutar ta hanyar iyaka da kuma kamuwa da mutum, inda yake ba a sani ba kuma hanyar watsawa dole ne a bayyana a fili.
G da abokan aiki sun bayar da shawarar cewa macizai sun kasance masu ɗaukar kwayar cutar daga bats zuwa mutane ta hanyar haɗin homologous a cikin furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China sun bayar da shawarar cewa pangolin - tsalle-tsalle masu tsalle-tsalle masu tsalle-tsalle masu tsalle-tsalle da aka yi amfani da su a cikin maganin gargajiya na kasar Sin, suna da alaƙa da kwayoyin halitta na coronavirus da aka gano a cikin pangolin da SARS-CoV-2, wanda zai iya zama matsakaiciyar mai karɓar bakuncin SARS-CoV-2.
Duk da haka, bambancin 1% tsakanin kwayoyin halitta biyu yana da mahimmanci, saboda haka, ana sa ran samun sakamako mai kyau don tabbatar da daidaitattun shaidu (Figure 3).
Har yanzu ba a san yawancin halaye na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya tsira a cikin yanayin in-vitro na tsawon sa'o'i 48 a cikin yanayin bushe, tsawon lokacin yana zuwa kwanaki 5 a yanayin zafi ƙasa da digiri na 20 da zafi 50%-40%.
SARS-CoV-2 na iya samun irin wannan fasalin.
An ruwaito cewa SARS-CoV-2 yana da mahimmanci ga waɗannan sassan da zasu iya kashe cutar yadda ya kamata: hasken ultraviolet da kuma kasancewa a cikin zafin jiki na tsawon minti 30 a digiri na 56 na Celsius; ether, 75% ethanol, maganin rigakafi wanda ya ƙunshi chlorine, prostactic acid, chloropherm da sauran maganin mai, amma chlorhexidine ba shi da irin wannan damar.
Gabaɗaya, dukkanin mutane ba su da kariya ga SARS-CoV-2 kuma saboda haka suna da ƙarancin ƙwayar cutar.
A halin yanzu, babu wani binciken da ya ba da cikakken rahoton amsawar rigakafi ga SARS-CoV-2.
Saboda haka, zamu iya komawa ga binciken da aka yi a baya akan sauran ƙwayoyin cuta, musamman SARS-CoV da MERS-CoV (Figure 4).
A gabaɗaya, ana gano kwayar cutar bayan ta kai hari ga jikin mai masaukin baki, da farko ta hanyar tsarin rigakafin da ke cikin gidan mai karɓar kwayar cutar (PRRs) wanda ya haɗa da masu karɓar nau'in -C na semi-lactin, masu karɓar na semi-pass (TLR), masu karɓar na semi-NOD (NLR), da masu karɓar RIG-I (RLR).
Kwayar cutar tana motsa ayyuka daban-daban kamar bayyana abubuwan kamuwa da cuta, ƙwayoyin haƙori masu girma da kuma haɗin Interferon Type I (IFNs) wanda ke iyakance yaduwar cutar da hanzarta fashewar ƙwayoyin cuta na ƙwayar cuta ta hanyar macrofaz.
Koyaya, furotin N na SARS-CoV na iya taimakawa wajen ceton cutar daga amsawar tsarin rigakafi.
Za a yi amfani da maganin rigakafi mai dacewa don magance cutar nan ba da daɗewa ba.
T lymphocytes sun hada da CD4 + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Kwayoyin T na CD4<sup>+</sup> suna tayar da kwayoyin B don tayar da wasu kwayoyin rigakafi na cutar, kuma kwayoyin T na CD8<sup>+ </sup> kai tsaye suna lalata kwayoyin da suka kamu da cutar.
Kwayoyin T suna taimakawa wajen samar da cytokines masu kumburi don taimakawa kwayoyin da ke karewa.
Koyaya, coronavirus na iya hana aikin T cell ta hanyar haifar da apoptosis.
Tsarin rigakafin jini ya ƙunshi ƙwayoyin cuta na C3a da C5a, kuma antibodies suna da tasiri wajen magance kamuwa da cutar.
Alal misali, antibodies da aka cire daga mai haƙuri da ya warke sun hana MERS-CoV.
A gefe guda kuma, matsanancin martani na tsarin rigakafi yana haifar da samar da manyan adadin radicals na gida wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin jiki, kuma a mafi munin yanayin, rashin aiki na gabobin jiki har ma da mutuwa.
Ana iya kamuwa da cutar SARS-CoV-2, wanda shine fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashe.
Yana da kyau mutane da yawa da suka kamu da cutar ko kuma waɗanda ke da ƙarancin aikin rigakafi su sami damar kamuwa da cutar fiye da sauran mutane.
Matsakaicin matsakaicin tsawon lokacin da cutar SARS-CoV-2 ke ciki ya kasance daga 1 zuwa 14 kwanaki, wanda binciken farko na mutane 425 a Wuhan ya nuna cewa tsawon lokaci ya kasance daga 3 zuwa 7 kwanaki.
Koyaya, binciken da aka gudanar akan marasa lafiya 1,099 ya nuna cewa tsawon lokacin da aka samu na yau da kullun ya kasance na matsakaici na kwanaki 3 kuma ya bambanta daga kwana 0 zuwa 24.
Wani sabon binciken da aka ambata a sama, ya nuna tsawon lokacin da aka samu a cikin 4.8 (7.2-3.0) kwanaki, bisa ga binciken alƙaluma na marasa lafiya 8,866.
Yana da mahimmanci ga hukumomin lafiya su sanya lokacin killacewa mai inganci bisa ga tsawon lokaci don hana watsa cutar ga wasu da suka kamu da cutar amma ba su da alamun cutar.
A matsayinka na al'ada, dole ne a killace mutanen da suka kamu da cutar ko kuma waɗanda suka kamu da cutar na tsawon kwanaki 14.
Shin za a kara tsawon lokacin killacewa zuwa kwanaki 24?
Sau da yawa zazzabi shine babban alamar COVID-19 wanda zai iya faruwa shi kaɗai ko kuma tare da wasu alamomi kamar taurin kai, numfashi mai wuya, ciwon tsoka, ciwon kai, ciwon wuya, ciwon wuya, fitsari, ciwon kirji, tari, kyalkyali, naƙuda da kuma zubar da jini.
Wasu marasa lafiya sun sami rashin numfashi da kuma / ko rage yawan oxygen a cikin kayan bayan mako guda bayan fara cutar.
A cikin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Dole ne a yi wa marasa lafiya da zazzabi da/ko alamun numfashi da zazzabi mai tsanani, ko da ba su da wani abu mai ban mamaki a cikin hotunan ƙwayar cuta, rigakafin cutar don ganewar asali mai sauri.
Wani binciken binciken a ƙarshen Disamba 2019 ya nuna cewa kashi 98 cikin dari na alamun bayyanar cututtuka a cikin marasa lafiya sune: 98 cikin dari na zazzabi, 76 cikin dari na rashin ƙarfi, 55 cikin dari na numfashi, da kuma 3 cikin dari na tari; 8 cikin dari na marasa lafiya suna buƙatar taimakon iska.
An samu irin wannan binciken a cikin binciken biyu na baya-bayan nan a kan wani rukuni na iyali da rukuni wanda aka samu ta hanyar watsawa na mutane marasa alamar.
A matsayin kwatancen, wani binciken demographic a shekarar 2012 ya nuna cewa marasa lafiya na MERS-CoV sun kamu da zazzabi (98%), zazzabi mai bushe (47%) da kuma numfashi mai tsauri (55%) a matsayin manyan alamun cutar.
Koyaya, kashi 80% na waɗanda ke buƙatar taimakon numfashi, wanda ya fi na COVID-19 yawa, kuma ya dace da mafi girman mutuwar mutuwar da aka samu idan aka kwatanta da COVID-19.
An kuma lura da asphyxiation (26%) da ciwon wuya (21%) a cikin marasa lafiya da ke fama da cutar.
A cikin marasa lafiya da ke da SARS, an gano cewa manyan alamun cutar sun haɗa da zazzabi (kashi 99 zuwa 100%), rashin ƙarfi (kashi 29 zuwa 75%), numfashi mai wuya (kashi 40 zuwa 42%), kurkuku (kashi 20 zuwa 25) da ciwon wuya (kashi 13 zuwa 25%) kuma kimanin kashi 14 zuwa 20% na marasa lafiya suna buƙatar taimakon numfashi.
Har zuwa 14 ga Fabrairu, lokacin da aka tabbatar da cutar a duniya zuwa 66,576, yawan mutuwar COVID-19 a duniya ya kai 2%.
Don kwatanta, an tabbatar da mutuwar SARS zuwa watan Nuwamba 2002 a kashi 10% na marasa lafiya 8,096.
Game da MERS, bisa ga binciken demographic a watan Yuni na 2012, mutuwar da mutuwa ta kasance daidai da 37% na 2,494 marasa lafiya na musamman.
Wani binciken da aka yi a baya ya ruwaito cewa SARS-CoV-2 yana da tsayi mai yawa da 6.47 tare da nesa mai tabbata (CI) mai kama da 7.23 zuwa 5.71, yayin da SARS-Cov ya kasance kawai 2 zuwa 4.
Ana kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da bayyanar cututtuka, mutuwa da kuma <i>R</i><i><sub>0</i></sub> a cikin tebur 1.
Wadannan kididdigar sun nuna cewa SARS-CoV-2 na da damar yadawa fiye da MERS-CoV da SARS-CoV, amma yawan mutuwar da ke faruwa a cikin waɗannan ɓangarorin biyu ya fi ƙasa.
Saboda haka, sarrafa cutar SARS-CoV-2 yana da matukar kalubale fiye da MERS-CoV da SARS-CoV.
Ƙungiyoyi sukan fara ne daga cikin iyali ko al'umma ko kuma wata motar motsa jiki kamar jirgin ruwa.
Mutane da yawa suna da tarihin tafiya ko zama a Wuhan ko wasu wurare masu kamuwa da cutar ko sun kasance a cikin wata hanya ta makonni biyu kafin cutar ta fara.
Koyaya, an ruwaito cewa mutane na iya samun cutar har tsawon makonni biyu ba tare da bayyanar alamun cutar ba, kuma yana yiwuwa marasa lafiya da suka warke daga asibiti suna da ƙwayar cutar a cikin jiki, wanda hakan ya haifar da sanarwar faɗakarwa don ƙara tsawon lokacin keɓewa.
A farkon matakin, yawan fararen fararen fararen fata (musamman lymphocytes) a cikin marasa lafiya yana da kyau ko kuma yana raguwa.
Alal misali, an lura da lymphophony tare da ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Ƙarfin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
A cikin cututtukan da ke da mummunan cutar, matakan D-dimer, wanda shine sakamakon lalata fibrin a cikin jini, ya tashi kuma yawan lymphocytes na tuba ya ragu.
Ana samun rashin daidaito a cikin radiography na ƙirjin mafi yawan marasa lafiya na COVID-19 kuma yana ƙunshe da inuwa mai kama da inuwa ko kuma gilashin gilashin gilashi a cikin huhu.
Mutane sukan kamu da cutar pneumonia marar kyau, mummunan rauni na huhu, da kuma cutar ta numfashi mai tsanani (ARDS).
Lokacin da cutar ta rikitarwa ta numfashi ta faru, rashin kulawa da kumburi, tarin ruwa da kuma ci gaba da fibrosis, yana haifar da matsala mai tsanani ga musayar gas na numfashi.
Rashin aiki na huhu na nonocin jini yana rage yawan surfactant na farko da na biyu, kuma a sakamakon haka, ƙara yawan ƙarfin jiki, wanda ya rage ikon huhu don faɗaɗa kuma ya kara haɗarin bugun jini.
Saboda haka, mafi munin binciken radiography na ƙirjin ya dace da mafi munin cututtuka.
A ranar 18 ga Fabrairu, 2020, bincike na farko na pathological na COVID-19 ya gabatar da alamun da ke ƙasa: kyallen takarda na huhu, bayyanar gashin gashin gashi, ɓarkewar ƙwayar cuta ta gani, da kuma ganin ƙwayoyin cuta na sinus na jiki a cikin huhu na marasa lafiya da suka mutu daga cutar; alamun da suka dace da cututtukan cututtukan cututtukan cutar ta hanyar cutar da ARDS (acute respiratory dysfunction syndrome) kuma sun kasance kamar alamun marasa lafiya na SARS da MS.
An gano RNA na SARS-CoV-2 ta hanyar hanyar karkatar da polymerase transcriptase reverse chain reaction (RT-PCR) a matsayin babban ma'auni don gano COVID-19.
Duk da haka, saboda yawan ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigardigar ƙididdigar ƙididdigar ƙ ƙididdigar ƙididdigar ƙ ƙididdigar ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ
Akwai irin wannan yanayin a cikin binciken SARS.
Saboda haka, haɗuwa da tarihin cutar, zanga-zangar asibiti, gwaje-gwajen dakin gwaje-gwaje, da kuma binciken radiological yana da mahimmanci, kuma yana da mahimmanci don ganewar asali.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta gabatar da yarjejeniyar amfani da fasaha ta SHERLOCK bisa CRISPR don gano cutar SARS-CoV-2, inda za a iya gano RNA na SARS-CoV-2 a cikin girma na 10 × 20 moles a kowace lita zuwa 10 × 200 moles a kowace lita (100-10 kwafi a kowace shigarwa microl) ta hanyar sanda a ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai rikitarwa ba.
Ana fatan wannan sabuwar fasaha za ta iya inganta ƙoshin lafiya da jin dadi idan an tabbatar da shi a cikin samfurin asibiti.
Saboda rashin kwarewa game da sabon coronavirus, likitoci suna ba da kulawa ta musamman ga marasa lafiya na COVID-19, yayin da suke ƙoƙari su yi amfani da hanyoyin warkewa daban-daban waɗanda aka yi amfani da su ko kuma aka ba da shawarar don magance cututtukan da suka gabata na coronavirus, ciki har da SARS-CoV da MERS-CoV da sauran cututtukan cutar (tebur 2).
Wadannan magunguna sun hada da magunguna na tunani da na yiwuwar amfani da maganin rigakafi, masu hana rigakafin jiki, steroids, ingantaccen plasma, maganin kasar Sin da kuma goyon bayan tunani.
Har ma da amfani da plasma na marasa lafiya da aka inganta don magance sababbin marasa lafiya an ba da shawarar.
Kamfanonin magunguna suna gasa don samar da rigakafi da allurar rigakafi ga cutar.
Kwayar SARS-CoV-2 tana kai hari ga huhu da kuma wasu sassan sauran sassan masu karɓar ACE2, kamar tsarin narkewa da ƙwayoyin cuta.
Duk da haka, rashin ƙarfi da rashin numfashi sune babbar barazana ga marasa lafiya da kuma babban dalilin mutuwa.
Saboda haka, hanyoyin numfashi na taimako suna da mahimmanci don sauƙaƙe bayyanar cututtuka da kuma ceton rayukan marasa lafiya, kuma sun haɗa da maganin oxygen na yau da kullun, dogon oxygen, iska mai iska, da iska mai iska ta atomatik, dangane da yanayin cutar.
Marasa lafiya da ke fama da alamun numfashi mai tsanani dole ne a sanya su a ƙarƙashin Oxygenation of the Outer Membrane (ECMO), wani fasaha na gyare-gyare na baya-bayan zuciya wanda aka yi amfani da shi don magance rashin lafiyar zuciya ko numfashi mai mutuwa.
Bugu da ƙari, kula da daidaiton electrolytes, hanawa da kuma magance cututtuka na biyu da kuma cututtukan cututtuka da kuma kare ayyukan gabobin jiki masu mahimmanci suna da mahimmanci a cikin dangantaka da marasa lafiya da cutar SARS-CoV-2.
An tabbatar da cewa cytoquinine ya haifar da matsanancin tsarin rigakafi a cikin marasa lafiya da ke fama da cutar SARS da MS.
Cytoquin cytocin yana da nau'i na tsarin inflammatory wanda ya ƙunshi sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Wadannan cytokines suna sa kwayoyin rigakafi su saki radicals masu yawa, wanda shine babban dalilin ARDS da rashin dacewa na gabobin jiki.
Dakatar da tsarin rigakafi yana da mahimmanci a cikin maganin cytocin, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da corticosteroids da toshilizumab, wanda shine anti-IL6 anti-monoclonal antibody, don magance cytochrome cytocin.
Sauran hanyoyin magance rigakafi na rigakafi don Cytochrome Cytochrome sun hada da: T cell-controlled immune response modulation; IFN-γ, IL-1 da TNF inhibitors; JAK inhibitors; Blinatomump inhibitors; Cytochrome 4 siginar inhibitors; da kuma HDAC inhibitors.
Ana amfani da steroids a matsayin magungunan rigakafi na tsarin rigakafi a cikin maganin SARS tare da manufar rage yawan cutar ta cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Koyaya, steroids masu yawa ba su taimaka ba don warkar da mummunan rauni na ƙwayar cuta a cikin COVID-19 da SARS marasa lafiya.
Maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman ƙarancin ƙwayoyin ƙashi wanda ke shafar bayyanar cututtuka.
Duk da haka, ana bada shawara cewa a yi amfani da corticosteroids a ƙananan zuwa matsakaici sashi don magance marasa lafiya na COVID-19 da ke cikin mawuyacin hali, tare da kulawa ga gajere.
A lokacin rubuce-rubuce, ba a tabbatar da wani maganin rigakafin cutar da ya dace ba.
Duk da haka, an samu wani sakamako mai kyau a cikin wani mai haƙuri na Amurka da ke fama da COVID-19, wanda shine wani nau'i na nucleotide.
RMSware sabon maganin rigakafi ne wanda Gilead ta haɓaka kuma ya kasance da niyyar magance cututtukan da ke haifar da ƙwayoyin cuta na Ebola da Marburg.
Daga baya, an gano cewa remdesivir na iya haifar da hanawa ga sauran kwayoyin RNA guda ɗaya, ciki har da kwayar cutar Mars da SARS.
A cewarsa, Gilead ta ba da wannan cakuda ga kasar Sin don gwada gwaji na asibiti guda biyu a kan kwayoyin da suka kamu da cutar SARS-CoV-2, kuma sakamakon ya kasance daidai da abin da ake tsammani.
Bugu da ƙari, an yi amfani da baricetinib, interferon alfa, lupinevir/retonavir, da ribavirin a matsayin magani mai yiwuwa don magance marasa lafiya da ke fama da alamun numfashi mai tsanani.
Ƙarƙashin zuciya, naƙasa, zubar da jini, lalacewar hanta da sauran abubuwan da ba a so na iya faruwa bayan maganin hadewa da Lupinovir/Retinavir.
Dole ne a bincika hulɗar da ke tsakanin wannan magani da sauran magungunan da mai haƙuri ke amfani da su.
Plasma daga marasa lafiya ya warke kuma ya samar da rigakafi
Tattara jini daga marasa lafiya da suka warke daga wata cuta mai yaduwa yana da babban burin magance sauran marasa lafiya da ke fama da wannan cuta ko kuma kare mutane masu lafiya daga kamuwa da cuta mai yaduwa.
A gaskiya ma, marasa lafiya da suka warke sukan sami matakan antibodies masu yawa don magance cutar a cikin jinin su.
Magunguna ne na immunoglobulin (Ig) wanda ake samarwa ta hanyar B lymphocytes don yaki da cututtuka da sauran ƙwayoyin waje waɗanda ke gano kwayoyin da ke cikin cututtuka kuma suna hana su kai tsaye.
Bisa ga wannan, an tattara plasma daga wani rukuni na marasa lafiya da suka warke daga COVID-19 kuma an yi musu allurar rigakafi ga marasa lafiya 10.
A cikin sa'o'i 24, an sami bayyanar cututtukan su sun warke kuma an sami raguwar kumburi, rage nauyin kwayar cutar da ingantaccen oxygen a cikin jinin su.
Koyaya, bayar da shawarar wannan hanyar don amfani a kan sikelin girma kafin a samar da wasu hanyoyin magani, yana buƙatar ƙarin amincewa da kuma bayyanawa game da shi.
Bugu da ƙari, a cikin maganin, dole ne a kula da rashin amfani da maganin plasma.
Alal misali, antibodies na iya motsa amsawar rigakafi ta hanyar wuce kima kuma ya haifar da cutar cytokine wanda zai iya haifar da cutar mai kisa.
Yawan antibody a cikin jini yawanci yana da ƙananan kuma yana da mahimmanci don maganin mutane masu cutar da yawa.
Ci gaba da samar da takamaiman rigakafi a cikin lokaci mai sauri yana da wuya a magance cututtukan duniya.
Saboda haka, rarraba kwayar B daga marasa lafiya ya inganta kuma gano kwayoyin halitta da ke ba da lambar antibodies masu tasiri ko tacewa don antibodies masu tasiri akan sunadarai masu tasiri na kwayar cutar ya zama mafi mahimmanci da aiki.
Wannan zai iya sauƙaƙe samar da rigakafi.
An yi amfani da maganin gargajiya a kasar Sin don magance cututtuka da yawa na shekaru dubbai.
Duk da haka, tasirinsa ya dogara ne da haɗuwa da wasu abubuwa na musamman na dabara guda ɗaya wanda ya dogara da gano cutar bisa ka'idodin maganin gargajiya na kasar Sin.
Yawancin abubuwan da ke aiki ba a sani ba ko kuma ba a fahimta ba saboda yana da wuya a gano da kuma tabbatar da waɗannan abubuwan ko haɗin da suka dace.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, ana ɗaukar TCM (farfadowar gargajiya ta kasar Sin) a matsayin ɗayan manyan magungunan maye gurbin marasa lafiya tare da bayyanar cututtuka masu sauƙi da matsakaici ko waɗanda suka warke daga matakan tsanani.
Alal misali, an lura cewa Shu Feng Jie Du da Lian Hua Qing Wen sun kasance masu tasiri wajen magance COVID-19.
Mafi yawan yawan yawan cututtukan COVID-19 a larduna da dama na kasar Sin inda aka yi amfani da maganin gargajiya na kasar Sin ga kashi 87 cikin dari na marasa lafiya, ciki har da: Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei inda aka yi amfani da maganin gargajiya na kasar Sin ga kimanin kashi 30 cikin dari na marasa lafiya na COVID-19 ne kawai, ya samu mafi ƙasƙanci na dawo da cutar (da kashi 13).
Duk da haka, wannan kwatanta ce mai wuya, saboda akwai wasu dalilai masu tasiri da yawa da za a yi la'akari da su a cikin kimantawa, kamar yawan marasa lafiya da kuma tsanani.
A ranar 18 ga Fabrairu, 2020, Bolly Zhang da abokan aikinsa sun buga wani bincike inda suka kwatanta maganin gargajiya na yammacin duniya (WM) da maganin gargajiya na gargajiya na kasar Sin.
Sun gano cewa lokacin da ake bukata don dawo da zafin jiki zuwa yanayin da ya dace, warware cututtuka da kuma shiga asibiti a cikin rukuni na gargajiya na gargajiya na kasar Sin ya kasance ƙasa da na yammacin rukuni kawai.
Abin sha'awa, yawan cututtukan cututtuka (daga mai sauƙi zuwa mai tsanani) a cikin rukunin WM+TCM (Ma'aikatar gargajiya ta kasar Sin+Ma'aikatar Yammacin Turai) ya kasance ƙasa da na yammacin Turai kawai (7.4% da 46.2%), kuma yawan mutuwar da mutuwa a cikin ƙungiyar gargajiya ta yamma +Ma'aikatar Yammacin Turai ya kasance ƙasa da na yammacin Turai kawai (8.8% da 39%).
Duk da haka, ana buƙatar kimanta inganci da amincin maganin gargajiya na kasar Sin ta hanyar gwaji mai zurfi a kan sikelin da yawa da kuma cibiyoyi masu yawa.
Yin ƙoƙari don gano yadda aikin yake aiki da kuma gano abubuwan da ke cikin hanyoyin gargajiya na maganin gargajiya na kasar Sin, ko kuma a duk inda zai yiwu, haɗuwa da su yana da ban sha'awa da kuma jan hankali.
Masu kamuwa da cutar COVID-19 da ake zargi ko kuma suka tabbatar da cutar suna fuskantar tsoro na cutar mai yawa, har ma da kisa, kuma waɗanda aka killace suna fama da rashin ƙarfi, kadaici da fushi.
Bugu da ƙari, cututtuka na iya haifar da zazzabi, rashin iskar oxygen, da kuma tari, da kuma sakamako masu illa na maganin, kamar rashin barci na corticosteroid, damuwa da rashin jin dadi.
A farkon farkon SARS, an bayar da rahoton yanayin rashin lafiyar hankali da ya haɗa da ci gaba da damuwa, damuwa, tashin hankali da firgici, tashin hankali na motsi, alamun rashin hankali, rikicewar tunani, har ma da son kashe kansa.
Kula da tuntuɓar da kuma killacewa na wajibi, a matsayin wani ɓangare na amsawar lafiyar jama'a ga yaduwar COVID-19, na iya haifar da damuwa da jin laifi a cikin al'ummomin da ke fama da cutar dangane da tasirin yin rajista, killacewa da kuma matsalar matsayi ga iyalai da abokai.
Saboda haka, dole ne a samar da kulawar lafiyar hankali ga marasa lafiya na COVID-19, masu zargin da kuma wadanda suka tuntube su, da kuma jama'a da ke bukatar wannan sabis ɗin.
Taimakon ilimin halayyar mutum ya kamata ya ƙunshi kafa ƙungiyoyin kula da lafiyar mutum tare da ƙwarewa da yawa, sanarwar gaskiya tare da cikakken bayani game da yaduwar SARS-CoV-2, da shirye-shiryen magani tare da amfani da na'urorin lantarki da aikace-aikacen magana don hana kusanci da wasu.
Alluran rigakafi masu tasiri suna da mahimmanci don yanke sarkar watsawa daga ɗakunan ajiyar dabbobi da kuma ƙwayar mutum mai cutar zuwa masu karɓar baƙi masu mahimmanci kuma galibi suna ba da maganin rigakafin cutar a cikin sarrafa cututtukan da ke haifar da ƙwayoyin cuta masu tasowa.
An yi ƙoƙari don samar da alluran rigakafi na tushen furotin S don samar da rigakafi masu aiki na dogon lokaci da ƙarfin hanawa da / ko rigakafin kariya daga SARS-CoV.
An gwada alluran rigakafin rai a cikin samfurin dabba don SARS.
Koyaya, kafin a fara binciken asibiti, dole ne a ƙayyade ingancin in-vivo na waɗannan masu neman allurar rigakafi a cikin ƙwayoyin cuta da kuma samfurin da ke mutuwa da kuma kare su daga kamuwa da cutar cutar Xenoptera.
Wannan yana iya faruwa ne saboda SARS ya ɓace shekaru 17 da suka gabata kuma ba a sami sabon ɓoye ba tun daga wannan lokacin.
A akasin haka, an lura da ɓangarori na musamman da kuma ƙididdigar ƙwayoyin cuta a Gabas ta Tsakiya, kuma suna faɗaɗa zuwa wasu yankuna saboda ci gaba da albarkatun zeonones a yankunan asali.
An kirkiro dabarun yin allurar rigakafi ta amfani da kwayar cutar mara aiki, plasmids na DNA, vectors na kwayar cutar, nanoparticles, ƙwayoyin cuta na ƙwayoyin cuta da kuma subunits na furotin na nutrikeb don Mars kuma an gwada su a wasu sassan a kan samfurin dabba.
Samar da wani rigakafi mai lafiya da tasiri akan SARS-CoV-2 ga mutanen da ba su da kariya daga cutar, abu ne na gaggawa da kuma gaggawa don sarrafa ci gaban annobar.
Duk da haka, magance wannan matsalar yana da wuya saboda dogon lokaci da ake buƙata don tsarawa da samar da allurar rigakafi (tsakanin watanni 18) da kuma canjin canjin coronavirus.
A matsayin sabon cuta, COVID-19 kwanan nan ya fara bayyana a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya suna warkewa a hankali, ba tare da wani sakamako mai illa ba.
Koyaya, kamar SARS da MS, COVID-19 yana da alaƙa da rashin lafiya mai yawa da mutuwa a cikin ɓangarorin da ke fama da mummunan yanayin cutar.
Saboda haka, tsara samfurin sanarwa na cutar yana da mahimmanci ga kungiyoyin kiwon lafiya masu kulawa don fifita ayyukan su, musamman a yankunan da ke da iyakanceccen albarkatu.
Bisa ga binciken asibiti da aka gudanar har yanzu, waɗannan dalilai na iya shafar ko kuma danganta da ganowar COVID-19:
Shekara: Shekara ita ce mafi mahimmancin sanarwa game da cutar SARS, kamar yadda yake a cikin COVID-19.
COVID-19 yana faruwa ne a cikin shekaru 65-30, wanda ya shafi kashi 47.7% na mutanen da suka wuce shekaru 50 a cikin binciken da ya shafi marasa lafiya 8,866, wanda aka bayyana a sama.
Marasa lafiya da ke bukatar kulawa ta musamman sun fi fuskantar cututtukan zuciya da cututtukan baya kuma sun fi tsufa fiye da marasa lafiya da ba su buƙatar kulawa ta musamman (tare da matsakaicin shekaru 66 zuwa 51), kuma wannan yana ba da shawarar cewa ana iya ɗaukar shekaru a matsayin sanarwa na sakamakon marasa lafiya da COVID-19.
Jima'i: Kamar yadda aka ambata a sama, SARS-CoV-2 ya kamu da maza fiye da mata (0.31 cikin 100,000, idan aka kwatanta da 0.27 cikin 100,000).
Cututtuka da cututtuka: Marasa lafiya da ke da cutar COVID-19 da ke buƙatar kulawa ta musamman suna da mafi kusantar samun rauni mai tsanani ko bugun zuciya.
Har ila yau, cututtukan zuciya sun kasance babban dalilin mutuwa a cikin marasa lafiya da ke fama da cutar ta SARS.
An ruwaito cewa SARS-CoV-2 na iya haɗuwa da Clanchocytes na ACE2-mai kyau wanda zai iya haifar da rikicewar hanta a cikin marasa lafiya COVID-19.
Ya kamata a lura cewa shekaru da cututtuka suna da dangantaka mai ƙarfi kuma suna iya yin hulɗa.
Abubuwan da aka gano a dakin gwaje-gwaje ba su da kyau: matakin furotin C mai amsawa a cikin jini yana nuna girman ƙonewa ko lalacewar ƙwayar cuta kuma an ba da shawarar cewa yana da mahimmanci a matsayin mai gano cutar, amsawa ga magani da kuma kyakkyawan farfadowa.
An bayar da shawarar cewa akwai alaƙa tsakanin matakin CRP da tsanani da kuma farkon COVID-19.
Bugu da ƙari, ƙaruwar matakan lactate dehydrogenase (LDH), aminotransferase aspartate (AST), aminotransferase alanine (ALT), da kuma creatine kinase (CK) na iya zama tasiri a cikin hasashen sakamakon.
Wadannan enzymes suna bayyana sosai a cikin wasu kayan jiki, musamman a zuciya da hanta, kuma suna saki lokacin da aka lalata kayan.
Saboda haka, suna da alamun gargajiya don gano cututtukan zuciya ko hanta.
Babban alamun asibiti: Don yin hasashen sakamakon da kuma sakamakon COVID-19, dole ne a yi la'akari da radiography na ƙirjin da ci gaban alamun asibiti tare da sauran abubuwan da suka shafi.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids sune masu hana rigakafin jiki waɗanda aka saba amfani da su azaman ƙarin magani don rage yawan cutar ta ƙonewa a cikin yaki da cututtuka masu yaduwa.
Tun da ake amfani da manyan allurai na corticosteroids a cikin marasa lafiya masu cutar SARS, yawancin waɗanda suka tsira daga ƙarancin jini na ƙarancin ƙwayoyin ƙashi suna fama da rashin ƙarfi na dogon lokaci da rashin ingancin rayuwa.
Saboda haka, idan ya zama dole, ya kamata a yi amfani da steroids a ƙananan sashi kuma a cikin gajeren lokaci ga marasa lafiya COVID-19.
Rashin damuwa: Kamar yadda aka bayyana a sama, a sakamakon barkewar cutar COVID-19, mutane da yawa sun sami damuwa sosai saboda yawanci an tilasta musu yin tsawan lokaci a cikin killace, suna da shakku da kuma shakku game da abubuwan da suka faru a baya, kuma sun ga mutuwar danginsu ko abokai na kusa.
Bayar da shawarwari na tunani da kuma goyon baya na dogon lokaci yana da mahimmanci don taimakawa waɗannan marasa lafiya su kawar da damuwa da komawa rayuwa ta al'ada.
A cewar binciken demographic da aka gudanar har zuwa yanzu, COVID-19 yana da halaye daban-daban na cutar idan aka kwatanta da SARS.
SARS-CoV-2 yana iya yin aiki sosai a cikin iska ta ƙasa, kamar sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Saboda haka, marasa lafiya masu kamuwa da cutar a farkon lokaci ko kuma a cikin lokaci mai tsawo na iya samar da ƙwayoyin cuta masu yawa a yayin ayyukan yau da kullun, wanda ke haifar da matsaloli masu yawa don sarrafa cutar.
Koyaya, binciken ya nuna cewa an watsa SARS-CoV lokacin da marasa lafiya ke cikin mawuyacin yanayin cutar, don haka yawancin ɓangarorin ba su faru a farkon matakin ba.
Saboda haka, cutar COVID-19 ta yanzu ta fi haɗari da kuma rikitarwa fiye da cutar SARS.
Ana yin kyakkyawan ƙoƙari a China, wanda ya haɗa da ƙarin sarrafawa da fita zuwa Wuhan da garuruwan da ke makwabtaka da kuma keɓe kusan dukkanin jama'a a cikin fatan a yanke sarkar watsa SARS-CoV-2.
Duk da cewa wadannan matakan sun yi mummunan illa ga tattalin arziki da sauran sassan kasar, adadin sabbin cututtuka na raguwa, wanda ke nuna jinkirin annobar.
Mafi kyawun hasashen shine cewa cutar za ta ƙare a watan Maris kuma za a ɗauki watanni 3 zuwa 4 don nazarin yanayin.
Duk da haka, wasu masana ba su da kyakkyawan fata.
Paul Hunter da abokan aikinsa sun kiyasta cewa cutar COVID-19, wadda ta fi cutar SARS yawa, ba za ta ƙare ba a shekarar 2020.
Ira Langini da abokan aiki sun tsara samfurin don hango ko hasashen sakamakon annobar, kuma sun ba da shawarar cewa cutar SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan duniya.
Wani rukuni na Kanada ya ruwaito cewa an gano cutar SARS-CoV-2 a cikin jerin samfurori biyu na nasal-glow swabs a cikin marasa lafiya da suka warke daga asibiti makonni 2 kafin a bar su.
Duk da haka, a cikin ƙarancin adadin sababbin cututtuka, wanda ke nufin yiwuwar nasarar dabarun da ake amfani da su a yanzu, akwai kyakkyawan hangen nesa a China.
Da farko an yi hasashen cewa cutar ta kamu da mutane miliyan daya kuma ta kashe mutane miliyan rabin.
Duk da haka, ta hanyar killacewa da kuma warewa, cutar ta ƙare a cikin iko.
Yana iya zama kamar SARS-CoV, SARS-CoV-2 zai iya zama mai rauni kuma a ƙarshe ya ɓace ko kuma ya zama ƙarancin ƙwayoyin cuta na mutum wanda ke rayuwa tare da mutane.
Ana kwatanta cutar COVID-19 da SARS da MS a ƙasa (Figure 5).
SARS-CoV-2 yana da tsananin ƙwayar cutar ta hanyar hawan jini ko ƙishirwa kuma yana iya yadawa ta hanyar kai tsaye zuwa kwayar cutar.
An kuma gano cutar a cikin kwayoyin halitta, wanda ya kara yiwuwar sabon kamuwa da cutar daga kwayoyin halitta.
Wani binciken da aka yi kwanan nan a kan marasa lafiya 138 ya ba da rahoton cewa mai yiwuwa kashi 41 cikin dari na mutane sun kamu da cutar ta hanyar kamuwa da cutar asibiti, wanda ya haɗa da marasa lafiya 17 da ke fama da wasu cututtuka da kuma 40 na ma'aikatan kiwon lafiya.
Saboda haka, dole ne a yi taka tsantsan sosai don kare mutane, musamman ma ma'aikatan kiwon lafiya, masu aikin agaji, 'yan uwa, abokan aiki, har ma da masu ziyarar marasa lafiya masu kamuwa da cutar ko mutane masu kamuwa da cutar.
Hanya ta farko da za a iya karewa don rage haɗarin kamuwa da cuta ita ce ta yin amfani da abin rufe fuska; yin amfani da duka nau'ikan masks na tiyata da kuma N95 masks na numfashi (series na 1860s) yana taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na tiyata suna hana iska ta watsa saukad da ruwa na numfashi daga ƙwayoyin cuta masu cutarwa zuwa wasu ko kuma su haɗa waɗannan saukad da zuwa saman kayan sannan kuma su wuce zuwa wasu.
Duk da haka, yin amfani da N95 masks (number na 1860s) zai iya kare numfashi daga masu cutar da ke cinyewa daga 10 zuwa 80 nanometers, wanda zai iya taimakawa wajen samun damar shiga cikin kashi 5% na masu cutar; SARS-CoV-2 yana da girman kama da SARS-CoV kuma girman duka biyu kusan 85 nanometers ne.
Tun da za a iya yin amfani da ƙwayoyin cuta a tsakanin fuskokin tiyata guda biyar, masu ba da sabis na kiwon lafiya da ke cikin haɗuwa kai tsaye da marasa lafiya dole ne su yi amfani da N95 (serial number 1860s) kuma su guji saka fuskokin tiyata.
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya da kiwon lafiya dole ne su sanya gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin gashin.
Hakanan ƙwayoyin cuta na iya kamuwa da mutum ta hanyar ido.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 yayin da yake rufe fuskar N95, mai yiwuwa ya shiga jikinsa ta hanyar cutar idanunsa.
Saboda haka, masu ba da sabis na kiwon lafiya na kulawa dole ne su yi amfani da takardun fuska masu tsabta ko tabarau yayin kula da marasa lafiya.
Don kiyaye lafiyar jama'a a wuraren da ke da cutar ko kuma waɗanda ke da yiwuwar kamuwa da cutar, ana ba da shawarar cewa mutane su wanke hannayensu da sabulu mai hana kamuwa da cutar fiye da yadda aka saba, su sanya kansu a cikin keɓewa, su zauna a gida, kuma su rage tuntuɓar waɗanda za su iya kamuwa da cutar.
Matsakaicin nisa da mutane zasu kasance tare da marasa lafiya shine ƙafa uku.
Wadannan matakan suna da tasiri wajen ragewa da kuma hana yaduwar cutar.
Ko da yake an san cutar SARS-CoV-2 a matsayin sabon cutar da ta fara bayyana a duniya, babban kamanceceniya da SARS-CoV da aka ruwaito a ranar 7 ga Janairu 2020 ya zama babban gargadi ga China, yana ba da labarin barkewar cutar SARS a shekara ta 2003.
Duk da haka, ba a yi wani ƙoƙari na samar da kwanciyar hankali ba har zuwa 19 ga Janairu, 2020, ranar da shugaban Cibiyar Kula da Cututtuka ta Wuhan ya sanar da cewa sabon kwayar cutar tana da iyakanceccen ikon watsawa da tasiri ga mutum, kuma yana da damar hana cutar.
Wannan sakon ya sa aka yi watsi da gargadin jama'a, musamman a yayin da kasar ta shirya bikin bikin bazara na sabuwar shekara, kuma ta haka ne ta rasa babbar dama don hana yaduwar cutar a Wuhan.
Cibiyoyin kula da cututtuka a China na iya ɗaukar wannan darasi mai wuya kuma suna yin manyan ci gaba don matakan gaba.
Alal misali, waɗannan kungiyoyi dole ne su (1) yi hankali sosai wajen sanar da jama'a saboda duk wani abu da suka bayyana zai iya shafar jama'a kuma ya canza halayensu da shawarwarin su; (2) su kasance masu saurin amsawa ga bayanan da ba na kowa ba daga asibitoci, maimakon su jira rahotanni na hukuma ko jami'an da ke da alhakin; (3) su yi aiki sosai don hana yiwuwar barkewar cutar a farkon matakan ba don kiran jama'a su kwantar da hankula ba; (4) su ci gaba da samar da tabbataccen, ingantaccen bayani ga jama'a don ƙara wayar da kan jama'a game da cutar, da kuma ci gaba da gwadawa da inganta tsarin amsawar jama'a.
Cutar COVID-19, wanda sabon kwayar cutar SARS-CoV-2 ta haifar, ta fara ne daga ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, cutar ta bazu ko'ina cikin kasar Sin kuma a yanzu haka, a cikin wasu ƙasashe 50 a duniya.
Tun da yake cutar ta yi kama da SARS-CoV kuma alamun COVID-19 da SARS suna kama, barkewar COVID-19 ta haifar da tunanin cewa SARS ya dawo.
Duk da haka, akwai bambance-bambance da yawa tsakanin COVID-19 da SARS waɗanda ke da mahimmanci don hana cutar da kuma kula da marasa lafiya.
COVID-19 yana shafar tsofaffi da maza fiye da matasa da mata, kuma yana da ƙarancin mutuwa a cikin yara fiye da matasa.
Yawan mutuwar SARS ya fi na COVID-19 girma (kashi 10.91 da 1.44%).
Masu kamuwa da cutar COVID-19 suna kamuwa da cutar ko da ba su da alamun cutar, yayin da masu cutar SARS yawanci suna kamuwa da cutar a lokacin da cutar ta fi tsanani, saboda haka hana yaduwar COVID-19 ya fi wuya fiye da SARS.
Wannan ya bayyana dalilin da ya sa SARS-CoV-2 ya yada da sauri kuma a mafi girma fiye da SARS-CoV.
A wasu marasa lafiya na COVID-19, ana iya yin gwajin RNA na yau da kullum don gano cutar SARS-CoV-2 tare da sakamako mara kyau.
A gefe guda kuma, marasa lafiya da suka warke za su iya sake kamuwa da cutar.
Wadannan binciken sun kara hadarin yaduwar cutar sosai.
Ganin wannan saurin ci gaba a bincike kan COVID-19, har yanzu akwai wasu muhimman batutuwa da ba a warware ba, ciki har da:
Daga ina cutar SARS-CoV-2 ta fito?
Ko da yake an gano kashi 96% na kamanceceniya tsakanin SARS-CoV-2 da kuma cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Wane dabba ne ya kasance matsakaici don watsa kwayar daga mahaifarsa na farko, wato, kwari zuwa mutum?
Ba tare da sanin amsoshin tambayoyi 1 da 2 ba, ba za mu iya yanke sarkar watsawa yadda ya kamata ba, kuma za a iya sake barkewar cutar a kowane lokaci.
Ko da yake ƙirar kwayoyin halitta da kimantaccen halittu sun nuna cewa SARS-CoV-2 yana haɗuwa da mai karɓar ACE2, ta yaya ainihin cutar ta shiga cikin ƙwayoyin iska kuma ta samar da yanayin canjin cututtuka?
Shin kwayar cutar tana haɗuwa da ƙwayoyin ACE2 a cikin sauran gabobin?
Har sai an amsa waɗannan tambayoyin a fili, ba za mu iya samun hanyar ganewa da sauri da kuma ingantacciyar magani ba.
Har yaushe cutar za ta kasance?
Ta yaya kwayar cutar ke samo asali yayin da ake watsawa tsakanin mutane?
Shin zai zama annoba ta duniya, kamar SARS, ko kuma ya sake fashewa kamar mura?
Neman amsar wannan tambaya da kuma wasu tambayoyi da yawa yana da mahimmanci amma yana iya ɗaukar lokaci.
Koyaya, duk da kuɗin da ake buƙata, zaɓinmu na gaba shine dakatar da cutar da wuri-wuri kuma mu dawo da rayuwa zuwa al'ada.
Tushen dabbobi na kwayar cutar coronavirus ta mutum
Tun shekaru dubbai, motsi da daidaitawa sun taimaka wajen haɓaka coronavirus (CoVs) da masu masaukin su, gami da mutane.
Kafin 2003, an san cewa cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttuk
Cutar cutar ta SARS da ta MERS ta haifar da lalacewar cutar ta cutar ta coronavirus a cikin mutum.
Fitowar SARS-CoV-2 a tsakiyar China a ƙarshen 2019, ya sake jawo hankalin masu cutar coronavirus kuma ya ba mu mamaki game da yiwuwar watsawa mai tsawo, amma yana da ƙananan cututtuka idan aka kwatanta da ɗan'uwansa SARS-CoV.
Cutar kwayar cutar korona ta mutum tana da asalin dabba (zoonosis) kuma gano asalin dabba na kwayar cutar korona na mutum na iya taimaka mana sosai.
Yawancin cututtukan cututtukan mutum suna farawa daga bats, wadanda ba su da cutar.
An kuma san wasu masu karɓar bakuncin tushen tushen wasu cututtukan mutum.
Gano dabbobi masu gida kai tsaye yana taimakawa wajen hana cututtukan mutum.
Binciken game da hulɗar da masu karɓar bakuncin coronavirus a cikin dabbobi na iya ba mu bayanai masu mahimmanci game da yiwuwar kamuwa da cutar a cikin mutane.
A cikin wannan binciken, za mu ba da cikakken bayani game da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
Mafi mahimmanci, muna kwatanta da kuma magance cututtukan mutum daban-daban daga ra'ayi na juyin halitta na kwayar cutar da kuma tsarin kwayoyin halitta.
Ana tattauna cutar coronavirus ta 2019 (COVID-19) a cikin wannan mahallin.
Bugu da ƙari, yanayin da ake bukata don samun nasarar canja wurin tsakanin masu masauki da kuma bayyanar cututtukan ci gaban cutar da ke da matsanancin cutar sun zama abin lura.
Coronavirus (CoVs) suna cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na RNA mai ɗaukar hoto mai ɗauke da madaidaicin madaidaicin abu.
"Kasuwancin, wanda ya fi girma a cikin jinsin 26 zuwa 32 kilobisi tsakanin kwayoyin RNA, sun zama masu guba saboda yanayin kirjin su kamar su a karkashin lantarki na lantarki, ""CoVs (coronavirus) "" ko kuma kwayar cutar kambi. "
A tsarin, coronavirus suna da kwayoyin halitta guda ɗaya waɗanda ke da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta, ciki har da sassan karatu biyu masu buɗewa (ORF1a da ORF1b), suna fassara zuwa kwafin pp1a da pp1ab polyprotein.
Ana ƙara sarrafa polyproteins don samar da furotin 16 na ba-sarrafawa, wanda aka sanya su nsp1 zuwa 16.
Abubuwan da suka rage na kwayoyin halitta sun hada da ORFs don sunadarai na tsarin, ciki har da spike (S), ƙwayar cuta (E), membrane (M), da nucleoprotein (N).
Wasu sunadarai na musamman na lineage suna ƙidaya ta hanyar nau'ikan nau'ikan coronavirus.
Saboda bambancin da ke cikin jerin sunadarai, ana rarraba coronavirus zuwa nau'i hudu (Alpha coronavirus, beta coronavirus, gamma coronavirus, da Delta coronavirus) kuma a cikinsu, jinsin beta coronavirus ya ƙunshi yawancin ƙwayoyin cuta na mutum kuma an rarraba shi zuwa ƙananan ƙananan nau'i hudu (A, B, C, da D).
Shaidar ilimin halittu ta nuna cewa bats da jellyfish suna aiki a matsayin tushen kwayoyin halitta na yawancin alpha da beta coronavirus, yayin da tsuntsaye sune babban ajiyar cutar gamma da delta coronavirus.
A cikin dubban shekaru, coronavirus sun ci gaba da ƙetare ƙuntatawa, wasu sun bayyana a matsayin manyan cututtukan mutum.
Har zuwa yau, an gano nau'ikan coronavirus guda bakwai na mutum.
Daga cikin su HCoV-229E da HCoV-NL63 sune na alpha coronavirus.
Sauran nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da bayyanar cututtuka masu sauƙi kamar faduwa na yau da kullun da/ko tari.
A gefe guda, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano kwanan nan suna da cututtuka masu yawa kuma suna haifar da kamuwa da cututtukan iska mai tsanani a cikin marasa lafiya da yawa, wanda ke ƙara yawan haɗarin kamuwa da cutar ta hanyar numfashi mai tsanani (ARDS) da kuma zanga-zangar waje.
HCoV-229E na farko, wato B814, ya rabu da mucus na marasa lafiya da suka kamu da cutar a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bayani ta hanyar gudanar da bincike mai zurfi akan HCoV-229E da HCoV-OC43, wanda duka biyu ke haifar da alamun kai-kai.
A gaskiya ma, kafin barkewar cutar SARS, an yarda da cewa kamuwa da cutar coronavirus na mutum ba shi da lahani gaba ɗaya.
Cutar SARS a shekara ta 2003 na daya daga cikin cututtukan zamani mafi muni, inda fiye da mutane 8,000 suka kamu da cutar kuma mutuwar ta kai kusan 10%.
Shekaru goma bayan haka, cutar ta ciwon kumburi ta tsakiyar gabashin (MERS) ta haifar da ci gaba da yaduwar cutar a yankin Saudiyya, kuma an yada wasu lokuta na rare a sauran sassan duniya.
Sabon cutar coronavirus ta 2019 (COVID-19) (wanda aka sake suna da SARS-CoV-2), shine dalilin da ya sa cutar ta COVID-19 ta ci gaba da yaduwa, kuma ya kashe mutane 3,120 zuwa 3 ga Maris, 2020 kuma ya kamu da fiye da 91,000.
An yi gargadi kuma dole ne duniya ta shirya don cutar ta SARS-CoV-2.
Dukkanin nau'ikan cutar korona na mutum guda bakwai sun fito ne daga dabbobi kamar bats, beraye da dabbobi masu gida.
Akwai shaidu da yawa da suka tabbatar da cewa dukkanin cututtukan coronaviruses na mutum sun samo asali ne daga bats, inda ƙwayoyin cuta suka dace sosai amma ba su da pathogenic kuma suna da babban bambancin kwayoyin halitta.
Cutar COVID-19 ta kawo manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da kuma ɗabi'a ga kasar Sin da kuma duniya.
Gano asalin dabbobi na kwayar cutar korona na mutum yana ba da damar fahimtar tarihin halitta, motsi, da kuma ƙuntataccen motsi na nau'in.
Hakanan zai iya taimakawa ko jagorantar bincike game da dabbobi masu riƙewa, masu matsakaici da masu karɓar SARS-CoV-2 kuma ana iya amfani da shi don hana irin wannan yanayin a nan gaba.
A cikin wannan binciken, za mu ba da cikakken bayani game da asalin dabbobi, watsawa tsakanin jinsuna, da kuma aikin kamuwa da cutar coronavirus a cikin mutane.
Musamman, za mu nuna kuma mu tattauna cewa, ana amfani da kwayoyin halitta na asalin kwayar cutar korona a cikin masu karɓar bakuncin ajiyarsu, amma suna zama masu cutar bayan an canja su zuwa sabon mai karɓar baƙi.
Muna kuma nazarin juyin halittar kwayar cutar ta mutum inda karuwar iyawar kamuwa da cutar sau da yawa ta zo tare da rage aikin kamuwa da cutar.
An tattauna sakamakon ci gaba da yaduwar SARS-CoV-2 a cikin wannan labarin.
An san dabba coronavirus tun daga ƙarshen shekarun 1930.
Kafin an fara gano HCoV-229E, nau'in B814 ya fito ne daga hanci na marasa lafiya da suka kamu da cutar, an samo nau'ikan coronavirus daga dabbobi masu kamuwa da cutar, ciki har da dabbobi masu kamuwa da cutar, gashin daji, beraye, shanu, alade, da karnuka.
A cikin shekarun da suka gabata, an gano cututtukan mutum guda bakwai.
Takaitaccen taƙaitaccen tarihin gano cutar ta mutum a cikin jerin lokuta (Table 1) na iya zama mai amfani da ilimi.
An fara gano nau'in HCoV-229E a cikin 1966 daga hanyoyin numfashi na marasa lafiya waɗanda suka kamu da cutar a saman tsarin numfashi, sannan ya dace da girma a cikin layin kwayoyin numfashi na WI-38.
Marasa lafiya da ke dauke da cutar HCoV-229E sun nuna alamun bayyanar cututtuka na yau da kullum, ciki har da ciwon kai, ƙishirwa, rashin lafiya da kuma ciwon wuya, tare da zazzabi da ciwon kumburi a cikin kashi 10 zuwa 20 cikin dari na lokuta.
Daga baya, a cikin 1967, HCoV-OC43 ya rabu da tsirarwar ƙwayoyin cuta da kuma sassan da suka biyo baya a cikin kwakwalwar jarirai.
An gano cewa halaye na asibiti na kamuwa da cutar HCoV-OC43 sun yi kama da na HCoV-229E, wanda a cikin alamun cututtuka ya yi kama da na sauran cututtukan numfashi, ciki har da ƙwayoyin cuta na influenza A da renoviruses.
HCoV-229E da HCoV-OC43 sun bazu a duniya kuma suna yaduwa a lokacin hunturu da kuma yanayi mai laushi.
A gaba ɗaya, lokaci na kamuwa da cutar biyu bai wuce mako guda ba, kuma ana ci gaba da gano cutar na tsawon makonni biyu.
Bisa ga binciken ɗan adam akan masu sa kai, mutane masu lafiya da suka kamu da cutar HCoV-229E sun kamu da ƙananan faduwa.
Sai dai wasu marasa lafiya da ke da tsarin rigakafi mara kyau sun kamu da cututtukan cututtukan jiki na ƙananan numfashi.
"SARS, wanda aka fi sani da ""pneumonia atypical"", shi ne farkon kwayar cutar sankarar cuta ta mutum a tarihin rayuwar mutum, kuma an gano mai haifar da cutar SARS-CoV, wato, cutar ta uku ta mutum".
An fara gano SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta haifar da kamuwa da cuta 8,096 da aka ruwaito tare da mutuwar 774 da kuma yadawa a ƙasashe da nahiyoyi da yawa.
Baya ga abubuwan da suka faru na yaduwar jama'a, an kiyasta cewa kowane abu zai iya haifar da kusan nau'i biyu na kamuwa da cuta na biyu, tare da tsawon kwanaki 4 zuwa 7 na rayuwa da kuma ƙaruwar cutar da ke bayyana a rana ta goma.
Marasa lafiya da aka kamu da SARS-CoV sun fara da alamun irin su ciwon tsoka, ciwon kai, zazzabi, rauni da jijiyoyi, sannan sun sami tashin hankali, rashin ƙarfi da rashin numfashi a cikin matakai na ƙarshe.
Lymphopeny, ƙididdiga a waje da gwajin aikin hanta da kuma matakan high-level creatine kinase sun kasance ɓangare na sakamakon rashin daidaituwa na dakin gwaje-gwaje na SARS.
A cikin marasa lafiya da ke da SARS, an lura da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Kimanin kashi 20 zuwa 30% na marasa lafiya suna buƙatar kulawa mai tsanani da kuma iska mai iska.
Baya ga tsarin numfashi na ciki, gabobin jiki da dama, ciki har da tsarin narkewa, hanta da gland, na iya kamuwa da cutar a cikin waɗannan lokuta; yanayin da yawanci ke tattare da hadari na cytokine kuma yana iya zama musamman a cikin marasa lafiya da ke da rauni na rigakafi.
An fara gano cutar ne daga binciken huhu na wani dangi mai cutar da ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai don gudanar da bincike kan cutar coronavirus ta mutum.
HCoV-NL63 ya rabu da Netherlands daga jariri mai watanni bakwai a ƙarshen 2004.
An fara lura da cewa yana da yawa a cikin yara masu ƙuruciya, masu rauni da marasa lafiya da ke da rauni na rigakafi ko rashin lafiyar numfashi.
Faduwa, kumburi, zazzabi da bronchiolitis suna da yawa a cikin cutar da aka haifar da HCoV-NL63.
Wani binciken da ya yi a kan kansa ya nuna cewa an cire irin wannan kwayar daga samfurin hanci na jariri mai wata takwas da ke fama da cutar a Netherlands.
Ko da yake an gano wannan a Netherlands, an bayyana shi a duk faɗin duniya.
An kiyasta cewa HCoV-NL63 yana da alhakin kusan kashi 4.7% na cututtukan huhu, kuma yana da ƙaruwa a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da laryngitis na ƙwayoyin cuta, wanda aka fi sani da ƙwayoyin cuta.
A wannan shekarar, an cire HCoV-HKU1 daga wani mutum mai shekaru 71 da aka yi masa asibiti a Hong Kong saboda nono da hanci da bronchiolitis.
Baya ga cututtukan kirji da na hanci da kuma cutar bronchiolitis da aka samu a cikin jama'a, an kuma ruwaito cewa HCoV-HKU1 yana da alaƙa da matsanancin cutar asma.
HCoV-HKU1 an gano shi a matsayin mai haifar da cututtukan numfashi mai laushi, kamar HCoV-NL63, HCoV-229E da HCoV-OC43 a duk duniya.
Dukkanin cututtukan cutar korona guda hudu na mutum tare da yaduwar yaduwar sun dace da mutane sosai kuma gabaɗaya suna da ƙarancin yiwuwar motsi don haifar da cututtukan cututtuka masu yawa, kodayake a cikin ƙananan lokuta akwai lokuta da ba a bayyana ba don wani nau'in cututtuka na HCoV-NL63, wanda kwanan nan aka ruwaito a China ya haifar da kamuwa da cututtukan tsarin numfashi mai tsanani.
Gabaɗaya, lokacin da waɗannan ƙwayoyin cuta na mutum suka sami ikon watsa su da kyau kuma su ci gaba da kasancewa a cikin mutane, za su iya zama masu ƙaruwa ko masu kamuwa da cutar.
An fara cire cutar MERS-CoV a shekarar 2012 a Saudiyya daga huhu na wani mutum mai shekaru 60 da haihuwa wanda ke fama da ciwon kirji da hanci da kuma rashin lafiya.
Ko da yake mafi yawan lokuta da aka tabbatar da gwaji sun fara ne daga Gabas ta Tsakiya, an lura da wasu cututtuka na shigowa da kuma cututtuka na biyu a wasu lokuta a cikin kasashen Turai da Tunisia saboda kusanci.
An samu kamuwa da cutar ta biyu a Koriya ta Kudu a shekarar 2015, inda aka tabbatar da cewa akwai mutane 186.
Maganin asibiti na cutar ta SARS yana kama da cutar SARS, wanda aka sani da ciwon kirji da hanci mai tsanani.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da cutar MERS suna da rashin ƙarfi mai tsanani wanda ke da banbanci ga MERS a cikin cututtukan da ke faruwa daga kwayar cutar coronavirus ta mutum.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun hanji kamar kuturta da zubar da jini.
Har zuwa 14 ga Fabrairu, 2020, an samu fiye da 2,500 lokuta na gwaji da aka tabbatar da cutar tare da babban adadin mutuwar 34.4%, wanda ya sa MERS-CoV ya zama ɗayan cututtukan da suka fi cutarwa ga mutane.
A tsakiyar watan Disamba na 2019, an gano tarin cututtukan da aka samu a cikin ƙirjin da ƙuƙwalwa a Wuhan, lardin Hubei, China, wanda yanzu an gano yana da alaƙa da kamuwa da cutar SARS-CoV-2.
Hukumar lafiya ta duniya ta bayyana yaduwar kamuwa da cutar ta hanyar numfashi ta hanyar SARS-CoV-2 a matsayin yanayin gaggawa na gaggawa ga lafiyar jama'a a duniya, kuma ta sanya cutar COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da adadin mutane 9,053 a duniya, kuma yawan mutuwar ya kai kusan 3.4%.
Ya kamata a lura cewa, yawan mutuwar a Hubei, China, ya kai 4.2% yayin da a ƙasashen waje ya kai 1.2%.
SARS-CoV-2 kamar SARS-CoV da SARS-CoV suna haifar da kamuwa da cutar numfashi mai tsanani wanda ke faruwa a cikin zazzabi, tari da kuma numfashi mai tsanani.
An kuma lura da asphyxiation a wasu marasa lafiya.
Gashin kai yana ɗaya daga cikin alamun mafi tsanani kuma yana iya zama a cikin wani abu mai tsanani na numfashi.
Ko da yake SARS-CoV da SARS-CoV-2 sun yi kama da juna saboda yawan halayen da suka shafi kashi 82% na tsayi na nucleotide, suna cikin ƙungiyoyi biyu daban-daban na bishiyoyin phylogenetic.
SARS-CoV-2 yana da ƙananan ƙwayoyin cuta idan aka kwatanta da SARS-CoV da MERS-CoV, amma yana da yiwuwar watsawa mafi girma.
An samu rahoton mutane marasa cutar SARS-CoV-2 kuma hakan na iya taimakawa wajen hanzarta yaduwar cutar a duniya.
Kwatanta da gano bambance-bambance tsakanin SARS-CoV-2 da sauran cututtukan coronavirus guda shida na mutum yana nuna cewa akwai wasu kamanceceniya da bambance-bambance masu ban sha'awa.
Na farko, lokacin kamuwa da cutar coronavirus da kuma tsawon lokacin kamuwa da ita suna kama da juna.
A wannan yanayin, SARS-CoV-2 yana nuna al'ada na sauran ɓangarorin shida na coronavirus na mutum.
Na biyu, matsanancin alamun COVID-19 yana tsakanin SARS-CoV da kuma cututtukan cututtukan mutum guda hudu (ciki har da HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 yana nuna halaye waɗanda galibi muke gani a lokacin kamuwa da cutar ta kwayar cutar coronavirus ta mutum, ciki har da bayyanar cututtuka na yau da kullun, sauƙi ko ma rashin bayyanar cututtuka.
A gefe guda kuma, ƙananan ƙananan ƙananan cututtukan COVID-19 na iya zama samfurin kamuwa da cutar SARS-CoV, ko da yake adadin ya ɗan ƙasa.
Na uku, watsa SARS-CoV-2 ya ci gaba da nuna wasu halaye masu ban sha'awa waɗanda ke nuna ƙwayoyin cuta na mutum tare da yaduwar jama'a da SARS-CoV.
A gefe guda kuma, yiwuwar watsa SARS-CoV-2 yana da girma kamar yadda sauran cututtukan coronavirus na mutum suke da yaduwar yaduwar.
A gefe guda kuma, dole ne a gano ko yiwuwar watsa SARS-CoV-2 zuwa mutane daban-daban bayan kamuwa da cutar ta rage, kamar yadda ya faru da SARS-CoV da MERS-CoV.
A ƙarshe, ana iya gano SARS-CoV-2 a cikin samfurori masu ƙwayoyin cuta kamar sauran ƙwayoyin cuta na mutum.
Ba a san ko watsawar SARS-CoV-2 ta hanyar hanta, aƙalla a wasu yanayi, tana taka muhimmiyar rawa kamar SARS-CoV ba.
Yana da ban sha'awa a ga ko SARS-CoV-2 yana nuna yanayi na yanayi kamar yadda yake a cikin cututtukan coronavirus na mutum tare da yaduwar jama'a.
Koyaya, halaye na SARS-CoV-2, gami da iyawar watsawa, kamuwa da cuta da kuma ci gaba da yaduwa bayan mutum, zasu iya tasiri a ƙarshen barkewar COVID-19.
Kowane ɗayan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
A wani bangare kuma, yana iya zama daidai cewa mutane sun dace da waɗannan ƙwayoyin cuta guda huɗu.
A wasu kalmomi, duka biyu na iya zama masu tsira daga cutar ta coronavirus ta zamani.
An cire kwayar cutar korona ta mutum da ke haifar da cututtuka masu tsanani a cikin mutane daga binciken.
Don haka, dole ne kwayar cutar ta mutum ta yi yawa a cikin mutane don ba da damar haɗuwa da motsin motsin motsin da ke hana ƙuntataccen mai masaukin.
A wannan yanayin, yayin da cutar SARS-CoV-2 ta zama mai dorewa kuma yawancin mutane sun kamu da cutar, cutar tana da mafi kyawun damar daidaitawa tare da mutane.
Idan an daidaita cutar da kyau, zai yi wuya a hana shi watsawa ta hanyar killacewa ko wasu hanyoyin sarrafa kamuwa da cuta.
A cikin shekaru masu yawa, an yi amfani da kwayar cutar coronavirus guda hudu a cikin mutane da yawa, kuma suna haifar da cututtuka na yau da kullun a cikin mutanen da ke da tsarin rigakafi na yau da kullun.
Wadannan ƙwayoyin ba sa buƙatar wani ajiyar dabba.
A akasin haka, ƙwayoyin cuta masu ƙwayoyin cuta na SARS-CoV da MERS-CoV ba su dace da mutane ba kuma ba za su iya zama masu ɗorewa ba.
Dole ne su ci gaba da yin amfani da su a cikin ɗakunan ajiya na dabbobi, kuma yawanci ta hanyar ɗaya ko fiye na matsakaici da masu karɓar baƙi, suna neman damar yin amfani da su don yin amfani da su ga manufofin mutane masu mahimmanci.
SARS-CoV-2 yana da halaye iri ɗaya da SARS-SARS-CoV/MERS-CoV da kuma ƙwayoyin cuta huɗu na mutum tare da yaduwar yaduwar.
Kamar yadda yake da kwayar cutar korona ta mutum, aƙalla a yanzu, tana da babban damar watsawa.
Duk da haka, yana da mafi yawan cututtukan cututtuka fiye da coronavirus tare da yaduwar jama'a, sai dai yana da ƙananan cututtuka idan aka kwatanta da SARS-CoV ko MERS-CoV.
Za a bayyana a nan gaba ko za a iya daidaita shi da mutane gaba ɗaya kuma a sauƙaƙe shi tsakanin mutane ba tare da buƙatar wani tanadi ko mai masaukin dabba ba.
Kafin mu tattauna game da asalin dabbobi na kwayar cutar coronavirus ta mutum, ya fi kyau muyi magana game da ma'anar da halaye na masu haɓaka, na halitta, masu ajiya, masu matsakaici da masu haɓaka kwayar cutar ta mutum.
Wani dabba yana da kyau idan ya kasance mai karɓar bakuncin juyin halitta na kwayar cutar mutum wanda ke da makamancin asalinsa kuma yana da babban homology a matakin jerin nucleotides.
Kwayar cutar ta asali tana da kyau tare da mai masaukin da ba mai cutar ba.
Hakazalika, mai masaukin ajiya yana riƙe da kwayar cutar ta mutum a kai a kai kuma na dogon lokaci.
A lokuta biyu, masu karɓar baƙi suna kamuwa da cutar ta halitta kuma suna aiki a matsayin masu karɓar baƙi na halitta na kwayar cutar ta mutum ko kuma na mahaifa.
A gefe guda kuma, idan an watsa kwayar cutar ta mutum zuwa wani matsakaici, kwanan nan, kafin ko kuma a lokaci guda da aka gabatar da ita ga mutum, ba za ta dace da sabon ba kuma sau da yawa tana da cututtuka ba.
Mai watsa shiri na matsakaici zai iya zama tushen dabba don kamuwa da mutum, yana taka rawa na mai watsa shiri wanda ke ba da damar kwayar cutar ta ɗan lokaci don sake kamuwa da ita sannan kuma ta watsawa ga mutane don ƙara yawan kamuwa da mutum.
Idan mutum bai iya ci gaba da watsawa a cikin wani gida ba, cutar ta ƙare a matsayin kamuwa da cuta.
A akasin haka, kwayar cutar korona ta mutum na iya daidaitawa da mai masaukin baki, har ma da haifar da cutar ta asali na dogon lokaci.
A wannan yanayin, mai watsa shiri na matsakaici ya zama mai watsa shiri na ajiya na halitta.
A cikin sake nazarin bayanan cututtukan cututtuka, an gano cewa alamar SARS tana da tarihin haɗuwa da dabbobi da aka farautar.
Binciken da aka yi game da cutar ta serum ya nuna cewa cutar immunoglobulin G na SARS-CoV ta fi yawa a cikin masu sayar da dabbobi fiye da jama'a.
An gano dabba mai kama da masks (Paguma larvata) da kuma kare mai kama da raccoon a kasuwannin dabbobi a matsayin masu dauke da kwayar cutar SARS-CoV, wanda kusan daidai yake da SARS-CoV.
Wannan ya tabbatar da cewa ba a sake samun wani labari na SARS ba bayan an kashe dukkan kwari a kasuwa.
Koyaya, an ruwaito cewa masked palm civets a cikin daji ko gonaki waɗanda ba su da hulɗa da kasuwannin dabbobi masu rai, sun kasance masu ƙarancin cutar SARS-CoV, a wasu kalmomin, ana iya kammala cewa masked palm civets na iya zama matsakaiciyar mai watsa shiri don kwayar cutar, ba ajiyar halitta na SARS-CoV ba.
Abin lura, tun da kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da maganin rigakafin SARS-CoV, ba za a iya watsi da yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa suna aiki a matsayin masu karɓar bakuncin SARS-CoV na matsakaici ba.
Dukkanin waɗannan sun zama masu karɓar bakuncin SARS-CoV.
Binciken gano mai masaukin dabba na halitta SARS-CoV ya haifar da gano wani kwayar cutar kwayar cutar Rhinolophus wanda ke da alaƙa da HKU3 (SARSr-Rh-BatCoV HKU3) wanda ke cikin kwayar cutar da ke cikin kudancin doki na kasar Sin.
Sakamakon gwajin antibody na SARS-CoV da kuma SARSr-Rh-BatCoV HKU3 jerin kwayoyin halitta sun kasance masu kyau a cikin waɗannan bat.
Wannan da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Wadannan binciken sun kafa sabon ra'ayi, wanda ke nufin cewa bats suna karɓar bakuncin kwayoyin cutar da ke fitowa daga mutum.
An gano wasu nau'ikan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
An san enzyme 2 mai canza angiotensin mutum (ACE2) a matsayin mai karɓar SARS-CoV.
An gano cewa WIV1 yana amfani da kwayoyin halitta na fuka-fuki, ACE2, fuka-fuki, da kuma mutane a matsayin mai karɓa don shigarwa a cikin tantanin halitta.
Abin sha'awa, ƙwayar cuta ta iya hana WIV1 daga marasa lafiya da ke warkewa daga cutar ta SARS.
Har zuwa yanzu, WIV1 ya nuna cewa SARS-CoV na kusa da juna a cikin bats yana da kashi 95% na haɗin haɗin nucleotide.
Duk da yawan daidaituwa tsakanin waɗannan ƙwayoyin cuta, ana yarda da cewa WIV1 ba shine matsakaiciyar ƙwayar cuta ta SARS-CoV ba kuma bawar garuruwa ba ne farkon masu karɓar bakuncin SARS-CoV ba.
Binciken phylogenetic ya nuna cewa MERS-CoV yana cikin rukuni guda na CoV-HKU4 bats da CoV-HKU5 bats.
CoV-HKU4 bats da MERS-CoV duka suna amfani da karɓar mai karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar kar
Tsarin RNA na RNA na MERS-CoV yana da kusancin phylogenetic zuwa nau'ikan kwayar cutar coronavirus na bat da aka gano a Turai da Afirka.
A halin yanzu, babu wani MERS-CoV mai rai a cikin bats.
MERS-CoV da kuma mafi kusa da zumunta na linzamin kwamfuta CoV-HKU25 suna da kashi 87% na homology na nucleotide iri ɗaya.
Saboda haka, bats bazai iya zama farkon masu karɓar bakuncin MERS-CoV ba.
A gefe guda kuma, nazarin da aka gudanar a Gabas ta Tsakiya ya nuna cewa dromedary camels suna da kyau, musamman a kan maganin rigakafin cutar MERS-CoV, kamar su camels na Gabas ta Tsakiya, wanda ke da yawa a wasu ƙasashen Afirka.
An samo MERS-CoV mai rai wanda yayi kama da kwayar cutar da ake samu a cikin mutane daga hancin wani kamara mai dutse, wanda ya nuna cewa kamara suna taka rawa a matsayin ainihin mai masaukin baki na MERS-CoV.
Ya kamata a lura cewa a cikin kullun, an lura da alamun bayyanar cututtuka masu sauƙi amma a cikin gwaji na MERS-CoV.
Ya kamata a lura cewa, magungunan da aka kamu da su ba kawai suna watsa cutar ta hanyar numfashi ba, har ma ta hanyar hanta-hanta, wanda shine babban hanyar watsa cutar a cikin bats.
Duk da haka, akwai tambayoyi da yawa, saboda yawancin mutanen da ke kamuwa da cutar MERS ba su da alaƙa da shuttles kafin bayyanar cututtuka, saboda haka za a iya kammala cewa cutar ta kamuwa da mutum ko ta hanyar hanyoyin da aka sani da nau'in dabbobi waɗanda ke dauke da MERS-CoV.
SARS-CoV-2 ya nuna homology na nucleotide a kashi 96.2% na cutar coronavirus RaTG13 na fuka-fuki wanda aka raba daga fuka-fuki Rhinolophus affinis.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 ya fi girma fiye da yadda za a iya la'akari da dangantaka ta iyaye tsakanin su.
A wasu kalmomi, bats bazai iya zama farkon masu karɓar bakuncin SARS-CoV-2 ba sai dai idan an gano wasu nau'ikan cututtukan coronavirus a cikin bat a nan gaba.
Mai yiwuwa, masu karɓar bakuncin dabbobi na SARS-CoV-2 dole ne su kasance a cikin jinsunan da ake kashewa a cikin kasuwar sayar da abincin teku ta Hunan, wani abu da ya danganta da yawancin farkon COVID-19 da ke nuna yiwuwar watsa daga dabba zuwa mutum.
Sabbin bincike da yawa da aka yi a kan tsarin halittu sun nuna cewa rukuni na ƙananan dabbobi masu haɗari da ke cikin haɗari da mutuwa da ake kira pangolin (Manis javanica) na iya zama asalin asalin coronavirus na beta da ke da alaƙa da SARS-CoV-2.
Wadannan sababbin kwayoyin cutar coronavirus na Pangolin suna da kashi 85-92% na homology na nucleotide tare da SARS-CoV-2.
Duk da haka, suna da kusan kashi 90 cikin dari na kamanceceniya a matakin jerin nucleotides tare da RaTG13.
Suna kama da nau'i biyu na SARS-CoV-like viruses a cikin cluster phylogenetic tree wanda ya fi kama da RBD (receptor binding domain) tare da SARS-CoV-2 kuma yana da kashi 97.4% na amino acid.
A cikin bambanci, SARS-CoV-2 da RaTG13 RBDs suna da ƙarin kamanceceniya, ko da yake akwai ƙarin jerin a cikin tsarin kwayoyin halitta.
Wani binciken da aka yi a kan marasa lafiya na pangolin ya kuma ba da rahoton gano cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
A cikin wannan binciken, an yi amfani da hanyoyi daban-daban na tattarawa da kuma zabin hannu don ƙirƙirar jerin kwayoyin halitta na musamman wanda ya ƙunshi kusan kashi 86.3% na tsawon lokacin gina jiki na kwayar cutar.
Ba za mu iya watsi da yiwuwar cewa pangolin yana ɗaya daga cikin masu karɓar bakuncin dabba na SARS-CoV-2.
Koyaya, a halin yanzu, saboda bambancin tsari tsakanin SARS-CoV-2 da SARS-CoV-2-related beta-virus a cikin pangolin, babu wata hujja game da kasancewar asalin pangolin kai tsaye ga SARS-CoV-2.
Bugu da ƙari, nesa tsakanin SARS-CoV-2 da RaTG13 ya fi gajeren nesa tsakanin SARS-CoV-2 da SARS-CoV-2 beta coronavirus a cikin pangolin.
Dole ne a gano hanyar juyin halitta na SARS-CoV-2 a cikin bats, pangolins da sauran dabbobi masu shayarwa.
Duk da yake an gano mafi girma a cikin homologous matching a RBDs tsakanin SARS-CoV-2 da pangolin, SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi girma a cikin homologous sequence sharing a cikin tsarin kwayoyin halittar.
An yi imanin cewa yawancin kamanceceniya tsakanin RBDs na SARS-CoV-2 da ke da alaƙa da SARS-CoV-2 a cikin pangolin da SARS-CoV-2 ya samo asali ne ta hanyar juyin halitta tare da matsakaici na zaɓi.
Wani shawarwari na juna shine a yi amfani da wani nau'i na nau'i tsakanin coronavirus beta pangolin da ke da alaƙa da SARS-CoV-2 da RaTG13 a cikin nau'in dabba na uku.
Nootropic yana ci gaba da kasancewa mai nasara a cikin yanayin yanayin beta na coronavirus.
A yanzu haka, ana gudanar da bincike game da asalin dabba na SARS-CoV-2 kuma ba za a iya yin cikakken bayani ba.
Bugu da ƙari, an yi nazarin ƙwayoyin cuta na mutum masu ƙwayoyin cuta, asalin dabba HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar ilimin lissafi ta nuna cewa HCoV-NL63 da HCoV-229E na iya fitowa daga kwayar cutar coronavirus a cikin kwari, yayin da aka gano ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin dabbobi.
An ruwaito cewa wani kwayar cutar kwayar cutar ARCoV.2 (Appalachian Ridge CoV) da aka gano a cikin kwayar cutar ta Arewacin Amirka tana da alaƙa da HCoV-NL63.
A gefe guda, HCoV-229E yana da nasaba ta hanyar kwayoyin halitta da wani kwayar cutar kwayar cutar Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da ake zaton cewa shuttles ne masu karɓar bakuncin.
Don ƙarin bayani, an taƙaita ilimin da ake samu game da asalin dabbobi na kwayar cutar ta mutum a cikin Figure 1 da Table 2.
Nazarin phylogenetic ya samar da hujja game da abubuwan da suka faru na watsawa tsakanin kwayoyin cutar coronavirus a cikin tarihi.
Lokacin da HCoV-OC43 ya sami hanyar watsawa tsakanin jinsuna daga dabbobi zuwa mutane a 1890, an lura da annobar kamuwa da cutar ta hanyar numfashi.
Ba a san ainihin tarihin watsa HCoV-229E tsakanin jinsuna ba.
An gano kwayar cutar Alpha a cikin kwari wanda ke da alaƙa da SARS-CoV-2.
Daga cikin su akwai Alpaca alpha coronavirus.
Akwai shaidu da yawa da ke tallafawa muhimmancin kai tsaye watsa kwayar daga bats zuwa mutum.
Da farko, mutane na iya tuntuɓar bats, ba alpacas ba, saboda kasancewa a cikin yanayin muhalli na kowa.
Maimakon haka, mutane suna da dangantaka ta kusa da Alpacas.
Na biyu, cutar korona ta Alpha a cikin bats da ke da alaƙa da HCoV-229E sun bambanta kuma suna hana su ci gaba a cikin bats, yayin da cutar Alpha alpaca ta haifar da yaduwar cutar numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, babu wani hali na Alpaca coronavirus a cikin dabbobin daji.
Saboda haka, ba za a iya watsi da yiwuwar cewa alpacas suna karɓar cutar korona mai alaƙa da HCoV-229E daga mutane ba.
A gaskiya ma, bats sune tushen kai tsaye na cututtukan mutum, ciki har da cutar Hari, Ebola, Nepa, da kuma cutar Hendra.
Saboda haka ba abin mamaki bane cewa bats na iya watsa HCoV-229E kai tsaye zuwa mutum.
A gefe guda kuma, ko da yake kwayar cutar Alpha ta bat tana aiki a matsayin mai adana kwayoyin HCoV-229E, alpacas da shuttles na dutse na iya zama masu watsa shirye-shiryen watsa shirye-shiryen watsa kwayar cutar zuwa mutane, kamar yadda ya faru game da MERS-CoV.
Cutar MERS-CoV misali ne mai kyau na watsawa tsakanin jinsuna daga bats zuwa tsuntsaye na dutse da kuma daga tsuntsaye zuwa mutane.
A farkon gano MERS-CoV, an gano cewa kunyar gizo-gizo ta samo asali ne daga ci gaban cutar, kuma binciken da aka samu daga baya ya tabbatar da hakan.
A bayyane yake cewa bats suna da wadataccen tushen nau'in ƙwayoyin cuta don musayar nau'in kwayoyin halitta da kuma watsawa tsakanin nau'in.
"Daga cikin tsawon rai, da tarin kwayoyin halitta, da kusanci da zamantakewa da kuma iyawar tashi, duk sun zama yanayi mai kyau ga bats a matsayin ""masu yada cutar"."
A gefe guda, MERS-CoV ya kasance a cikin shuttles na shekaru da dama.
Wannan kwayar cutar ta dace da waɗannan shuttles da suka zama daga matsakaici zuwa mai riƙe da ajiyar yanayi.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma ƙimar motsi a cikin waɗannan dabbobi ba ta da yawa.
Yaduwar cutar zuwa mutane ba zato ba tsammani ne, kuma mutane suna da iyakacin gidan MERS-CoV saboda ba za a iya ci gaba da watsa ta tsakanin mutane ba.
Idan aka kwatanta da rawar da shuttles ke takawa wajen watsa MERS-CoV, rawar da pangolin ke takawa - idan sun taka rawa - wajen watsa SARS-CoV-2 ta bambanta.
Musamman, cutar sankara ta beta-pangolin tana da matukar cutarwa a cikin pangolin.
Suna iya zama masu karɓar bakuncin kwayar cutar Alpha da ke da alaƙa da SARS-CoV-2, kamar yadda suke da alaƙa da SARS-CoV.
Akwai yiwuwar da yawa don watsa SARS-CoV-2 daga dabba zuwa mutum a cikin nazarin gaba.
Na farko, bats na iya zama masu karɓar bakunan wani kwayar cutar da ke da alaƙa da SARS-CoV-2, wanda yake kusan kama da SARS-CoV-2.
Mutane na iya samun haɗin haɗin halittu ta hanyar aiki a cikin butcher ko ma'adinai tare da bats.
Na biyu, pangolin na iya zama ɗaya daga cikin masu karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar
Mutane suna kamuwa da cutar ta hanyar shan nama da cin nama.
Yawancin dabbobi masu shayarwa, ciki har da dabbobi da na gida, na iya kamuwa da SARS-CoV-2.
Ana buƙatar bincike a kan dabbobi da dabbobin daji don nazarin iska mai iska.
Na uku, an ambata cewa SARS-CoV-2 na iya faruwa a cikin nau'i na uku wanda ya kasance tare da bat da pangolin.
Ana gudanar da bincike kan asalin dabba na SARS-CoV-2.
Tare da nau'ikan masu karɓar baƙi na dabba, akwai manyan abubuwa uku na cutar da ke sauƙaƙa ƙetare shinge na nau'ikan coronavirus.
Da farko dai, suna da ƙimar haɓaka ta kwayoyin halitta a lokacin da suke yin kwayar RNA.
" Idan aka kwatanta da sauran kwayoyin RNA guda ɗaya, dangane da lokacin da coronavirus ke daidaitawa da sababbin masu masauki, ana iya ɗaukar ƙimar motsi don coronavirus bisa ga matsakaicin maye gurbin 10  4 maye gurbin a shekara a wurin 2, ""mai matsakaici"" zuwa ""mai tsayi"".
Coronavirus yana da wani exoribonuclease wanda ba a iya karantawa ba, kuma kawar da shi yana haifar da motsi da rauni mai yawa ko ma lalacewa.
Abin sha'awa, an san wani analog na nucleotide mai suna remdesivir a cikin hana aiwatar da kwayar cutar ta hanyar hana wannan exoribonuclease da RNA polymerase da ke da alaƙa da RNA.
RMSVIR yana daya daga cikin magungunan da suka fi dacewa don magance SARS-CoV-2, wanda dole ne a gwada shi a asibiti.
Koyaya, ƙimar motsi na coronavirus kusan sau miliyan ɗaya fiye da na mahaifinsu.
Bugu da ƙari, yawanci yawan motsi yana da yawa idan coronavirus bai dace da mai masaukin ba.
Idan aka kwatanta da yawan motsi a SARS-CoV, yawan motsi na SARS-CoV-2 ya ragu sosai, wanda ke nuna cewa yana da mafi girma a cikin mutum.
Yana yiwuwa ya riga ya dace da wani mai masaukin da yake da dangantaka da mutum.
Bugu da ƙari, SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da shuttles na wata ƙasa.
A ka'idar, ba zai yiwu ba cewa juyin halitta zai iya hana alluran rigakafi da riga-kafi na SARS-CoV-2 da sauri.
Na biyu, manyan kwayoyin RNA a cikin coronavirus suna haifar da ƙarin sassauci a cikin gyaran kwayoyin halitta don motsi ko ƙwayoyin cuta, wanda ke haifar da haɓaka yiwuwar juyin halitta tsakanin jinsuna, wanda ke taimakawa wajen samar da sabon coronavirus yayin da ake shirya yanayi.
Wannan yana tallafawa ta hanyar manyan ɗakunan karatu na musamman da kuma ayyukan furotin da aka sanya a ƙarshen 3′ na kwayar halitta.
"Na uku, coronavirus suna yin amfani da wata hanyar ""zabin kwafin"" don canza samfurori a cikin bazuwar da kuma sau da yawa a lokacin da RNA ke karuwa".
A cikin wani shiri wanda ke aiki a matsayin mai haɗawa, juyawa na fili yana faruwa sau da yawa yayin da RNA na coronavirus ke canzawa.
Ana iya haɗa RNAs tare da dogon homologue da tsawon kari da kuma ƙananan genomics don samar da sababbin coronavirus.
An lura da hujjojin halitta na phylogenetic na halitta, a cikin HCoV-HKU1 da HCoV-OC43 da kuma a cikin ƙwayoyin cuta na dabba kamar SL-CoV da CoV-HKU9 a cikin fuka-fuki.
Halin da ake yi tsakanin mai watsa shiri da kwayar cutar dangane da watsawa
Baya ga abubuwan da aka ambata a sama, hulɗar ƙwayar cuta da mai karɓar mai karɓar wani muhimmin abu ne da ke shafar yaduwar jinsuna.
A nan an dauki SARS-CoV a matsayin misali mai kyau kuma an nuna shaidar zaɓin zaɓi mai kyau a yayin abubuwan da suka faru na watsawa tsakanin jinsuna.
Bayan nazarin kwatancen isole-isole na SARS-CoV na mutum da na albasa, an gano cewa SARS-CoV yana daidaitawa da sauri tare da masu masaukin baki daban-daban, musamman ma ta hanyar motsi a cikin RBD da furotin S.
A general, RBD a cikin furotin S na coronavirus yana hulɗa da mai karɓar kwayar halitta kuma yana da matukar zabi ta hanyar amsawar rigakafin mai masaukin baki.
RBD na SARS-CoV yana cikin amino acid 318 zuwa 510 a kan S1 wanda ke haifar da haɗuwa da ACE2 na mutum da kuma masu karɓar haɗin gwiwa don shigar da kwayar.
Ƙungiyar haɗin gwiwar mai karɓar SARS-CoV tana iya gano masu karɓar ACE2 na dabbobi daban-daban, ciki har da bats, bats, beraye, da kuma kare raccoons, wanda ke ba da damar watsa kwayar cutar tsakanin jinsuna.
A gaskiya ma, an lura da amino acid 6 kawai da RBDs sun bambanta tsakanin ƙwayoyin cuta na mutum da na albasa, kuma 4 daga cikinsu suna cikin motsi na haɗin mai karɓa don aiki da aiki tare da masu karɓa na ACE2.
SARS-CoV yana da bambancin K479N da S487T a cikin RBD wanda zai iya haifar da haɓaka haɗin haɗin kai na spike tare da masu karɓar ACE2 na mutum.
A wasu kalmomi, waɗannan maye gurbin amino acid guda biyu na iya taka muhimmiyar rawa wajen daidaita kwayar cutar da mutane.
Ya kamata a lura cewa mai karɓar kwayar SARS-CoV-2 yana kama da SARS-CoV.
Bambanci na kashi 30 cikin dari tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na furotin S ya nuna cewa yana yiwuwa a canza sha'awar haɗa furotin S tare da ACE2 na mutum.
A gaskiya ma, wani binciken cryo-EM ya nuna cewa wannan haɗin yana da dangantaka da yawa fiye da yadda aka haɗa shi da proteins ACE2 da S proteins na SARS-CoV.
Zai zama da ban sha'awa a gano ko wani mai karɓar taimako na musamman ya zama dole don watsawa idan aka kwatanta da yawan motsi a SARS-CoV-2.
Abin sha'awa shine, HCoV-NL63 yana da alaƙa da enzyme mai canza angiotensin 2 (ACE2), amma tare da wani ɓangare daban na S.
Akwai sauran masu karɓar kwayar cutar ta mutum da yawa, ciki har da aminopeptidase N don HCoV-229E da 9-O-stelaic acid for HCoV-OC43.
Wannan na iya zama dalilin nasarar da aka samu na daidaita wadannan coronavirus a cikin mutane bayan an watsa su daga dabba mai masauki.
Bugu da ƙari, masu karɓar kwayar halitta, sakamakon watsawar kwayar cutar ta mutum, yana shafar sauran dogaro da mai masaukin baki da kuma ƙuntatawa.
Wannan haɗin gwiwar waɗannan furotin masu karɓar baƙi tsakanin mutane da masu karɓar bakuncin yanayin yanayin coronavirus na mutum kamar kwari, bat, da kuma tsuntsaye na iya zama cikas ga watsawa tsakanin jinsuna.
Don samun nasarar watsawa tsakanin jinsuna, kwayar cutar ta mutum dole ne ta ɗauki abubuwan da ke tattare da mahalarta kuma ta shawo kan abubuwan da ke hana mahalarta.
A wannan yanayin, dole ne a gano kuma a gano abubuwan da ke ƙayyade kwayoyin halitta a cikin wannan muhimmin yanayin na hulɗar ƙwayar cuta-mai watsa shiri.
Ana iya samun sakamako mai kyau ta hanyar yin amfani da fasaha mai ci gaba na CRISPR, a cikin allon kwayoyin halitta na masu ba da sabis da kuma ƙuntataccen dalilai na SARS-CoV-2.
Fitowar sabbin cututtukan coronavirus: komawar zuwa sifili
Bambancin kwayar cutar kwayar cutar ta bats yana ba da dama ga fitowar sabbin kwayar cutar ta mutum.
Bisa ga wannan, ƙwayoyin cuta na bats suna aiki a matsayin tushen kwayoyin cutar korona na mutum.
Bugu da ƙari, saurin juyin halitta da kuma ƙwayoyin halitta na halitta suna haifar da ƙwayar halitta na kwayar cutar coronavirus, kuma suna aiki a matsayin matakai biyu masu muhimmanci a cikin wannan tsari.
Alal misali, samun ko rasa sababbin kwayoyin da ke ƙayyade furotin zai iya gyara tsarin phenotypes na ƙwayoyin cuta sosai.
Daga cikin sunadarai masu zuwa na SARS-CoV, ORF8 yana da mahimmanci a cikin dacewa da mutane, saboda an rabu da ƙwayoyin cuta na fuka-fuki da ke da alaƙa da SARS-CoV, amma an gano cewa sunadarai na ORF8 suna ƙonawa.
An gano wani abu game da kawar da SARS-CoVs na nucleotide 29 a cikin jinsunan da aka rabu da su a farkon annobar mutum.
Wannan cirewa ya raba ORF8 zuwa ORF8a da ORF8b, kuma yana da nau'i na daidaitaccen motsi wanda ke sauƙaƙe motsi tsakanin runduna.
Bugu da ƙari, SARS-CoV yana da tarihin ƙwayoyin cuta tsakanin zuriyar alpha da kuma matakan coronavirus, wanda ya sa aka gano ƙananan ƙananan ƙananan ƙananan ƙwayoyin cuta a cikin RNA mai dangantaka da RNA.
An kuma gano wuraren da aka tsara a nsp9, babban ɓangaren nsp10 da kuma sassan nsp14.
Hakazalika, an gano cewa a cikin annobar MERS-CoV, an lura da abubuwan da suka faru na rarrabuwa tsakanin zuriya daban-daban a cikin shuttles na wani dutse a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an lura da abubuwan da suka faru na ƙwayoyin cuta a cikin sauran cututtukan mutum inda cututtukan mutum ke ƙwayoyin cuta tare da sauran cututtukan dabba a cikin kwayoyin halitta na su.
Ya kamata a lura cewa zabin mutum na iya haifar da canje-canje a cikin kwayoyin halitta na kwayar cuta, wanda zai iya haifar da watsi da kwayar cuta daga matsin lamba, misali, ta hanyar tsarin rigakafin jiki na mahaifar.
Misali na irin wannan tasirin shine rasa cikakken tsawon ORF4 a cikin HCoV-229E, wanda ke faruwa saboda cire nucleotides biyu.
Ko da yake ana iya ganin ORF4 mai lafiya a cikin kwayoyin cutar HCoV-229E na linzamin kwamfuta da na kamara, cutar Alphaphaca tana da ƙwayar nucleotide wanda ke haifar da motsi na juya karatun.
A kwanan nan, juyin halitta na sabon kwayar cutar ta mutum yana ci gaba da matsin lamba a cikin masu karɓar bakuncin su.
Lokacin da kunyar da ke kamuwa da cutar coronavirus, an gano marasa alamar ko kuma marasa alamar, wanda ke nuna daidaituwa tsakanin coronavirus da kunyar.
Wannan ya nuna cewa kunar bakin wake sun dace da coronavirus sosai, ko dai ta hanyar ilimin lissafi ko ta jiki.
Alal misali, rashin kunnawar amsawar farko na kumburi a cikin bats yana rage tasirin cututtukan da aka kunna tare da coronavirus.
Bugu da ƙari, aikin kwayoyin halitta na kwayoyin halitta a cikin kwayoyin halitta yana da damuwa saboda yawan haɓakar ƙwayar halitta mai hana NKG2/CD94 mai hana kwayar halitta da kuma haifar da ƙananan matakin bayyanawar kwayoyin ƙwayoyin ƙwayoyin cuta na farko na aji na 1.
Bugu da ƙari, babban matakin sinadarai masu dauke da oxygen mai aiki (ROS) na sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinad
Ƙungiyoyin coronavirus da ke da mafi girman pathogenic suna haɓaka tare da nutritional, wanda ke haifar da samun sababbin sunadarai ko kuma sunadarai na sunadarai don dacewa da mahalarta.
Saboda haka, ba abin mamaki bane cewa sababbin cututtukan mutum guda uku sun bayyana a cikin shekaru biyu da suka gabata.
Coronavirus ba su da cutar ko kuma suna haifar da bayyanar cututtuka masu sauƙi a cikin masu masaukin ajiyarsu kamar bats da shuttles.
Suna ninkawa sosai ba tare da samun amsa mai ƙarfi daga mai masaukin ba.
Akwai wasu abubuwan da ke haifar da rikice-rikice game da dalilin da yasa ake ganin masu ɗaukar hoto marasa alama da abin da ke haifar da mummunan kamuwa da cuta a cikin mutum.
Alamun cututtuka na musamman, yawanci saboda yawan aiki da tsarin rigakafi da kuma hadarin cytokine, inda idan tsarin rigakafi ya fi karfi, cutar huhu za ta fi tsanani.
A wani ɓangare kuma, a cikin masu watsawa marasa alama, an cire amsawar rigakafi daga karuwar coronavirus.
Wannan dabarun na rarraba amsa ta rigakafi na iya samun sakamako mai kyau a maganin SARS-CoV-2.
Amsar interferon a cikin bats, a wani nau'i, tana da ƙarfi sosai.
Saboda haka, amfani da Interferon Type I ya kamata ya kasance da amfani a cikin mutane, aƙalla a farkon matakin kamuwa da SARS-CoV-2.
Bugu da ƙari, aikin NLRP3 inflammatory activation a cikin bats yana da lahani.
Tare da wannan ma'anar, hana NLRP3 na ƙonewa tare da MCC950 na iya zama da amfani wajen magance COVID-19.
Fitowar SARS-CoV-2 ta bi tsarin da ya haifar da SARS-CoV da MERS-CoV.
Ko da yake beta coronavirus yana da kashi 95% na homology na nucleotide tare da SARS-CoV, akwai wani kwayar cutar kwayar cutar da ke da kashi 96% na homology na nucleotide tare da SARS-CoV-2.
Duk da yake an san dabbobi masu rarraba da sauran dabbobi a kasuwa a matsayin masu karɓar bakunan da suka yi kama da SARS-CoV, ba a san farkon mai karɓar bakunan SARS-CoV-2 ba.
An gano kwayar cutar ta beta-pangolin da ke da kamanceceniya da SARS-CoV-2, wanda ya nuna cewa akwai yiwuwar cewa pangolin sun kasance a matsayin ɗaya daga cikin masu karɓar bakuncin ko kuma cutar ta beta-pangolin na iya kasancewa cikin ɓangarorin gene wanda ya haifar da sigar ƙarshe ta SARS-CoV-2.
Ko da yake wannan tambaya ta kasance, babu wata shaida cewa SARS-CoV-2 ta kasance da gangan ko ta hanyar mutum.
Coronavirus sun sake komawa cikin hankali saboda yaduwar SARS-CoV-2.
Nazarin coronavirus a cikin bats da sauran dabbobi ya sauya fahimtarmu game da muhimmancin asalin dabbobi da dabbobi na adana kwayar cutar ta mutum a cikin watsa ta zuwa mutum.
Shaidar tabbatacciya ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun fito ne daga bats kuma an watsa su zuwa mutane ta hanyar masu masaukin baki.
Duk da cewa kamuwa da cutar SARS-CoV ya samo asali ne daga hulɗa tsakanin mutane da kwari a kasuwa, rufe kasuwanni da kashe kwari zai iya kawo ƙarshen cutar SARS.
Tare da wannan ma'anar, saboda gano cewa wasu zuriyar cutar coronavirus ta beta-pangolin suna da alaƙa da SARS-CoV-2, dole ne a tattara pangolin daga kasuwannin fata don hana yaduwar dabbobi.
Ko da yake, ko SARS-CoV-2 zai iya kamuwa da mutum ta hanyar pangolin da sauran dabbobi ko da alkama, da kuma yadda za a iya gano shi a cikin bincike na gaba.
A gefe guda, MERS-CoV ya kasance a cikin samfurori na dutse na dogon lokaci.
Wadannan shuttles suna da muhimmanci a matsayin hanyar sufuri kuma suna da babban tushen nama, madara, fata da kayan lambu ga mazauna yankin.
Sun yada a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a yi hadaya da dukkan shuttles don sarrafa MERS ba, kamar yadda ya faru don sarrafa yaduwar SARS-CoV da SARS-CoV-2 a cikin namun daji na kasuwar Sin.
Don dakatar da sake fashewar MERS, dole ne a yi cikakken tsarin samar da alluran rigakafi don magance MERS-CoV a cikin samari, tare da duk matakan da suka dace don sarrafa kamuwa da cuta.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin ba, sababbin jinsuna na iya bayyana kuma su haifar da yaduwar.
Akwai nau'ikan nau'ikan coronavirus na dabba a cikin namun daji.
Musamman, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Akwai dama da dama ga wadannan kwayar cutar ta dabba su bunkasa ko kuma su samu ci gaba, wanda zai haifar da fitowar sababbin kwayar cutar da za su iya zama masu yaduwa da/ko kisa ga mutane a nan gaba.
Dole ne a manta da al'adun cin dabbobi a wasu yankunan kasar Sin don rage yawan hulɗar da ba ta da muhimmanci tsakanin mutane da dabbobi.
Saboda rikice-rikicen da SARS, MERS da COVID-19 suka haifar, ya kamata a tsara shirin shiri da amsa mafi kyau.
A gaskiya ma, yawancin ƙwayoyin cuta sun kasance a duniyar nan na dogon lokaci.
Suna zama a cikin ɗakunan ajiyar su na halitta don samun damar yaduwa.
Ko da yake bats suna da siffofi masu yawa da ke taimakawa wajen yaduwar ƙwayoyin cuta, za a iya rage yiwuwar mutum ya tuntube su da bats da sauran jinsunan daji idan mutane suka sami horo don su guje wa waɗannan dabbobi.
Kulawa mai tsawo a kan dabbobi masu shayarwa yana da mahimmanci don fahimtar yanayin yanayin coronavirus da mahaifinsu na halitta, wanda zai taimaka wajen hana su shiga daga dabba zuwa mutum da kuma yaduwarsu a nan gaba.
A ƙarshe, hanya mafi inganci don hana yaduwar cutar daga dabba zuwa mutum ita ce ta nisantar mutane daga wuraren ajiyar kwayoyin halitta na ƙwayoyin cuta da aka watsa daga dabba zuwa mutum.
Wasu abubuwa da dama a cikin jigon asalin dabba na SARS-CoV-2 sun ɓace.
Da farko dai, idan bats sun watsa wani kwayar cutar SARS-CoV-2 zuwa pangolins, zai zama mai ban sha'awa ganin a wane yanayi bats da pangolins zasu iya yin haɗin kai a cikin yanayin muhalli.
Na biyu, idan kunyar gizo-gizo ta taka rawa kai tsaye wajen watsawa ga mutum, dole ne a gano yadda mutane ke hulɗa da kunyar gizo-gizo.
Na uku, idan dabba mai shayarwa ta uku ta yi aiki a matsayin mai masaukin baki na gaske, dole ne a gano yadda ta yi hulɗa da nau'o'in mutane, bats, da pangolins.
A ƙarshe, saboda yawancin dabbobi masu shayarwa, ciki har da dabbobi masu gida, na iya kamuwa da SARS-CoV-2, dole ne a lura da su kuma a yi gwaji.
Ko dai an samu wannan a cikin wani yatsa, wani pangolin ko wani dabba mai shayarwa, ana sa ran SARS-CoV-2 ko kuma wasu kwayoyin da suka yi kama da su za a samu a nan gaba a cikin mahaifinsu na halitta.
Binciken da ake yi a wannan fannin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da muhimman bayanai game da rigakafi da kuma kula da COVID-19 a cikin mutane.
"Ana buƙatar daidaita matakan gano COVID-19 don "abubuwan da ake zargi" da "abubuwan da aka tabbatar".
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta fitar da jagora mai sauri don ganowa da magance kamuwa da cutar coronavirus ta 2019 (2019-nCoV) wanda ya ba da shawarar abubuwan da muka samu kuma ya ba da kyakkyawan jagora don magance cutar ta duniya.
Koyaya, cutar Coronavirus 2019 (COVID-19) sabuwar cuta ce, kuma sanarwa da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ƙwarewar aikin asibiti. Saboda haka, ana sabunta dabarun ganewa da magani akai-akai.
A cikin wannan wasikar, mun amsa da ra'ayi ɗaya game da jagorarmu, kuma mun gabatar da sabbin matakan ganewar asali da aka tabbatar da su bisa ga sabon jagorar ganowa da maganin COVID-19 (siffa) da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin ya bayar.
A watan Disamba na 2019, sabon coronavirus 2019 (2019-nCoV) ya haifar da barkewar cutar annoba wacce yanzu a hukumance aka sanya wa sunan cutar coronavirus 2019 (COVID-19) da kuma cutar coronavirus mai tsanani.
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin cuta mai yaduwa.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta samar da jagorar shawarwari mai sauri wanda aka buga a kan layi a cikin Military Medical Research a ranar 06 ga Fabrairu, 2020.
Wannan batu ya jawo hankali sosai tun lokacin da aka buga shi.
Ka lura cewa COVID-19 sabon cuta ne, kuma bisa ga binciken bincike da gwaji na asibiti, sanarwa da iliminmu suna ƙaruwa a hankali. Saboda haka, ana sabunta hanyoyin ganewa da magani a kai a kai.
Misali, hanyoyin ganowa da kuma kula da COVID-19 da kwamitin kula da lafiyar jama'ar kasar Sin (http://www.nhc.gov.cn/) ya fitar, a tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, an buga su a cikin bugu bakwai, wanda ya canza wasu ka'idoji.
Yanzu da muka sami umarninmu na asali daga Zhou da abokan aiki, sun ba da shawara mai sauƙi don yin ƙimar bisa ga kwarewarsu ta asibiti.
Ayyukan su sun kara da cewa akwai sabon shaida a cikin jagorarmu kuma suna ba da kyakkyawar alama ga wannan annoba a duniya.
Muna ba da tabbacin kokarin da suka yi kuma muna ba da shawarwarinmu.
Koyaya, saboda sababbin hanyoyin ganowa da kula da COVID-19 (nau'in gwaji na bakwai) da kuma nazarin kwanan nan, aikin su yana buƙatar sabuntawa.
Bisa ga gyara na bakwai (3 ga Maris, 2020), don tabbatar da abin da ake zargi, dole ne a haɗa kowane ɗayan halaye na tarihin annobar tare da alamun asibiti guda biyu don gudanar da cikakken bincike, ko kuma dole ne a sami alamun asibiti guda uku idan akwai tarihin annobar:
Tarihin annobar: (1) Tarihin tafiya ko zama a birnin Wuhan da yankunan da ke kewaye da shi ko wasu al'ummomin da aka ruwaito cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka a wurin; (2) Tarihin tuntuɓar mutane masu kamuwa da cutar SARS-CoV-2 (ta hanyar gwajin nucleic acid mai kyau); (3) Tarihin tuntuɓar marasa lafiya da ke da zazzabi ko alamun numfashi daga birnin Wuhan da yankunan da ke kewaye da shi ko wasu al'ummomin da aka ruwaito COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka a wurin; (4) Tarihin tuntuɓar tarin abubuwan da aka tabbatar (haɗari 2 na kamuwa da zazzabi da/ko alamun numfashi sun faru a cikin makonni 2 a kananan yankuna kamar gidajen aiki, aji na makaranta, da sauransu).
Alamomin asibiti: (1) zazzabi da/ko alamun numfashi. (2) suna da bayanin hoto na kamuwa da COVID-19; (3) yawan adadin fararen globular, a farkon matakin farawa a cikin nau'in yawan halitta, ragewa, ko ragewa na lymphocytes.
Dole ne ganewar asali da aka tabbatar ya kasance bisa ga wata sanarwa ko cutar ta hanyar cutar ta hanyar gwajin: (1) gwajin PCR na ainihi don SARS-CoV-2 tabbatacce; (2) jerin kwayoyin cuta na kwayar cuta da ke nuna babban homogeneity tare da sabon coronavirus; (3) sakamako mai kyau ga takamaiman IgM antibody da IgG antibody ga SARS-CoV-2 a cikin gwajin magani; ko canzawa na musamman na IgG antibody na SARS-CoV-2 daga mai kyau zuwa mai kyau ko karuwa na jini sau 4 ko fiye a cikin lokaci na farfadowa fiye da haka a cikin lokaci mai tsanani.
Za mu iya ganin cewa an ƙara gwajin PCR na ɗan lokaci, don nucleic acid a cikin tsarin numfashi ko samfurin jini zuwa sigar biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An kara da binciken cututtukan jini zuwa sashi na hudu (27 ga Janairu, 2020) da na biyar (8 ga Fabrairu, 2020); sannan an kara da shaidar serology zuwa na bakwai.
Waɗannan gyare-gyare sun dogara ne akan ci gaba da ƙoƙarin masu bincike don neman ingantaccen kit na ganewar asali na nucleic acid don ganewar asali mai sauri, har ma da samfurori na tsarin numfashi, ciki har da samfurin jini, wanda ya haifar da gano ƙa'idodin da aka tabbatar da su tare da karuwar wadatar samfurori daban-daban da ƙarin tallafi don dogara ga sakamakon gwajin antibody mai kyau.
Bugu da ƙari, akwai ƙarin hujjoji da ke nuna mana mu yi hankali da marasa lafiya da ke da alamun bayyanar cututtuka ko kuma ba su da alamun bayyanar cututtuka.
Saboda haka, dole ne a daidaita jadawalin tafiyar da Zoo da abokan aiki, saboda sun sanya mutane ba tare da alamun asibiti ba a cikin ƙananan haɗari.
Dole ne a ƙara tabbatar da tsarin ƙimar a cikin matakan da nazarin asibiti.
A ƙarshe, muna fatan samun ƙarin hujjoji kai tsaye kuma muna roƙon masu karatu su ba da ra'ayoyinsu.
Don gano abin da ake zargi da kuma tabbatarwa, muna ba da shawarar cewa ku bi sababbin jagororin ƙasashenku.
Ƙungiyarmu za ta ci gaba da samar da jagora don taimakawa, a kan lokaci.
Bangladesh ta ba da rahoton sabbin mutuwar biyar na COVID-19, mafi girma a cikin rana ɗaya
Jiya, Bangladesh ta sanar da cewa za a yi amfani da makamai biyar a rana ɗaya saboda COVID-19.
Wannan shi ne mafi yawan mutuwar da aka samu a cikin rana daya sakamakon cutar.
A jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton mutane 114 da suka kamu da cutar da kuma 33 da suka warke daga ƙarin cututtuka a gida.
An yi rajistar mutuwar mutane 17.
A wani rahoto na kan layi, darektan IEDCR, Dokta Mirjadina Sabrina Flora, ta ce, mutane hudu da mace guda ne suka mutu.
A cewar Dr. Mirjaddy, mutane biyu sun wuce shekaru 60, biyu sun kasance tsakanin shekaru 51 zuwa 60 da kuma daya daga cikin shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda suka mutu sun kasance 'yan Dhaka.
Hukumar lafiya ta duniya (WHO) ta ayyana COVID-19 a matsayin annoba ta duniya a ranar 11 ga Maris.
Wani jami'in asibitin ya shaida wa wata jaridar gida da ke karkashin hukumar Anadolu cewa daya daga cikin kuskuren shi ne shugaban hukumar yaki da cin hanci da rashawa ta Bangladesh, Jalal Saiful Rahman, wanda ke kula da shi a asibitin Maitreya na Kuwait.
A wani sakon bidiyo da aka yi a yanar gizo a ranar Asabar, Ministan Sufuri na Hanyar Hanya da Bridges na Bangladesh, Abd al-Qadar ya ce, har zuwa ranar Asabar mai zuwa, za a yi hutu a kan sufurin jiragen sama na gida fiye da yadda aka tsara.
Shirin izinin jigilar kayayyaki na gida ya fara ne a ranar 26 ga Maris kuma ya kamata ya ƙare a ranar Asabar, 4 ga Afrilu.
Har yanzu ana ba da izinin jigilar kayayyaki masu mahimmanci - magani, wuta da abinci.
An fara samun kamuwa da cutar COVID-19 a Bangladesh a ranar 8 ga Maris, inda aka samu mutum biyu da ke dawowa daga Italiya, kuma matar ɗaya daga cikinsu ta kamu da cutar.
A ranar 19 ga Maris, waɗannan uku sun warke.
Masu kamuwa da cutar SARS-CoV-2 sun wuce miliyan daya a duniya
A ranar Alhamis, adadin masu kamuwa da SARS-CoV-2 a duniya ya wuce miliyan daya, a cewar bayanan Jami'ar Johns Hopkins.
Akalla mutuwar 52,000 na COVID-19 ta danganta da cutar coronavirus.
Wannan shi ne ranar da Malawi ta fara samun kamuwa da cutar coronavirus, kuma Zambia ta fara samun kamuwa da cutar.
Koriya ta Arewa ta yi ikirarin cewa ita ce daya daga cikin 'yan kasashen da suka tsira daga kamuwa da cutar korona a ranar Alhamis.
A jiya, WHO ta ba da rahoton 10,516,635 da aka tabbatar da su, ciki har da 7,93,332 a cikin awanni ashirin da huɗu kafin karfe 10 na safe (00800 UTC) na tsakiyar Turai a ranar 4 ga Afrilu.
A Amurka, an samu fiye da 244,000 na kamuwa da cutar coronavirus, wanda ya kashe aƙalla 5,900.
Labaran CBC sun ruwaito, suna magana ne akan bayanan Jami'ar Johns Hopkins, cewa fiye da mutane 1,000 sun rasa rayukansu a Amurka a ranar Laraba saboda kamuwa da cutar Corona.
A duniya, ƙasashe suna ɗaukar takamaiman matakai don hana yaduwar cutar.
A ranar Alhamis, Sargayi Sobyanin Sharwal na Moscow ya tsawaita hutun birnin har zuwa 1.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa Rasha za ta karɓi albashi ba tare da yin aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta tsawaita dokar ta baci na kwanaki 15 da aka yanke shawara, sakamakon ya kasance da kuri'u 215 a kan, 10 a kan, da kuma kuri'u daya a kan.
Saudiyya ta sanar da dokar hana zirga-zirga a cikin biranen Makka da Madina na tsawon yini; a baya dokar ta hana zirga-zirga tana aiki ne kawai tsakanin karfe 3 na yamma da 6 na safe.
An sanya dokar hana zirga-zirga a Thailand tsakanin 10 na dare da 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa gwamnati ta tsawaita dokar zama a gida har zuwa wata na farko.
Shaguna a Ostiraliya sun rage iyakancewar sayar da kayan wanka a kowane ma'amala
A ranar Lahadi da Asabar da yamma, manyan kantunan Australiya na Walworth da Coles sun rage yawan sayen takarda zuwa biyu da ɗaya a kowane sayayya a duk shagunan ƙasar.
ALDI ta sanar da iyakancewar sayayya guda ɗaya a ranar Litinin.
An sanya waɗannan ƙuntatawa a matsayin saƙo a wurin akwatin biyan kuɗi da shafukan Facebook na shagunan.
An ruwaito cewa masu sayayya suna adana soda saboda tsoron COVID-19 da kuma rashin amfani da su.
A ranar Laraba, Woolworths ta ci gaba da iyakance sayan kayan wanka don isar da ƙofar gida zuwa kunshin ɗaya a kowane tsari.
Wannan sauyawar ta biyo bayan wasu buƙatu guda hudu na kowane iyakancewar ma'amala wanda Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris, bi da bi.
Coles Supermarkets a wata hira da ta yi da kafofin watsa labarai a ranar 8 ga Maris, ta ruwaito cewa duk da ƙuntatawa na fakiti huɗu, ""yawanci daga cikin shagunan suna zuwa ga siyarwa na gaba a cikin sa'a guda bayan isar da kaya"," kuma ya kira bukatar ""marasa misaltuwa"", yayin da shagunan sarkar ALDI, a cikin sakon Facebook a ranar Talata, suka kira siyarwar ""maras tsammani"".
"A cewar wani mai magana da yawun Wallworth, tallace-tallace sun tashi da "mai tsanani".
Kasuwancin Castaco a Canberra ya iyakance adadin da aka ba shi zuwa fakiti biyu a makon da ya gabata.
Don rage wannan karancin, Coles ya ba da umarni ga manyan masu samar da kayayyaki kuma ya kara yawan isar da kayayyaki, Walworth ya ba da umarni ga ƙarin ajiya, kuma Aldi ya riga ya ba da ajiya don tayin na musamman na Laraba.
Rachel Zimmerman, babban darektan kungiyar masu sayar da kayayyaki ta Australiya, ta ce masu sayar da kayayyaki suna ƙoƙari su kara yawan kayayyaki, amma takunkumin da hukumomin yankin suka kafa game da lokacin da ake amfani da manyan motoci ya sanya aiki ya zama da wuya.
Ya yi tsammanin cewa farashin samarwa zai karu, saboda masu samarwa suna ƙoƙari su biya buƙata kuma suna da ƙananan abubuwa na musamman.
A ranar Talata, ALDI (Shirye-shiryen Sayarwa) ta sanar da cewa saboda fitowar hannun jari da wuri, wasu shaguna ba za su iya yin siyarwar musamman a ranar Laraba ba.
A cikin wani rahoto daga News.com.au, ƙwararren masanin kasuwancin kiri, Dr. Gary Mortimer na Jami'ar Fasaha ta Queensland ya ce shagunan suna kammala kayayyakin su kowace dare.
Ya lura cewa kayan wanka abu ne mai girma wanda ke ɗaukar ƙananan sarari a sarari. Idan aka sayar, babban sararin zai kwantar da ɗakunan ajiya kuma ya haifar da rashin ƙarfi.
"Rachel Zimmerman ta shaida wa ABC News cewa, "Koles da Wallworth sun yi imanin cewa idan akwai isasshen kaya a kan ɗakunan ajiya, idan akwai isasshen kayayyaki kamar tawul da kuma maganin rigakafi, za ku iya rage wannan tsananin farashi. """
Wani mai kera kayan wanka mai amfani da kayan wanka mai suna Who Gives a Crap ya ce sun ƙare ranar Laraba kafin su kasance.
A cewar News.com.au, Kimberly-Clark, mai samar da kayan wanka na Clinix da Solaris Paper, mai samar da kayayyakin Sorbent, sun jaddada cewa suna aiki 24 hours a mako don biyan bukatun kasuwa.
Shafin Domain.com, wanda ke aiki a fannin dukiya, ya ruwaito cewa yayin da masu siye ke hutu saboda dogon ranar ma'aikata, kuma ana yin ƙananan gwanjo, wasu masu sayar da dukiya suna ba da kayan wanka kyauta ga mai sayarwa na farko a cikin gwanjo na Melbourne.
Labarin Alhamis na NT News, jaridar da ake buga a Darwin, ya ƙunshi shafi takwas da aka buga don wanka da amfani da su a matsayin kayan wanka.
A cewar rahoton ABC Australia a ranar 3 ga Maris, shagunan da farko ba su da niyyar yin amfani da takunkumi, suna bayyana cewa ba su da shirin yin amfani da takunkumin sayayya.
Russell Zimmerman ya kara da cewa: "Akwai wasu kayayyaki kamar masks, disinfectants, dryers, foda da ruwa don wanke hannu da ake bukata sosai.
Hakazalika, a waje da Ostiraliya, an lura cewa ranar Lahadi da yamma, babban kanti na kan layi na Burtaniya Okadu ya iyakance sayen tawul din gidan wanka zuwa 12 na biyu.
Hukumar lafiya ta duniya ta sanar da barkewar cutar COVID-19
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana ci gaba da barkewar cutar COVID-19 da ta haifar da cutar coronavirus SARS-CoV-2 a matsayin annoba.
"Ko da yake kalmar nan ""zazzabin annoba"" tana nufin yadda cutar ta yadu ne kawai, kuma ba ta nuna cewa akwai wasu cututtuka masu haɗari ba, Hukumar Lafiya ta Duniya ta yi nuni da bukatar ƙarfafa gwamnatoci zuwa ga:
"Dukkanin kasashe na iya canza yanayin annobar a yau".
Tedros Adhanum, shugaban hukumar lafiya ta duniya ya yi imanin cewa, "Idan ƙasashe suka yi aiki na musamman wajen gano, gwada, warkarwa, warewa, ganowa da kuma tattara mutane, za su yi aiki".
"Muna matukar damuwa game da matakan barazanar yaduwar cutar da kuma tsanani da kuma rashin kulawar da ake yi".
"Daga cikin maganganun Dr. Tom Friedman, tsohon darektan Cibiyoyin Kula da Cututtuka na Amurka, wannan annoba ce ta ""ba a taba gani ba"."
"A cikin wata sanarwa da CNN ta wallafa a watan Fabrairu, ta ce, ""ba a gano wani kwayar cutar numfashi ba sai cutar mura daga lokacin bayyanar cututtuka zuwa ci gaba da yaduwar duniya.
Ghebreyesus ya yi irin wannan bayani, yana cewa: "Ba mu taɓa ganin cutar sankara ta coronavirus ba.
Ya ci gaba da cewa, "Ba mu taba ganin wata annoba da za a iya sarrafa ta a lokaci guda ba".
Sabuwar halin da ake ciki a matsayin annoba, ya biyo bayan shawarar Hukumar Lafiya ta Duniya, wadda a watan Janairu ta ayyana barkewar cutar a matsayin gaggawa na kiwon lafiyar jama'a a matakin duniya.
"Darakta Anthony Fosse, darektan Cibiyar Kula da Cututtuka da Cututtuka ta Kasa ta Amurka, ya ce, "A cikin duka, abubuwa suna kara muni".
A ranar Alhamis, Associated Press ta ruwaito cewa akwai akalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya haifar da mutuwar mutane fiye da 4,600.
Cutar cutar coronavirus 2020-2019 wata annoba ce ta ci gaba da kamuwa da cutar coronavirus 2019 (COVID-19), wanda ya haifar da cututtukan numfashi mai tsanani na coronavirus 2 (SARS-COVID-2).
An gano cutar a watan Disamba na 2019 a Wuhan, China, a ranar 30 ga Janairu, 2020 an ayyana ta a matsayin dokar ta baci ta lafiyar jama'a ta kasa, kuma a ranar 11 ga Maris, 2020 an bayyana ta a matsayin cutar annoba.
Ya zuwa ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210 da yankuna, wanda ya haifar da mutuwar kusan mutane 97,000.
Kimanin mutane 364,000 sun warke.
An kiyasta cewa mutuwar mutane a kasar Sin ta kai kashi 4 cikin 100, duk da haka, a duniya, ta bambanta daga kashi 13.4 cikin 100 a Algeria zuwa 0.08 cikin 100 a New Zealand.
Alamomin da aka saba da su sun hada da zazzabi, tari da kuma numfashi.
Abubuwan da ke tattare da cutar sun hada da huhu da kuma cututtukan numfashi mai tsanani.
Ana ɗaukar kwanaki 5 daga lokacin da aka fara kamuwa da cutar zuwa lokacin bayyanar cututtuka, amma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
Babu wani magani ko maganin rigakafi na musamman don cutar.
Maganin farko shine ainihin maganin bayyanar cututtuka da kuma magani na tallafi. Ana ba da shawarar matakan rigakafi, ciki har da wanke hannu, rufe bakinka lokacin da kake shan cough, nisantar da kai daga wasu mutane da kuma bincika da killace mutanen da ake zaton suna da cutar.
Hukumomi a duk faɗin duniya sun amsa ga takunkumin tafiye-tafiye, killacewa, ƙuntatawa, sarrafa haɗarin aiki da hutun wurare.
Wannan annoba ta haifar da mummunan rikicewar tattalin arzikin zamantakewa a duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu, da kuma ƙarancin albarkatu da ke haifar da tsoron cin kasuwa.
Makarantu da jami'o'i a kasashe 193 sun rufe ko dai a matakin ƙasa ko na gida, kuma wannan ya shafi kusan kashi 99.4% na yawan ɗaliban duniya.
An wallafa bayanan da ba daidai ba game da cutar a kan layi, kuma an lura da wasu lokuta na tsoratarwa da nuna bambanci ga Sinawa, sauran mutane na launin fata da kuma yankin Gabas da kudu maso gabashin Asiya da sauran yankuna da suka sami yawan kamuwa da cutar.
Saboda rage yawan tafiye-tafiye da hutun masana'antu masu nauyi, iska ta lalace da kuma fitar da carbon.
Hukumomin lafiya na Wuhan, China (Babban birnin lardin Hubei), sun ba da rahoton wani lamari na cutar pneumonia da wani sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen san sanannen sanannen san san san sanannen sanannen sanannen san san sanannen sanannen san san san san san san san san san san san san san san san san san sanannen san san san san san san san san san san san sanannen san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san san
Masu cutar sun kasance suna hulɗa da kasuwar sayar da kayayyakin teku na Hunan, saboda haka ana tunanin cewa cutar ta samo asali ne daga cutar zeonosis (rashin lafiya na mutum da dabba).
Wannan kwayar cutar da aka sani da SARS-CoV-2 ita ce sabuwar kwayar cutar da aka gano da ke da halaye masu kama da kwayar cutar bats, coronavirus pangolin da SARS-CoV. An gano cewa mutumin da ya fara nuna alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma ba shi da wata hulɗa da kasuwar kayayyakin teku.
Daga cikin rukunin farko na abubuwan da aka ruwaito a watan Disamba na 2019, an gano cewa kashi biyu bisa uku na abubuwan da suka faru suna da alaƙa da kasuwa.
A ranar 13 ga watan Maris, 2020, wani rahoto da ba a tabbatar ba daga South China Morning Post ya nuna cewa, wani abu kamar wanda aka gano a ranar 17 ga Nuwamba, 2019 a cikin wani mutum mai shekaru 55 a lardin Hubei, na iya zama farkon kamuwa da cutar. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, a cikin sabon raguwar sabbin lokuta a China, Italiya, Iran da Koriya ta Kudu, adadin kamuwa da cutar ya karu da sauri, adadin sababbin lokuta a waje da China ya wuce adadin sababbin lokuta a China a karon farko.
Ƙila ba a bayar da rahoton muhimman bayanai ba, musamman a cikin waɗanda ke da alamun da suka fi sauƙi.
Har zuwa 26 ga Fabrairu, an samu rahotanni na rashin lafiya a cikin ƙananan shekaru, kuma kashi 2.4% na yawan marasa lafiya a duniya sun kasance shekaru 19 da ƙasa da haka. Patrick Wallace, babban mai ba da shawara kan kimiyya na gwamnatin Burtaniya ya kiyasta cewa don samun rigakafin jama'a, dole ne 60% na yawan mutanen Burtaniya su kamu da cutar.
An gano cewa an gwada mutane da suka kamu da cutar COVID-19 kuma an tabbatar da gwajin su a matsayin tabbatacce bisa ga tsarin aiki.
Tun daga ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da 3% na yawan jama'arta, kuma manufofin hukuma na ƙasashe da yawa, ciki har da Italiya, Netherlands, Spain da Switzerland, sun ƙi yin gwaji ga mutanen da ke da alamun bayyanar cututtuka.
Wani binciken da aka buga a ranar 16 ga Maris ya nuna cewa a kasar Sin, har zuwa 23 ga Janairu, kusan kashi 86% na kamuwa da cutar COVID-19 ba a gano su ba, kuma waɗannan kamuwa da cutar da ba a sanya musu takunkumi ba sun kasance tushen kamuwa da cutar ga kashi 79% na kamuwa da cutar da aka sanya musu takunkumi.
Nazarin kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa yawan kamuwa da cuta a Italiya ya fi yawan wadanda aka ruwaito.
Kwanan farko na ƙididdigar ƙimar haɓaka (R0) don COVID-19 ya kasance daidai da 1.4 zuwa 2.4 lokuta.
Wani binciken da Cibiyar Kula da Cututtuka ta Amurka ta wallafa ya bayyana shi da 5.7.
Yawancin mutane da ke da cutar COVID-19 sun warke.
Ga wadanda ba haka ba, lokacin bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, wanda ya fi yawa shine kwanaki 14.
Tun daga ranar 10 ga Afrilu, 2020, an yi rahoton kusan mutuwar 97,000 na COVID-19.
A kasar Sin, tun daga ranar 5 ga Fabrairu, kimanin kashi 80% na mutuwar sun faru a cikin mutanen da suka wuce shekaru 60, kuma kashi 75% na su sun sami cututtukan cututtuka na baya, ciki har da cututtukan zuciya da ciwon sukari.
Yawan mutuwar COVID-19 na gaske ya fi girma, saboda ba ya haɗa da waɗanda suka mutu ba tare da gwaji ba, misali, a gida ko asibitoci.
Bayanai na farko daga Italiya sun nuna cewa adadin mutuwar da aka samu daga cutar ta ninka sau 5 zuwa 4 na adadin mutuwar da aka sanar a hukumance daga COVID.
"Shugaban kula da cututtuka na Amurka (CDC) ya tabbatar da cewa ""mun san cewa [hadarin] ya fi na ainihi". " Rahotanni daga wasu lokuta da ba a sani ba a Amurka sun tabbatar da wannan. Wannan ƙididdigar ba ta da gaskiya, sau da yawa a cikin annobar cutar sankarar halittun alade kamar cutar H1N1 ta H1N1. An bayar da rahoton mutuwar farko a ranar 9 ga Janairu, 2020 a Wuhan. "
Mutuwar farko a waje da kasar Sin a ranar 1 ga Fabrairu a Philippines da kuma mutuwar farko a waje da nahiyar Asiya a ranar 14 ga Fabrairu a Faransa.
A ranar 28 ga watan Fabrairu, an samu fiye da goma daga cikin wadanda suka kamu da cutar a kasashen waje kamar Iran, Koriya ta Kudu da Italiya.
Har zuwa ranar 13 ga Maris, an ruwaito mutuwar a cikin kasashe da yankuna sama da arba'in, a duk nahiyoyi sai dai kudancin duniya. Ana amfani da wasu ma'auni don ƙayyade yawan mutuwar.
Wadannan lambobi sun bambanta a yankuna daban-daban da kuma lokatai daban-daban, kuma suna shafar abubuwa kamar yawan gwaje-gwajen da aka yi, ingancin tsarin kulawar jiyya, zaɓuɓɓukan magani, tsawon lokacin da aka fara yaduwar cutar, da kuma halaye na yawan jama'a kamar shekaru, jinsi, da lafiyar jama'a.
A cewar kididdigar Jami'ar Johns Hopkins, a duniya, adadin mutuwar da aka samu daga cutar ya kai kashi 6% (9,7039 daga 161,7204).
Lambobin sun bambanta dangane da yankin.
A kasar Sin, an rage yawan mutuwar da aka kiyasta daga kashi 17.3% (mutanen da suka fara bayyanar cututtuka na 1 zuwa 10 ga Janairu 2020) zuwa kashi 0.7% (mutanen da suka fara bayyanar cututtuka bayan 1 ga Fabrairu 2020). Sauran kididdigar sun haɗa da: CFR (CFR) wanda ke nuna kashi na mutanen da aka gano suna mutuwa daga cutar da kuma yawan mutuwar kamuwa da cutar (IFR IFR) wanda ke nuna kashi na mutanen da aka kamu da cutar (wanda aka gano da waɗanda ba a gano ba) da ke mutuwa daga cutar.
Wannan adadi ba shi da iyaka a lokaci kuma ya dogara da wani al'umma daga kamuwa da cutar zuwa warkewa.
Wasu masu bincike na jami'a sun yi ƙoƙari su lissafa wannan adadin don wani al'umma.
Cibiyar Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar cutar ta duniya a duniya ya kasance tsakanin 0.1% zuwa 0.39%.
Wannan kimantawa na wannan zangon ya yi daidai da sakamakon gwajin COVID-19 na bazuwar a Jamus da kuma nazarin ƙididdigar nazarin tasirin gwajin akan kimantawar CFR.
Hukumar lafiya ta duniya ta amince cewa za a iya sarrafa cutar ta duniya.
Ƙarshen yaduwar cutar da kuma lokacin da ta ƙare ba a san shi ba kuma zai iya bambanta dangane da wuri.
Maciej Boni na Jami'ar Jihar Penn ya ce: "Idan ba a bincika cutar ba, yawanci ba za a iya juyawa ba bayan wani lokaci kuma za a rage bayan an gama da rundunar da ke wurin.
"Amma a yanzu, babu wani kyakkyawan tsinkaya game da lokacin da cutar za ta ƙare".
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin, Zhong Nanshang, ya ce idan dukkan kasashe suka iya karfafawa kowa don bin shawarwarin Hukumar Lafiya ta Duniya game da matakan da za a dauka na dakile yaduwar cutar, "za a iya kammala shi a watan Yuni".
A ranar 17 ga watan Maris, Adam Kucharski na Kwalejin Lafiya da Magunguna ta London ya bayyana cewa SARS-CoV-2 "yana yaduwa kuma yana iya kasancewa shekara guda ko biyu".
"A cewar wani binciken da aka gudanar da kwalejin Imperial karkashin jagorancin Neil Ferguson, za a bukaci a yi nisa da jiki da kuma wasu matakai" har sai an samu maganin (kimanin watanni 18 ko fiye).
William Schaffner na Jami'ar Vanderbilt ya ce, "Na yi imanin cewa cutar ba za ta iya ɓace ba - saboda tana da matukar yaduwa", kuma "yana iya zama cuta ta yanayi da ke sake barkewa a kowace shekara".
Matsayin da za a iya kamuwa da cutar ya dogara da rashin lafiyar shanu da kuma yawan motsin su.
Alamun COVID-19 na iya zama marasa ƙayyadaddun kuma mutane masu kamuwa da cutar na iya zama marasa alamar.
Alamomin biyu na kowa sune zazzabi (kashi 88) da kuma rashin ƙarfi (kashi 68%).
Alamun da suka fi muni sun haɗa da gajiya, samar da numfashi (rashin numfashi), rashin jin ƙanshi, numfashi mai ƙyama, ciwon tsoka da haɗin gwiwa, wuya, ciwon kai, rawar jiki, zubar da jini, tari ko ciwon huhu. Ƙungiyar lafiya ta duniya ta ce kusan mutum ɗaya cikin shida yana rashin lafiya sosai kuma yana fama da wahalar numfashi.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta bayyana alamun gaggawa a matsayin rashin numfashi, ciwon ciwon kirji ko jin damuwa, rikicewar hankali, rashin jin dadi daga barci da kuma cizon fuska ko lebe; idan akwai waɗannan alamun, ana ba da shawarar gaggawa na likita. Ƙarin ci gaba na cutar na iya haifar da ciwon kirji mai tsanani, cutar numfashi mai tsanani, ciwon hanci, damuwa, da mutuwa.
Wasu mutane masu kamuwa da cutar na iya zama marasa bayyanar cututtuka kuma ba su da alamun asibiti, amma sakamakon gwajin gwajin ya tabbatar da cewa suna kamuwa da cutar, saboda haka masu bincike sun ba da shawarar cewa mutanen da ke da kusanci da waɗannan cututtuka su yi bincike da kyau don hana yaduwar kamuwa da cuta.
An kiyasta adadin marasa lafiya marasa alamun cutar a China daga ƙananan ƙididdiga zuwa 44%.
Lokacin incubation (lokacin kamuwa da cuta da fara bayyanar cututtuka) yawanci ya bambanta daga kwana ɗaya zuwa goma sha huɗu; a mafi yawan lokuta, yana da kwanaki biyar. Misali na rashin tabbas shine, ƙididdigar ƙarancin mutanen da ke fama da COVID-19 waɗanda suka rasa ƙanshi sun ragu da 30% da 15% daga baya.
Wasu bayanai game da yaduwar cutar sun bayyana kwanan nan.
An yi imanin cewa a farkon matakan, cutar ta kamu ne ta hanyar kusanci da ƙananan saukad da ke faruwa yayin da kuka yi tari, jin ƙishirwa ko magana, idan aka yi la'akari da kusanci tsakanin mita 1 zuwa 2 (ƙaffi 3 zuwa 6).
Nazarin ya nuna cewa lokacin da aka yi amfani da shi ba tare da wani abu ba, za a iya motsa saukad da daga mita 4.5 (ƙaffi 15) zuwa mita 8.2 (ƙaffi 27).
Wasu sun ba da shawarar cewa cutar na iya yadawa ta hanyar saukad da ruwa masu saurin yaduwa, alal misali, lokacin magana da ke rataye a cikin iska na tsawon lokaci. Saukad da numfashi na iya yadawa yayin numfashi da lokacin magana, kodayake ba a yadu da cutar ta hanyar iska.
Wadannan saukad da zasu iya shiga cikin bakunanmu ko hancin mutanen da ke kusa da mu kuma su shiga cikin huhu.
Wasu hanyoyin likita kamar bututun jini da kuma CPR na iya haifar da yaduwar iska ta numfashi, wanda zai haifar da fitar da iska.
Idan ka taɓa wani abu mai cutarwa kamar fata sannan ka taɓa idanunka, hanci da bakinka, cutar za ta iya yaduwa.
Duk da cewa akwai damuwa game da yaduwar cutar daga kwayar cutar, wannan haɗarin ba shi da mahimmanci.
Gwamnatin kasar Sin ta yi watsi da yiwuwar kamuwa da cutar ta hanyar cutar SARS-CoV-2. Kwayar cutar tana da yawa a cikin kwanaki uku na farko bayan bayyanar cututtuka, amma tana iya yaduwa ga wasu kafin bayyanar cututtuka da kuma a ƙarshen cutar.
An gwada mutane da kyau har kwana uku kafin bayyanar cututtuka, wanda ke nuna cewa ana watsawa kafin bayyanar bayyanar cututtuka.
Akwai wasu rahotanni kaɗan na marasa alamar da aka tabbatar da su a cikin dakin gwaje-gwaje, amma an gano wasu ƙasashe a cikin binciken da aka yi na gano mutane ba tare da alamar ba.
Cibiyar Tsaro da Kula da Cutar Cutar ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar za ta iya yaduwa ba, mutum ɗaya da aka kamu da ita zai iya kamuwa da wasu mutane biyu zuwa uku. Kwayar tana zama a saman farfajiya na tsawon sa'o'i zuwa kwanaki.
A musamman, an lura cewa cutar tana iya ganewa fiye da kwana uku a kan filastik (polypropylene) da kuma bakin karfe 304 a rana ɗaya a kan aljihu da kuma fiye da sa'o'i hudu a kan tagulla.
Amma wannan ya canza dangane da zafi da zafin jiki. Gwajin COVID-19 ya tabbatar da cewa dabbobi da sauran dabbobi sun kasance masu kyau.
Babu tabbaci cewa dabbobi za su iya watsa cutar ga mutum, ko da yake hukumomin Birtaniya sun ba da shawarar cewa a wanke hannayenka bayan ka sadu da dabbobi, kamar yadda kake yi idan ka taɓa wasu wurare masu cutar.
Coronavirus 2 acute respiratory syndrome (SARS-CoV-2) sabon cutar ce da aka fara ganowa a cikin mutane uku da ke fama da cututtukan kirji da gwiwoyi a cikin jini waɗanda suka rasa iskar oxygen a cikin jini da kuma matsalolin numfashi.
Dukkanin siffofin sabon coronavirus suna bayyana a cikin sauran coronavirus na halitta. A waje da jikin mutum, ana kashe kwayar tare da sabulu na yau da kullun, saboda an warware shi a cikin sabulu. SARS-CoV-2 yana da alaƙa da SARS-CoV.
Ana ganin cewa cutar ta samo asali ne daga cutar zoonosis ko kuma ta kasance ta ɗan adam da dabba.
Nazarin kwayoyin halitta ya nuna cewa kwayar cutar ta hanyar kwayoyin halitta tana da nau'i na Betacoronavirus da kuma Sarbecovirus (B) tare da nau'i biyu na asalin kunyar fuka.
Wannan kwayar cutar tana da kama da kashi 96% na dukkanin kwayoyin halitta tare da sauran samfurori na kwayar cutar BatCov RaTG13.
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa a wasu sassan tsarin kwayoyin halittar mutum, akwai bambanci guda daya kawai tsakanin kwayar cutar pangolin da na mutum.
Idan aka kwatanta da dukan kwayoyin halittar mutum zuwa yau, akwai kashi 92% na kwayoyin halitta da aka haɗa tsakanin coronavirus pangolin da SARS-CoV-2, wanda bai isa ya tabbatar da pangolin a matsayin mai masaukin baki ba.
Ana iya gano kamuwa da cutar ta wucin gadi ta hanyar bayyanar cututtuka, ko da yake ana iya tabbatar da cikakken ganewar asali ta hanyar hanyar jujjuyawar polymerase transcription chain reaction (Rrt-PCR) na kamuwa da cuta ko CT imaging.
Wani binciken da ya kwatanta polymerase chain reaction (PCR) da CT scan (CT) a Wuhan ya nuna cewa CT ya fi PCR hankali, ko da yake ba shi da ƙwarewa kuma yana da yawancin siffofin hoto tare da sauran nau'ikan ƙirji da kuma hanyoyin cutar.
"Tun daga watan Maris na shekarar 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "" kada a yi amfani da CT don yin allurar rigakafi ko gwajin layin farko na gano COVID-19"."
Hukumar lafiya ta duniya ta fitar da wasu hanyoyin gwajin RNA don SARS-CoV-2, wanda ya fara a ranar 17 ga Janairu.
Gwajin yana amfani da jerin abubuwan da ke cikin polymerase mai karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar
Ana iya yin gwajin a kan samfurori na numfashi ko jini.
Sakamakon yawanci yakan zo cikin 'yan sa'o'i zuwa kwanaki.
Ana yin gwajin ne da maganin antibody, ko da yake ana iya amfani da maganin anti-glucose. Yawancin dakunan gwaje-gwaje da kamfanoni suna samar da gwaje-gwaje na serological don gano antibodies.
Har zuwa ranar 6 ga Afrilu, 2020, babu ɗayan waɗannan da aka yi amfani da su don amfani da su sosai.
A Amurka, gwajin serological da Cellex ta tsara ya sami izinin amfani da gaggawa kawai daga dakunan gwaje-gwaje masu izini.
Bayanan hoto na musamman a cikin hotunan radiology da CT na mutane masu alamun sun haɗa da ƙirar gilashin gilashi kuma ba a lura da ɓarna ba.
Kungiyar Radiology ta Italiya tana tattara bayanai a kan layi na binciken hoto na abubuwan da suka faru na cutar.
Saboda lokaci tare da sauran cututtuka kamar adenoviruses, daukar hoto ba tare da tabbacin PCR na ƙarshe ba yana da iyakancewa ga gano COVID-19.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na kwandon ƙirjin da PCR kuma ya nuna cewa, ko da yake daukar hoto ba shi da amfani sosai ga wannan kamuwa da cuta, yana da mahimmanci da sauri kuma yana iya zama kayan aikin bincike a yankunan annobar.
An kirkiro cibiyoyin sadarwa masu mahimmanci na AI don gane siffofin hoto na cutar a cikin hotunan radiology da CT.
Hanyoyi na hana kamuwa da cutar sun hada da kiyaye lafiyar mutum gaba ɗaya, wanke hannu, kada ku taɓa idanu, hanci ko baki da hannayen da ba a wanke ba, kuma ku yi sallama ko ƙwanƙwasa a cikin tawul, da kuma jefa tawul cikin sauri a cikin shara.
Wadanda suka riga sun kamu da cutar an bada shawara su yi amfani da abin rufe fuska na tiyata a wuraren da jama'a ke.
Ana kuma ba da shawarar yin nesa ta jiki don hana yaduwar. Yawancin gwamnatoci sun iyakance duk balaguron da ba dole ba zuwa ƙasashe da yankuna da ke fama da yaduwar cutar.
Koyaya, a manyan sassan duniya, cutar ta riga ta kai matakin yaduwa a cikin al'umma.
Wannan yana nufin cewa cutar tana yaduwa tsakanin al'ummomi kuma wasu mutane ba su san inda ko yadda suka kamu ba. Ana ba da shawarar cewa masu ba da sabis na kulawa waɗanda za su iya kula da wanda ke kamuwa da cutar su ɗauki matakan kariya, kiyaye hankali yayin tuntuɓar da kuma kiyaye idanu. Bin diddigin tuntuɓar mutumin da ke kamuwa da cutar hanya ce mai mahimmanci da hukumomin lafiya ke amfani da ita don gano tushen kamuwa da cutar da hana ƙarin yaduwa.
Amfani da bayanan wuri na wayoyin hannu da gwamnatoci ke yi ya haifar da damuwa game da kiyaye sirrin sirri, inda Amnesty International ta yi aiki tare da fiye da kungiyoyi 100 da suka ba da sanarwar neman iyakance irin wannan aikin sa ido.
An yi amfani da aikace-aikacen wayar hannu da yawa ko kuma an ba da shawarar yin amfani da su a matsayin aikin sa kai, kuma tun daga ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyi goma sha biyu na masana suna aiki a kan hanyoyin da za su kiyaye tsare sirri kamar amfani da Bluetooth don shiga wayar hannu tare da masu amfani da su.
Masu amfani za su karɓi saƙo inda za a tambaye su ko sun kasance a cikin tuntuɓar kai tsaye da wani wanda ya yi gwajin COVID-19 a kwanan nan. Abubuwan da ba daidai ba game da yadda za a hana kamuwa da cuta sun zama gama gari, misali, wanke hanci da kuma shafawa da ruwan wanke-wanke ba su da tasiri.
Babu allurar rigakafin COVID-19, duk da haka ƙungiyoyi daban-daban suna aiki don samun ta.
Ana bada shawara a wanke hannu don hana yaduwar cutar.
Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta ba da shawarar cewa mutane su wanke hannayensu da sabulu na akalla na biyu, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun zama ƙazanta sosai; kafin cin abinci; bayan sun yi ta wanka, suna taho ko suna jin ƙishirwa.
Domin cutar tana kashewa a waje da jikin mutum tare da sabulu na yau da kullum, saboda sabulu yana kawar da murfin kariya.
CDC ta kuma ba da shawarar yin amfani da maganin hana shan giya na hannu tare da aƙalla 60% barasa idan babu ruwa da sabulu.
Hukumar lafiya ta duniya ta shawarci mutane da su guji taɓa idanu, hanci ko baki da hannayensu marasa wanka.
Za'a iya yin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin
Sauran mafita kamar benzalkonium chloride da chloride gluconate suna da tasiri kaɗan.
A cewar shawarar CDC, idan mutum yana da wata shakka game da COVID ko kuma an tabbatar da shi a wani wuri kamar ofishi ko cibiyar kula da cutar, dole ne a gurbata dukkan wuraren kamar ofisoshin, sabis na kiwon lafiya, wuraren watsa labarai, kayan lantarki na kowa kamar kwamfutar hannu, nunin taɓawa, allon maɓalli, na'urorin sarrafawa na nesa da na'urorin ATM da marasa lafiya ke amfani da su.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su riƙe tawul ko ƙuƙwalwarsu a gaban bakinsu da hanci lokacin da suke tari ko suna tari, kuma su jefa tawul ɗin takarda a waje nan da nan.
Ana ba da shawarar yin amfani da masks na tiyata ga mutanen da suka kamu da cutar, saboda mask zai iya rage girman da kuma nisa na saukad da numfashi yayin magana, tari da kuma tari.
Hukumar lafiya ta duniya ta fitar da umarni game da lokacin da kuma yadda za a yi amfani da abin rufe fuska.
"A cewar Stephen Griffin, masanin ilimin cutar na Jami'ar Leeds, ""saka abin rufe fuska zai iya rage sha'awar mutane su taba fuskarsu, wanda shine babban abin da ke haifar da kamuwa da cuta, yayin da suke zaune tare da hannu. "" An kuma bada shawarar yin amfani da abin rufe fuska ga mutanen da ke kula da abubuwan da ake zargi da cutar. "
Hukumar lafiya ta duniya ta ba da shawarar cewa masu lafiya su yi amfani da abin rufe fuska ne kawai idan suna da haɗari mai yawa, misali, suna kula da waɗanda ke da cutar COVID-19, duk da haka ta tabbatar da cewa yin amfani da abin rufe fuska na iya taimakawa mutane su guji taɓa fuskarsu.
Kasashe da dama sun fara ƙarfafa jama'a su yi amfani da abin rufe fuska.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na likita wanda ba na likita ba ne wanda aka yi da masana'anta. Musamman, China ta ba da shawarar yin amfani da abin rufe fuska na likita sau ɗaya ga mutanen da ke da lafiya a cikin al'umma, musamman a kusan mita 1 (ƙafa 3 ko ƙasa da haka) tare da wasu mutane.
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska na tiyata a cikin zirga-zirgar jama'a ko wuraren da ke da mutane da yawa.
Jami'an lafiya na Thailand suna karfafa mutane su samar da abin rufe fuska a gida da kuma wanke tufafinsu.
Jamhuriyar Czechoslovakia ta haramta zuwa wuraren jama'a ba tare da saka abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa ya saka abin rufe fuska don kare kansa da kuma wasu a wuraren jama'a.
Gwamnatin Austria ta tilasta masu shiga kantin sayar da abinci su saka abin rufe fuska.
Isra'ila ta bukaci dukkan 'yan kasar su sa abin rufe fuska a wuraren jama'a.
Taiwan, wadda ta kai karfin samar da masks miliyan goma a rana tun tsakiyar watan Maris, ta sanya amfani da masks a kan fasinjojin jiragen kasa da bas din tsakanin birane daga ranar 1 ga Afrilu.
A Panama, yin amfani da abin rufe fuska a waje wajibi ne, kuma waɗanda ba za su iya yin amfani da abin rufe fuska ba dole ne su yi amfani da shi a gida.
An yi amfani da masks a Japan, Koriya ta Kudu, Malaysia da Singapore.
Tsayawa ta zamantakewa (wanda kuma aka sani da nesa ta jiki) ya ƙunshi matakan sarrafa kamuwa da cuta da aka aiwatar da nufin rage cutar ta hanyar rage lamba tsakanin mutane.
Hanyoyi sun haɗa da killacewa; ƙuntatawa na tafiya; da kuma hutu a makarantu, wuraren aiki, wuraren wasanni, gidajen wasan kwaikwayo, ko wuraren cin kasuwa.
Mutane za su iya kiyaye nesa ta hanyar kasancewa a gida, ta hanyar iyakance tafiya, ta hanyar guje wa wuraren da mutane suke da yawa, ta hanyar yin amfani da kuri'un zabe ba tare da tuntuɓar su ba, da kuma ta hanyar kiyaye nesa da wasu.
Yawancin gwamnatoci sun riga sun tilasta ko kuma sun ba da shawarar yin nesa da jama'a a cikin wuraren da ake yin killacewa waɗanda ke fama da cutar.
Yawan jama'a a cikin al'ummomin da hukumomin gwamnati da kungiyoyin kiwon lafiya a Amurka suka ba da shawarar, ya ragu da sauri daga 250 (idan babu yaduwar COVID-19 a yankin) zuwa 50 da kuma 10 a gaba.
"Tun daga ranar 22 ga Maris, 2020, Jamus ta haramta yin taro da mutane fiye da biyu. Mutanen da ke fama da cututtukan cututtuka masu zuwa kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini da rashin ƙarfi na tsarin rigakafi suna da haɗarin kamuwa da cututtuka masu tsanani da kuma rikice-rikice, kuma a cewar shawarar CDC, ya kamata su kasance a gida a wuraren da jama'a ke yaduwa kamar yadda zai yiwu. A ƙarshen Maris, 2020, Hukumar Lafiya ta Duniya da sauran kungiyoyin kiwon lafiya sun canza kalmar ""nesa ta zamantakewa"" zuwa ""nesa ta jiki"" don gano manufar rage saduwa ta jiki yayin da kiyaye sadarwar zamantakewa ta hanyar sadarwa ta hanyar sadarwa ko ta nesa. "
"Amfani da kalmar ""rashin zaman lafiya"" ya haifar da ra'ayin cewa mutane su shiga cikin ƙarin zamantakewar zamantakewa, ba don ƙarfafa su su yi hulɗa da wasu ta hanyar maye gurbin ba. Wasu hukumomi sun ba da jagororin kiwon lafiya na jima'i a lokacin annobar. "
Wadannan sun hada da shawarar yin jima'i na iyakance ga abokin tarayya wanda ba shi da alamun cutar.
An ba da shawarar sanya masu kamuwa da COVID-19 da waɗanda ake zaton suna da cutar a cikin keɓewa.
Kungiyoyin kiwon lafiya sun ba da cikakkun hanyoyin da za a iya yin amfani da su don yin amfani da kai. Yawancin gwamnatoci sun ba da shawarar yin amfani da kai-kafaren kai ga dukan mutanen da ke zaune a yankunan da aka kamu da cutar.
An ba da umarnin yin keɓancewa kai tsaye mafi mahimmanci ga ƙungiyoyin haɗari.
An shawarci mutanen da suka yi hulɗa da wani wanda ke da cutar COVID-19 da kuma waɗanda suka yi tafiya zuwa ƙasar ko yankin da ke da yaduwar cutar kwanan nan su kasance cikin keɓewa na kwanaki 14 daga lokacin da aka yi musu hulɗa da su.
Dabarun sarrafa yaduwar cutar sun haɗa da iyakancewa ko ragewa da rage yawan yaduwar.
Ana sanya takunkumi a farkon fasalin yaduwar cutar kuma ana nufin ganowa da kuma ware masu kamuwa da cutar, da kuma gabatar da wasu matakan sarrafa cutar da yin allurar rigakafi don dakatar da yaduwar cutar zuwa wasu mutane.
Lokacin da ba za a iya hana cutar farawa ba, ƙoƙarin zai koma ga raguwa: an ɗauki matakan rage saurin yaduwar cutar da rage tasirin ta akan tsarin kiwon lafiya da al'umma.
Ana iya amfani da haɗuwa da matakan iyakancewa da ragewa a lokaci guda.
Dakatar da cutar na bukatar tsauraran matakai don samun ƙimar yaduwar cutar ta zama ƙasa da 1. Wani ɓangare na gudanar da cutar shine rage ƙimar cutar, wanda ake kira daidaitawar cutar ta cutar.
Wannan zai rage haɗarin yin amfani da sabis na kiwon lafiya da kuma ba da ƙarin lokaci don samar da allurar rigakafi da magani.
Hanyoyin da ba na magani ba waɗanda zasu iya sarrafa yaduwar cutar sun haɗa da matakan kariya na mutum, kamar kiyaye tsabtace hannu, sanya abin rufe fuska da keɓewa; matakan jama'a don yin nisa ta jiki kamar hutun makaranta da soke taron taro; haɗin gwiwar jama'a don ƙarfafa karɓa da shiga cikin irin waɗannan ayyukan; da kuma matakan muhalli kamar tsabtace farfajiyar. Mafi yawan matakan da aka ɗauka don hana yaduwar cutar a China lokacin da aka bayyana girman yaduwar, kamar keɓewar birane gaba ɗaya da haramcin tafiya.
Sauran ƙasashe sun ɗauki matakai daban-daban don rage yaduwar cutar.
Koriya ta Kudu ta yi amfani da allurar rigakafi da killacewa na gida, kuma ta yi gargadin yin zirga-zirga da kuma motsa mutane masu kamuwa da cutar.
Singapore ta ba da tallafi ga masu cutar da suka yi wa kansu killacewa kuma ta ba da manyan tarar waɗanda suka yi watsi da killacewa.
Taiwan ta kara samar da masks kuma ta yi la'akari da manyan tarar kudi don amfani da kayan aikin likita. Simulations da aka yi game da Birtaniya da Amurka sun nuna cewa rage cutar (ragewa da kuma dakatar da saurin cutar) da kuma jinkirta (sake mayar da saurin cutar) suna da manyan kalubale.
Manufofin daidaitawa na iya rage yawan buƙatun kiwon lafiya zuwa kashi biyu bisa uku da rabi, amma har yanzu suna haifar da mutuwar dubbai da kuma wucewa da damar tsarin kiwon lafiya.
Ana iya yin taurin kai, amma dole ne a ci gaba da yin hakan har sai an yi amfani da cutar tsakanin mutane (ko kuma an yi allurar rigakafi, duk abin da ya faru da wuri), in ba haka ba, idan an rage matakan gaggawa kaɗan, cutar za ta sake tashi kuma ta iya yaduwa.
Wannan ya haifar da dogon lokaci na tsayayya da annoba, da kuma amfani da zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19 da aka amince da shi, amma ana ƙoƙari don gwada maganin da ke akwai.
Shan maganin zubar da jini ba tare da takardar sayan magani ba, shan ruwa da hutawa na iya taimakawa wajen rage alamun.
Dangane da tsanani, magani tare da oxygen, ruwa a cikin jijiyoyin jini da kuma numfashi na taimako na iya zama dole.
Yin amfani da steroids na iya ƙara rikicewar cutar.
Yawancin magungunan da suka kasance masu tasiri a cikin maganin sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutuka.
Hukumar lafiya ta duniya ta ce wasu "kayan gida da na gargajiya" na iya rage sakamakon cutar SARS-CoV-19.
Ƙara ƙarfin da kuma aiwatar da kulawar lafiya don biyan bukatun marasa lafiya na COVID-19 ta WHO an bayyana shi a matsayin muhimmin mataki na mayar da martani ga yaduwar cutar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) da kuma ofishin yanki na Hukumar Lafiya ta Duniya (WHO) sun ba da umarni ga asibitoci da sabis na kiwon lafiya da na farko don juya albarkatu a matakan daban-daban, gami da mayar da hankali daga ayyukan dakin gwaje-gwaje zuwa gwajin COVID-19, soke hanyoyin zaɓin idan ya yiwu, cirewa da killace marasa lafiya masu cutar COVID-19, da haɓaka ƙwarewar kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka yawan injunan iska da na'urori.
Akwai ka'idoji daban-daban game da asalin mutumin da ya fara kamuwa da cutar (wanda ake kira mai haƙuri na 0).
Wanda aka fara gano sabon cutar korona zai iya dawowa ranar 1 ga Disamba, 2019 a Wuhan, Hubei da China.
A cikin wata daya, adadin masu kamuwa da cutar korona a Hubei ya karu.
Yawancin su sun shafi kasuwar sayar da abincin teku ta Hunan, inda ake sayar da dabbobi masu rai a can, kuma akwai ka'idar cewa cutar ta samo asali ne daga waɗannan nau'ikan dabbobi; ko kuma, a wasu kalmomin, zoonotic. An gano tarin huhu tare da wani sanannen dalili a ranar 26 ga Disamba kuma an sanar da shi a Cibiyar Kula da Cututtuka ta Hunan a ranar 27 ga Disamba, a karkashin kulawar Dr. Zhang Jian.
"A ranar 30 ga watan Disamba, wani rukuni na likitoci a babban asibitin Wuhan sun yi gargadin abokan aikin su game da wani ""Coronavirus na SARS"."
Likitoci takwas, ciki har da Li Wenliang, sun yi wa 'yan sanda tuhuma don yada jita-jita, kuma wani likita, mai suna IFN, ya yi wa jami'an sa na sama ba'a saboda ƙara yawan matakin gargadi.
Hukumar kula da lafiyar birnin Wuhan ta fitar da sanarwar jama'a a ranar 31 ga watan Disamba kuma ta sanar da Hukumar Lafiya ta Duniya.
An bayar da rahoton wasu lamuran cutar huhu da ba a san su ba a farkon watan Janairu, wanda ya haifar da fara bincike a Wuhan. A farkon farkon barkewar cutar, adadin lamuran ya ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairu na 2020, cutar ta bazu zuwa sauran lardunan kasar Sin saboda abubuwan da suka faru na sabuwar shekara ta kasar Sin da kuma gaskiyar cewa Wuhan yana daya daga cikin manyan tashoshin jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton kusan sababbin kamuwa da cutar 140, ciki har da mutum biyu a Beijing da kuma mutum daya a Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa, a ranar 20 ga Janairu, 2020, mutane 6,174 sun kamu da cutar. A ranar 26 ga Maris, Amurka ta fi China da Italiya yawan adadin mutane da suka kamu da cutar a duniya. A ranar 9 ga Afrilu, 2020, an samu fiye da miliyan 1.61 na kamuwa da cutar a duniya; fiye da 97,000 sun rasa rayukansu kuma fiye da 364,000 sun warke.
Aƙalla aƙalla an sami rahoton kamuwa da cutar guda ɗaya a cikin ƙasashe da yankuna 200.
Saboda annobar a Turai, ƙasashe da yawa sun iyakance motsi a yankin Schengen kuma sun kafa kulawar iyaka.
Sakamakon haka ya shafi matakan hanawa kamar yin rigakafi (a karkashin lakabi kamar umarnin zama a gida, umarnin samun mafaka a gida ko cikakken keɓewa) da kuma hanawa. Har zuwa ranar 2 ga Afrilu, kusan mutane miliyan 300 a Amurka ko kusan kashi 90 cikin dari na yawan jama'a suna ƙarƙashin wani nau'in keɓewa na gida, fiye da miliyan 50 a Filifin, kimanin miliyan 59 a Afirka ta Kudu da miliyan 13.3 a Indiya suna cikin keɓewar gida.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya sun shiga wani nau'i na killacewa, wanda ya karu zuwa biliyan 2.6 kwana biyu bayan haka, kusan kashi ɗaya bisa uku na yawan duniya.
An fara samun kamuwa da COVID-19 a Wuhan a ranar 1 ga Disamba, 2019, kuma ba a tabbatar da cewa an fara samun kamuwa da COVID-19 a ranar 17 ga Nuwamba ba.
Dakta Zhang Ji-jian ya gano tarin marasa lafiya da ke fama da cutar huhu da ba a san dalilinsa ba a ranar 26 ga watan Disamba, kuma nan da nan a ranar 27 ga watan Disamba, asibitin ya ba da labarin ga Cibiyar Kula da Cututtuka ta Jiang Han Wuhan.
Gwajin farko na kwayoyin halitta na samfurin marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna kasancewar cutar coronavirus na SARS.
An ba da sanarwar jama'a ta Hukumar Lafiya ta Wuhan a ranar 31 ga Disamba.
Hukumar lafiya ta duniya ta sanar da hakan a wannan rana.
"Da sanarwar, 'yan sanda sun gargadi Likitoci Wuhan game da ""rashin yada jita-jita"" game da annobar".
"Tuni dai Hukumar Lafiya ta kasar Sin ta ce babu wata hujja mai kyau game da yadda cutar za ta iya kamuwa da mutane".
A ƙarshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yakin neman zabe mai zurfi wanda sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya bayyana a matsayin "yaƙin jama'a" don hana yaduwar cutar.
"A lokacin da abin da aka kwatanta da "babban kulle-kulle a tarihin 'yan adam" ya faru, an sanar da cewa an sanya belin lafiya a ranar 23 ga Janairu, wanda ya dakatar da shiga da fita daga Wuhan, kuma ya shafi biranen Hubei 15, wanda ya shafi kusan mutane miliyan 57. "
An haramta amfani da motocin sirri a cikin birni.
An rufe bikin Sabuwar Shekara ta Sin (kwanan Janairu 25) a yankuna da yawa.
Hukumomi sun kuma sanar da cewa an gina asibitin wucin gadi, asibitin Huoshenshan, wanda aka kammala cikin kwanaki 10.
Bayan haka, an gina wani asibiti mai suna Leishenshan Hospital don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta ci gaba da mayar da wasu cibiyoyi 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta kara daukar wasu matakan hana yaduwar COVID-19, ciki har da bayar da sanarwar lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
Jami'o'i da makarantu sun rufe a duk faɗin ƙasar.
Yankunan Hong Kong da Macau sun dauki matakai da dama, musamman a kan makarantu da jami'o'i.
An aiwatar da matakan hanawa a wasu yankuna na kasar Sin.
An sanya takunkumin tafiye-tafiye a ciki da wajen lardin Hubei.
An sauya zirga-zirgar jama'a kuma an rufe gidajen tarihi a duk faɗin China.
An sanya dokar hana zirga-zirga a birane da dama kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan ƙuntatawa a waje da gida. Bayan barkewar cutar ta shiga fasalin duniya a watan Maris, hukumomin China sun ɗauki matakan tsananin hana shigowar cutar daga wasu ƙasashe.
Misali, Beijing ta sanya dokar killacewa ta kwanaki 14 ga dukkan matafiya na kasa da kasa da suka shiga birnin. A ranar 23 ga Maris, babban yankin kasar Sin ya sami kamuwa da cutar guda daya a cikin kasar, wanda ya kamu da cutar ta hanyar matafiya da ke dawowa daga Willettball zuwa Guangzhou kwanaki biyar da suka gabata.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Ke Chiang ya ba da rahoton cewa an dakatar da kamuwa da cutar a cikin kasar kuma an sarrafa yaduwar cutar a kasar Sin.
A wannan ranar, an rage takunkumin tafiye-tafiye a Hubei banda Wuhan bayan watanni biyu da aiwatar da dokar hana fita. Ma'aikatar harkokin wajen gwamnatin kasar Sin ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shiga kasar ga mazauna da masu biza daga ranar 28 ga Maris, kuma ba a bayyana cikakken bayani game da tsawon lokacin da wannan manufar za ta ci gaba ba.
Duk wanda ke son shiga kasar Sin dole ne ya nemi takardar visa a ofisoshin jakadancin kasar Sin ko kuma a ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta karfafa masu kasuwanci da masana'antu da su fara aiki daga ranar 30 ga watan Maris, tare da yin la'akari da tanadin tallafi na kudade ga kamfanoni. Majalisar Jiha ta sanar da ranar makoki ta kasa da za a yi a cikin nutsuwa na minti uku a ranar 4 ga Afrilu da karfe 10:00 na ranar bikin King Ming, duk da cewa gwamnatin tarayya ta nemi iyalai ta yanar gizo su kiyaye nesa ta jiki don hana sabon barkewar cutar COVID-19.
An tabbatar da cewa COVID-19 ya mamaye Koriya ta Kudu daga China a ranar 20 ga Janairu, 2020.
Hukumar lafiya ta kasar ta sanar da cewa an samu karuwar adadin wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, wanda ya fi dacewa da taron da aka yi a Daegu don sabon motsi na addini da ake kira Shincheonji Church of Christ.
Masu goyon bayan Shinchongji da suka sadu da Daegu daga Wuhan sun yi shakkar asalin cutar.
A ranar 22 ga Fabrairu, an samu rahoton bayyanar cututtuka a cikin mutane 9,336 na Ikilisiya, ko kusan kashi 13 cikin 100 na mutane, daga cikin mutane 9,366. Koriya ta Kudu ta sanar da matakin fargaba mafi girma a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an samu fiye da 2000 na kamuwa da cutar a Koriya, wanda ya kai 3,150 a ranar 29 ga Fabrairu.
Bayan an samu gwajin korona na sojoji uku, an killace dukkan sansanonin soja na Koriya ta Kudu.
Hakanan an yi tasiri a kan rarraba lokutan jiragen sama, wanda shine dalilin da ya sa suka zama. An gabatar da shirin Koriya ta Kudu a matsayin mafi girma da kuma mafi kyawun shirin da aka tsara a duniya wanda ya yi nasara wajen bincika yawan jama'a dangane da cutar da kuma cire masu kamuwa da cutar, da kuma ganowa da killace mutanen da suka yi hulɗa da su.
Hanyoyin bincike sun hada da bayar da rahoton alamun cutar ga sababbin shiga ta hanyar aikace-aikacen wayar hannu, gwajin gwaji na ƙwayoyin cuta wanda sakamakon zai bayyana a rana mai zuwa, da kuma ƙara yawan mutane 20,000 a kowace rana.
Koriya ta Kudu ta yi nasara wajen hana yaduwar cutar, duk da rashin killace dukkan biranen. Da farko, al'ummar Koriya ta Kudu sun zama masu nuna bambanci a cikin martani ga Shugaba Moon Jae-in ga wannan rikicin.
Yawancin 'yan kasar Koriya sun sanya hannu kan takardar da ta bayyana laifin da aka yi wa Mun saboda abin da suka ce gwamnati ta yi a kan yadda ake gudanar da annobar, yayin da wasu suka sanya hannu don yabon yadda ya amsa.
An ruwaito cewa Koriya ta Kudu ta samu mafi karancin adadin kamuwa da cutar a rana guda a cikin makonni hudu a ranar 23 ga Maris.
A ranar 29 ga Maris, an ruwaito cewa daga ranar 1 ga Afrilu, duk sababbin da suka shigo cikin ƙasar daga ƙasashen waje za a yi musu keɓewa na makonni biyu.
A ranar 1 ga watan Afrilu, kafofin watsa labarai sun ruwaito cewa Koriya ta Kudu ta karbi bukatar taimako daga kasashe 121 don gwajin cutar.
Iran ta sanar da farkon kamuwa da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qam, inda mutane biyu suka mutu a wannan rana, a cewar Ma'aikatar Lafiya da Ilimin Likita.
Matakan farko da gwamnati ta sanar sun hada da soke kide-kide da sauran abubuwan al'adu, gasa ta wasanni da sallar Juma'a da kuma hutun jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ba da tiriliyan 5 na kasar Sin don yaki da cutar.
A ranar 26 ga watan Fabrairun 2020, Shugaba Hassan Rouhani ya bayyana cewa babu shirin killace yankunan da cutar ta kamu da su, kuma dole ne kawai a killace mutane.
An sanar da tsare-tsaren da za a yi na iyakance zirga-zirgar birane a watan Maris, duk da haka, har yanzu akwai zirga-zirga mai yawa tsakanin biranen Iran kafin sabuwar shekara.
Har zuwa ranar 16 ga Maris, 2020, wuraren ibada na Shi'a a garin Qum sun bude wa masu ziyara. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A cikin zargin da ake yi na yin watsi da yadda cutar ta yadu a Iran, fiye da kasashe goma sun danganta kamuwa da cutar da suka kamu da ita zuwa ranar 28 ga Fabrairu, wanda ke nuna cewa cutar ta iya zama mafi muni fiye da 388 da gwamnatin Iran ta ruwaito zuwa wannan ranar.
Majalisar ta rufe kuma mutane 23 daga cikin mambobi 290 sun ba da rahoton cewa sun gwada cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, mai kula da haƙƙin ɗan adam ya bukaci hukumomin kurkuku na Iran da su saki masu kare hakkin ɗan adam da aka tsare saboda rashin jituwa ba tare da wani yanayi ba, tare da kuma barin dukkan fursunoni da suka cancanci yin aiki a kan wani lokaci.
An ce a wuraren da aka rufe kamar cibiyoyin tsare da kuma rashin kulawar lafiya, akwai haɗarin yada cutar.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda, wanda shine mafi girma a kasar tun lokacin da cutar ta barke.
An bayyana mutuwar akalla 'yan siyasa 12 da kuma jami'an gwamnatin Iran da ke aiki ko a baya har zuwa ranar 17 ga Maris.
A ranar 23 ga watan Maris, Iran ta samu sabbin mutane 50 da suka kamu da cutar a kowace awa, da kuma mutuwar daya sakamakon cutar korona.
Wani jami'in hukumar lafiya ta duniya ya ce, ana iya samun karin kamuwa da cutar a Iran sau biyar fiye da yadda aka ruwaito.
An kuma yi hasashen cewa takunkumin Amurka kan Iran na iya shafar karfin kasar na kudi wajen amsa yadda ya kamata game da yaduwar cutar.
Babban kwamishinan kare hakkin bil'adama na Majalisar Dinkin Duniya ya yi kira ga rage matsin lamba ga kasashen da suka fi fama da cutar, ciki har da Iran.
A ranar 31 ga Janairu, an tabbatar da barkewar cutar a Italiya, daidai da lokacin da aka tabbatar da gwajin gwajin biyu na masu yawon bude ido na kasar Sin da cutar SARS-CoV-2 a Roma.
Yawan masu cutar ya karu da sauri, kuma ya sa gwamnatin Italiya ta dakatar da zirga-zirgar jiragen sama zuwa da fita daga kasar Sin kuma ta ayyana dokar ta baci.
An gano wani rukuni na marasa alaƙa na shari'o'in COVID-19 daga cikin 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta sanar da amincewa da sabuwar doka don hana yaduwar cutar, wanda ya haɗa da killace mutane sama da 50,000 a sassa 11 daban-daban a arewacin Italiya.
"Firai Minista, Josepe Conte ya ce ""a cikin yankunan da cutar ke yaduwa, an hana shiga da fita".
"An riga an ba da umarnin dakatar da ayyukan aiki da wasanni a cikin waɗannan yankuna. "A ranar 4 ga Maris, bayan mutuwar mutane 100 a Italiya, gwamnati ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar.
Duk manyan wasanni, ciki har da gasar kwallon kafa ta Serie A, an gudanar da su a rufe a watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasanni na wata daya.
A ranar 11 ga watan Maris, Firayim Minista Kent ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci sai dai manyan kasuwanni da kantuna. A ranar 6 ga Maris, Kwalejin Italiyanci ta Anesthesia, Infectious, Rehabilitation and Special Care (SIAARTI) ta wallafa shawarwari game da halayyar likita game da hanyoyin da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta fi yawan mutanen da suka mutu sakamakon cutar korona a duniya, inda ta samu rahoton 3,405 a rana daya sakamakon annobar cutar daga kasar Sin.
A ranar 22 ga watan Maris, an ruwaito cewa Rasha ta tura jiragen sama tara na soja zuwa Italiya tare da kayan aikin likita.
Tun daga ranar 5 ga Afrilu, an tabbatar da 12,898,157 mutuwar da 2,1815 sake dawowa a Italiya, yawancin lokuta a Lombardy.
Wani rahoto daga CNN ya nuna cewa haɗuwa da abubuwa biyu na yawan mutanen Italiya da rashin iyawar yin gwajin duk waɗanda suka kamu da cutar har zuwa yau na iya haifar da babban adadin mutuwar.
Amsar Birtaniya ga cutar ta fara nuna cewa ita ce mafi muni a cikin ƙasashe da aka fi fama da ita, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya wani nau'i na nesa da jama'a ko matakan killace jama'a a kan 'yan ƙasa ba.
A sakamakon haka, an soki gwamnati saboda rashin amfani da saurin aiki da kuma gaggawa wajen amsa damuwar jama'a. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya haramta balaguron da ba dole ba da kuma sadarwa ta zamantakewa a jawabinsa, yana kira ga mutane su yi aiki daga gida idan zai yiwu kuma su guji zuwa wurare kamar shaguna, gidajen abinci da fina-finai.
A ranar 20 ga watan Maris, gwamnatin kasar ta sanar da rufe dukkan wuraren shakatawa kamar gidajen cin abinci da kuma wuraren wasanni da sauri, kuma ta yi alkawarin biyan ma'aikatanta har zuwa kashi 80 cikin dari na albashi har zuwa farashi na dala 2,500 na Australiya a wata don hana karuwar rashin aikin yi a wannan rikicin. A ranar 23 ga watan Maris, Firayim Minista ya sanar da sanya wasu ka'idojin nesa da zamantakewa, hana tarurruka na mutane fiye da biyu, da kuma iyakance tafiye-tafiye da ayyukan waje zuwa inda ake bukata.
Wannan takunkumin ya bambanta da matakan da aka dauka a baya, wanda 'yan sanda da kuma masu bayar da takunkumi da kuma tarwatsa al'ummomi za su iya amfani da su.
"An ba da izinin barin yawancin kasuwancin, sai dai ga abubuwan da aka yi la'akari da ""daidaitacce"", ciki har da manyan kasuwanni, kantunan shan magani, bankuna, kantunan sayar da kayayyaki, famfo na gas, da garages".
A ranar 20 ga watan Janairu, an gano mutum na farko da ya kamu da cutar COVID-19 a jihar Pacific Northwest a Washington a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga watan Janairu.
An kafa kungiyar Coronavirus ta fadar White House a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya ta jama'a kuma ta sanya takunkumi ga matafiya da ke shigowa daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, cibiyar kula da lafiyar jama'a ta gwamnatin Amurka ta sanar da cewa sun kirkiro kayan gwajin kansu.
Duk da haka, Amurka ta fara gwajin cutar, wanda ya sanya ainihin yaduwar cutar cikin duhu.
Saboda kuskuren gwajin gwaji, wanda gwamnatin tarayya ta samar a watan Fabrairu, saboda rashin amincewa da gwajin gwaji na gwamnati, ta hanyar gwamnatin tarayya (ta hanyar jami'o'i, kamfanoni da asibitoci) har zuwa karshen Fabrairu, da kuma ƙuntataccen ƙa'idodin ga mutanen da suka cancanci yin gwaji, gwaje-gwajen da aka yi har zuwa farkon Maris (dokta ta likita ta zama dole) sun zama marasa inganci.
A ranar 27 ga Fabrairu, Washington Post ta ba da rahoton cewa an yi gwajin gwaji kasa da 4,000 a Amurka.
Har zuwa ranar 13 ga Maris, Atlantic ta ba da rahoton cewa an yi gwaji kasa da 14,000.
A ranar 22 ga watan Maris, Associated Press ta ruwaito cewa: Mutane da yawa da ke da alamun rashin lafiya da kuma shawarar likita don yin gwaji sun jira na tsawon sa'o'i zuwa kwanaki don yin gwaji. Bayan da aka fara bayar da rahoton mutuwar a Amurka a ranar 29 ga Fabrairu, G. Innsley, gwamnan jihar ya sanar da dokar ta baci ta jihar, wani mataki da sauran jihohi suka bi nan da nan.
Makarantu a yankin Seattle sun rufe makarantun su a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, ƙungiyar masu ilimin cututtuka a Royal College of London sun ba da tsinkaya game da tasirin coronavirus a Amurka.
A wannan ranar, Shugaba Trump ya sanya hannu kan yarjejeniyar bayar da tallafin tallafi da kuma shirye-shirye, wanda ya ba da dala biliyan 8.3 don tallafawa ayyukan tarayya da ake buƙata don amsa cutar.
Kamfanoni sun sanya takunkumin tafiye-tafiye ga ma'aikata, sun soke taron, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
A ranar 11 ga watan Maris, Trump ya sanya takunkumin tafiye-tafiye na kwanaki 30 ga yawancin kasashen Turai, banda Ingila, wanda ya fara aiki daga ranar 13 ga Maris.
Kashegari, ya kafa wasu takunkumi musamman ga Ingila da Ireland.
A ranar 13 ga Maris, ya ayyana dokar ta baci ta kasa wanda ya sa asusun tarayya suka kasance a cikin sabis don amsa wannan rikicin.
Tun daga ranar 15 ga Maris, yawancin kasuwancin Amurka sun rufe ko rage awoyi don rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da cutar a duk jihohi 50 da kuma yankin Columbia. A ranar 23 ga Maris, an ruwaito cewa New York City tana da kamuwa da cutar coronavirus 10,700, wanda ya fi yawan adadin kamuwa da cutar a Koriya ta Kudu.
A ranar 25 ga watan Maris, Wally ya bayyana cewa nisan zamantakewa yana da tasiri, saboda ƙididdigar saurin ninka lokuta ya ragu daga kwanaki 2 zuwa kwanaki 4.7.
A ranar 28 ga Maris, an tabbatar da cewa akwai mutane 32,308 da suka kamu da cutar a birnin New York City, kuma mutane 672 sun mutu saboda kamuwa da cutar. A ranar 26 ga Maris, an ruwaito cewa Amurka tana da ƙarin kamuwa da cutar fiye da kowace ƙasa a duniya, ciki har da China da Italiya. A ranar 8 ga Afrilu, an tabbatar da 4,0335 a Amurka, kuma mutane 12,841 sun rasa rayukansu.
A cewar rahotanni a kafofin watsa labarai a ranar 30 ga Maris, Shugaba Trump ya yanke shawarar tsawaita ka'idodin nisan jama'a har zuwa ranar 30 ga Afrilu.
A wannan rana, USNS Comfort ta kama wani jirgin asibiti mai dakuna 1,000 a New York.
A ranar 3 ga Afrilu, Amurka ta karya rikodin mutuwar 884 na coronavirus a cikin sa'o'i 24.
A ranar 3 ga watan Afrilu a jihar New York, an samu kamuwa da cutar ta kamuwa da mutane fiye da 100,000. An soki fadar White House saboda watsi da barazanar da kuma iyakance umarnin da hukumomin lafiya da masana suka bayar don daidaita sanarwa da kuma wallafawa game da cutar tare da ofishin mataimakin shugaban kasar Mike Pence.
An raba yawan gamsuwa da yadda Trump ya gudanar da rikicin a jam'iyyun biyu.
Wasu jami'an Amurka sun soki amincewar shigo da kayayyaki na asali daga kasar Sin, ciki har da kayayyakin kiwon lafiya.
An gudanar da nazarin tsarin tafiye-tafiye na iska don tsarawa da hango ko hasashen yadda cutar ke yaduwa kuma an buga shi a cikin mujallar Travel Medicine a tsakiyar watan Janairu 2020.
A cewar bayanan 2018 na kungiyar sufuri ta kasa da kasa, Bangkok, Hong Kong, Tokyo da Taipei sun sami mafi yawan fasinjoji daga Wuhan.
An ruwaito cewa Dubai, Sydney da Melbourne sun zama wuraren da matafiya suka fi so daga birnin Wuhan.
Bali ta kasance mafi girma a cikin shahararrun biranen 20 na rashin shiri, yayin da biranen Ostiraliya suka kasance mafi shirye-shirye don shiri. Ostiraliya ta sanar da shirin gaggawa na gaggawa don sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Sanarwar ta ce har yanzu ba a gano bayanai da yawa game da COVID-19 ba, kuma Australia za ta jaddada kula da iyaka da sadarwa a cikin martani ga annobar.
A ranar 21 ga Maris, an ayyana dokar ta baci ta tsaro a Australia.
Saboda tsauraran dokar hana fita ta zirga-zirgar jama'a a Wuhan da Hubei, kasashe da dama sun shirya fitar da 'yan kasarsu da ma'aikatan diflomasiyya daga yankin, musamman ta hanyar jiragen haya daga kasar, bisa ga ka'ida da kuma izinin hukumomin kasar Sin.
Kanada, Amurka, Argentina, Jamus da Thailand sun kasance na farko da suka aiwatar da shirin fitar da 'yan ƙasarsu.
Pakistan ta ce ba za ta mayar da wani ɗan ƙasa daga China ba.
A ranar 7 ga Fabrairu, Brazil ta fitar da 'yan ƙasar Brazil 34 ko kuma danginsu, tare da' yan Poland hudu, dan kasar Sin da dan Indiya.
'Yan ƙasar Poland, China da Indiya sun sauka daga jirgin a Poland, inda jirgin Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan kasar Brazil da suka je Wuhan a wani sansanin soja kusa da Brazil.
A wannan rana, an tura Canadians 215 (mutanen 176 daga jirgin sama na farko da 39 daga jirgin sama na biyu da gwamnatin Amurka ta haya) daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama da ke dauke da 'yan Kanada 185 daga Wuhan ya tashi a CFB Trenton.
Hukumomin Austria sun kwashe 'yan kasar 277 zuwa gidan yari na Kirsimeti Island, wanda aka mayar da shi wuri na keɓewa, a ranar 3 da 4 ga Fabrairu, inda suka zauna har tsawon kwanaki 14.
Jirgin saukar jiragen ruwa na New Zealand ya shiga Auckland a ranar 5 ga Fabrairu; fasinjojinsa (ciki har da mutanen daga Australia da Pacific) sun tsaya a tashar jiragen ruwa ta Wangaparwa a arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta kori Amurkawa daga jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama dauke da fasinjoji 129 na Kanada da aka kwashe daga jirgin ruwa na Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta yi aikin kwashe 'yan kasar daga Iran. A ranar 14 ga Maris, jirgin sama na kamfanin jirgin saman Afirka ta Kudu ya dawo da' yan kasar 122.
An yi bincike na asibiti kafin a yi tafiya, kuma 'yan Afirka ta Kudu hudu da ke da alamun cutar sun zauna a can don rage haɗarin.
Sai dai mutanen Afirka ta Kudu da suka samu sakamako mara kyau ne kawai suka koma ƙasar.
Sakamakon gwajin ya kasance mara kyau ga dukkan 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji waɗanda aka sanya su a cikin sintiri da ke cikin killacewa na kwanaki 14 a filin shakatawa na Ranch don taka tsantsan.
A ranar 20 ga watan Maris, Amurka ta janye wasu sojojinta daga ƙasar Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen kasar Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin a jami'o'i na Amurka sun hada kai don taimakawa wajen tura tallafi ga yankunan da ke fama da cutar ta coronavirus a kasar Sin. Kamar dai wata kungiya ta hadin gwiwa a yankin Chicago ta gudanar da aikawa da masks 50,000 na N95 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da dala miliyan 100 ga Hukumar Lafiya ta Duniya don tallafawa bincike kan allurar rigakafi da kuma hanyoyin magance cutar da kuma tallafawa "rayukan da ke cikin hadari a Afirka da Kudancin Asiya".
Interaksyon ta ruwaito cewa gwamnatin kasar Sin ta ba da masks 200,000 ga Philippines a ranar 6 ga Fabrairu, kuma bayan haka Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga Fabrairu, Red Cross ta Singapore ta sanar da cewa za ta aika tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da masks miliyan daya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayayyakin kiwon lafiya fiye da 13 ton zuwa Wuhan, Malaysia ta sanar da bayar da safofin hannu na likita miliyan 18 ga China, Jamus ta aika da nau'ikan kayan kiwon lafiya da suka hada da tufafi na musamman 10,000, kuma Amurka ta aika da kayayyakin kiwon lafiya 17.8 zuwa China, kuma ta yi alkawarin tallafawa ƙasashe masu cutar da kudade miliyan 100.
A watan Maris, kasar Sin, Cuba da Rasha sun tura kayan aikin likita da kwararru zuwa Italiya don taimakawa wajen magance yaduwar cutar coronavirus.
Shahararren mai sayar da kayayyaki na Jack Ma ya aika da kaya masu gwaji miliyan 1.1 da masks miliyan 6 da kuma kayan kariya 60,000 da kungiyar tarayyar Afirka ta rarraba zuwa Addis Ababa, Habasha.
Ya aika da kayan gwaji 5,000, masks 100,000, da kuma masu iska 5 zuwa Panama.
"Mu" kuma mun ba da kayan aikin likita ga Kanada. Netherlands, Spain, Turkiyya, Georgia da Jamhuriyar Czech sun nuna damuwa game da masks da kayan aikin ganewar asali na kasar Sin. "
Misali, Spain ta yi watsi da amfani da kayan gwaji na kasar Sin da suka yi daidai da kashi 30 cikin dari, yayin da Netherlands ta yi nuni da masks na kasar Sin da suka lalace da kusan dubu shida.
Belgium ta ƙi karɓar masks 100,000 da ba za a iya amfani da su ba, saboda an yi tunanin cewa sun fito ne daga China, amma a gaskiya sun fito ne daga Colombia.
A gefe guda kuma, an samu tallafin da kasar Sin ta bayar a sassa na Latin Amurka da Afirka. Tun daga ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da ayyukan gaggawa na tallafi ga kasashe masu tasowa.
Hukumar lafiya ta duniya ta yaba da kokarin da jami'an kasar Sin ke yi na sarrafa cutar.
Hukumar lafiya ta duniya ta kwatanta wannan yanayin da annobar SARS a 2002-2004, lokacin da aka zargi jami'an kasar Sin da ɓoye bayanai, wanda hakan ya shafi kokarin hana yaduwar cutar da kuma rage yaduwar cutar, kuma a halin yanzu, a cikin rikicin da ke faruwa, gwamnatin tarayya ta "yi aiki na yau da kullum don hana barkewar cutar kafin hutun sabuwar shekara ta hasken rana".
A ranar 23 ga watan Janairu, wakilin Hukumar Lafiya ta Duniya, Gooding Gali, a cikin martani ga shawarar da manyan hukumomi suka yanke na aiwatar da haramcin sufuri a Wuhan, ya bayyana cewa, "ba lallai ba ne shawarar Hukumar Lafiya ta Duniya ce", amma "babban alama ce ta sadaukar da kai ga hana annobar a inda ta fi muni a ko'ina", kuma ya kira ta "ba a taɓa gani ba a tarihin lafiyar jama'a". A ranar 30 ga watan Janairu, bayan an tabbatar da kamuwa da cutar a kasashen waje da kuma karuwar adadin mutane a wasu ƙasashe, Hukumar Lafiya ta Duniya ta bayyana barkewar cutar a matsayin dokar ta baci ta duniya da kuma karo na shida da ta faru tun lokacin da aka fara cutar a lokacin annobar cutar mura ta 2009.
Tedros Adhanom, Sakataren Janar na Hukumar Lafiya ta Duniya, ya ce PHEIC ta kasance mai tasiri saboda "hadarin yaduwar duniya, musamman a ƙasashe masu ƙananan da matsakaiciyar kuɗi da rashin tsarin lafiya".
"A cikin martani ga takunkumin da aka sanya kan tafiya, Tedros ya bayyana cewa:" Babu wani dalili na yin wasu ayyuka marasa mahimmanci da ke shafar tafiya da kasuwancin duniya"," kuma ya ci gaba da cewa ""World Health Organization ba ta bada shawarar iyakance kasuwanci da motsi ba".""
A ranar 5 ga watan Fabrairu, Majalisar Dinkin Duniya ta bukaci al'umma ta duniya da ta ba da dala miliyan 675 don tallafawa shirye-shiryen shirye-shiryen da ake yi a ƙasashe masu karancin kudin shiga, kuma ta yi nuni da bukatar taimakon ƙasashe da "ba su da tsarin da ya dace don gano mutanen da ke da cutar ko ma da alamun bayyanar cututtuka".
"Tadros ya ci gaba da bayyana cewa ""mu masu rauni ne da ke da karfi kamar yadda muke da karfi"" kuma ya bukaci al'ummar duniya su "yi zuba jari a yau ko kuma su kashe sau da yawa daga baya". A ranar 11 ga Fabrairu, Hukumar Lafiya ta Duniya ta sanar da cutar COVID-19 a wani taron manema labarai.
A wannan ranar, Tedros ya bayyana cewa Sakataren Majalisar Dinkin Duniya, Antonio Guterres, ya amince da amfani da ""ƙarin ƙarfin tsarin Majalisar Dinkin Duniya a cikin amsa ga cutar""".
"A sakamakon haka, ƙungiyar gudanar da rikicin Majalisar Dinkin Duniya ta shiga aiki don daidaita tsarin amsawar Majalisar Dinkin Duniya, kuma za a ba su damar, a cewar Hukumar Lafiya ta Duniya, ""daidaita kansu kan maganin likita, yayin da sauran hukumomi za su iya aiwatar da kwarewarsu a fannoni mafi girma na zamantakewa, tattalin arziki da kuma juyin halitta sakamakon barkewar cutar"."
A ranar 14 ga Fabrairu, ƙungiyar ta hadin gwiwa ta jagoranci WHO da WHO a cikin China don taimakawa wajen gudanar da aikin gida da kimanta "karfi da yaduwar cutar", ta gudanar da bita da tarurruka tare da cibiyoyin ƙasa da kuma gudanar da ziyara a fili don kimanta " tasirin ayyukan amsawa a larduna da jihohi / jihohi da yankuna na karkara. A ranar 25 ga Fabrairu, WHO ta ba da sanarwar cewa "duniya dole ne ta yi aiki sosai don shirya don yiwuwar barkewar cutar coronavirus", kuma ta ce lokaci ya yi da za a kira ta annoba, duk da haka, dole ne ƙasashe su kasance "a shirye".
"Domin amsa ga karuwar annobar a Iran, Hukumar Lafiya ta Duniya ta tura tawagar hadin gwiwa don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an Hukumar Lafiya ta Duniya sun ce, kimanta barazanar cutar coronavirus a duniya zai karu daga ""babba"" zuwa ""babba".
Mike Ryan, darektan zartarwa na shirin gaggawa na WHO, ya yi gargadin a cikin wata sanarwa cewa, "Wannan gaskiya ne ga dukan gwamnatocin duniya: tashi".
"Cutar tana kan hanya kuma dole ne ku kasance a shirye kuma ku lura cewa amsa mai kyau na iya taimakawa duniya ta kauce wa ""karuwarta".
Ryan ya ce, bayanan da ake samu yanzu ba su tabbatar da cewa jami'an lafiya na duniya za su bayyana cewa akwai annoba a duniya ba, saboda irin wannan sanarwa na nufin cewa ""mu na da tabbacin cewa kowane mutum a duniya zai kamu da cutar.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta ayyana yaduwar cutar coronavirus a matsayin annoba ta duniya.
Babban daraktan ya ce WHO "ta damu da gaske game da matakan fargaba na yaduwar cutar da kuma rashin kulawar cutar da matakan fargaba na rashin kulawar cutar". WHO ta fuskanci sukar da yawa saboda abin da ake ganin rashin kula da cutar, ciki har da jinkirta sanarwar dokar ta baci ta kiwon lafiya da kuma rarraba cutar a matsayin annoba. "
Wannan martani na siyasa ya hada da da'awar zuwa ga babban darektan Hukumar Lafiya ta Duniya, Tedros Adhanum, game da shawarar saurawa, wanda mutane 733,000 suka sanya hannu tun daga ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, da dama daga cikin masana kare hakkin bil adama na Majalisar Dinkin Duniya sun jaddada girmama hakkin mutane a lokacin annobar COVID-19.
Kungiyar ta ce dole ne a samar da matakan ceto ga kowa da kowa kuma gwamnati ce ke da alhakin yin hakan.
Kungiyar ta jaddada cewa rashin samun kudi ko rashin inshorar lafiya ba zai iya zama hujja ga nuna bambanci ga wani rukuni na mutane ba.
Masana sun jaddada cewa kowa yana da hakkin kiwon lafiya, ciki har da nakasassu, yara, 'yan gudun hijira, marasa gida, waɗanda ke rayuwa cikin yanayi mai matukar rashin daidaito, waɗanda ke tsare da kuma 'yan gudun hijira da sauran mutanen da ke bukatar tallafin gwamnati.
Hukumomin duniya suna kula da tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Hukumar Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Takin Takin Tattalin Arzikin Tattalin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin Arzikin Takin
Daga manufofin ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa nazarin tasirin killacewa da ƙuntatawa na tafiya, Digital Hub ya ƙunshi bin manufofin ƙasa (yadda ƙasashe ke amsa wannan rikicin) kuma yana nufin taimaka wa ƙasashe su koya daga abubuwan da suka faru da juna da kuma sauƙaƙe daidaitaccen amsa duniya ga ƙalubalen coronavirus.
Gwamnatin kasar Sin ta fuskanci sukar da Amurka, Ministan majalisar dattijai na Birtaniya Michael Gove da Eduardo Bolsonaro, dan shugaban Brazil, Jair Bolsonaro, suka yi a kan yadda suka shawo kan annobar da ta barke a lardin Hubei na kasar Sin.
An kori wasu shugabannin jam'iyyar kwaminis ta kasar Sin (CPC) daga aiki saboda gudanar da aikin da suka yi na yin rigakafin a tsakiyar kasar Sin, wanda ya nuna rashin jin dadin da 'yan siyasa suka yi game da barkewar cutar a yankunan.
Wasu masu sukar sun yi imanin cewa wannan mataki ne na kare sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping, daga fushin jama'a a kan cutar coronavirus.
Wasu manyan jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da saninsu na farkon barkewar cutar ta Wuhan, wanda ya sa aka yi watsi da ka'idodin da Amurka da Italiya suka yi game da China game da ainihin dalilin barkewar COVID-19.
Gwamnatin Donald Trump a Amurka ta kira coronavirus "Cinese virus" ko "Wuhan virus", inda ta ce "Censorship, wanda ya haifar da yaduwar cutar da ta zama annoba ta duniya", ya fuskanci sukar wasu masu sukar nuna wariyar launin fata da kuma "karkatar da hankali ga rashin nasarar gwamnatinsa wajen hana cutar".
" Daily Beast ta samu damar samun hanyar sadarwa ta hanyar sadarwa ta Majalisar Tsaro ta Duniya, ta amfani da dabarun da ake kira ""Duk abin da ke ƙarƙashin China"."
"Ana bukatar mu yi iyakar kokarinmu don isar da sakon ga jama'a ta kowace hanya da za ta iya, ciki har da taron manema labarai da hirarraki na talabijin. "Shafukan labarai kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da kasar Sin ke yi na tura tallafi ga kasashen da cutar ta shafa, wani bangare ne na yada labaran kasar domin tasiri a duniya".
Joseph Burrell, wanda ke da alhakin manufofin kasashen waje na EU ya yi gargadin cewa "akwai wani bangare na siyasa na duniya wanda ya ƙunshi ƙoƙarin yin tasiri ga hanyar karkatar da hankali da kuma 'yancin kai'".
Burrell ya kara da cewa, "Sin na neman nuna wa kowa cewa ba Amurka ba ce wadda za ta iya tabbatar da cewa ita mai sadaukarwa ce".
Kasar Sin ta bukaci Amurka ta cire takunkumin da ta dauka kan Syria da Venezuela da Iran domin ta taimaka musu, yayin da ta tura tallafi mai yawa ga sauran kasashen biyu.
An dakatar da bayar da masks 100,000 daga Jack Ma ga Cuba a ranar 3 ga Afrilu saboda takunkumin Amurka.
Har ila yau, an zargi jami'an Amurka da canja wurin tallafin da aka bayar daga wasu ƙasashe zuwa ƙasarsu.
An ruwaito cewa akwai bambance-bambance game da abin rufe fuska tsakanin sauran ƙasashe, kamar Jamus, Austria da Switzerland; da kuma Czech Republic da Italiya.
Bugu da ƙari, Turkiyya ta kwashe ɗaruruwan motocin iska zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki Tarayyar Turai saboda rashin hadin kai da Italiya da ke fama da cutar coronavirus.
Jakadan Italiya a Tarayyar Turai, Maurizio Massari, ya ce, kasar Sin ce kawai ta yi aiki biyu.
"Ba lallai ba ne wannan alama ce mai kyau ta EU ba".
A ranar 22 ga watan Maris, bayan da ya yi kira ta waya da Firayim Ministan Italiya, Giuseppe Conte, Shugaban Rasha, Vladimir Putin, ya tura sojojin Rasha zuwa Italiya don aikawa da magungunan soja, kayan aikin rigakafi na musamman da sauran kayan aikin likita.
Jaridar La Stamp ta Italiya ta ce, daga wani "masu sanarwa mai zurfi" wanda ba a san shi ba, kashi 80 cikin dari na taimakon da Rasha ta ba wa Italiya "ba a amfani da shi ko kuma ba shi da amfani".
"Ma'aikatar ta zargi Rasha da cin zarafin "jiopolitical da diplomatic" da ta yi ta hanyar ta'addanci.
Attilio Fontana, shugaban Lombardy da Ministan Harkokin Wajen Italiya Luigi Di Maio, sun yi watsi da rahoton kafofin watsa labarai kuma sun yaba da kokarin.
Rasha ta tura wani jirgin sama mai dauke da kayan aikin likita zuwa Amurka.
"Dimitri Puskov, kakakin Kremlin ya ce, ""A lokacin da muka ba abokan aikinmu a Amurka taimako, mun yi tunanin cewa idan masana'antun kayan aikin likita da kayayyakin kiwon lafiya a Amurka suka fara aiki, za su iya taimaka mana idan ya zama dole. """
"Za a gudanar da shirin NATO na "Defense 2020" a Jamus, Poland da kasashen yankin Baltic, a cikin mafi girman yakin da aka yi tun bayan karshen yakin sanyi".
"Sakataren Janar na Kamfen na kawar da makaman nukiliya, Kate Hudson, ya soki aikin Defender 2020: ""A cikin rikicin lafiyar jama'a a halin yanzu, ba kawai rayukan sojoji na Amurka da sauran kasashen Turai da ke wurin ba ne ke fuskantar barazana, har ma da rayukan mazaunan kasashen da ake gudanar da ayyukan. "" Gwamnatin Iran ta yi matukar tasiri da cutar, kusan 'yan majalisa ashirin da hudu da wasu mutane goma sha biyar daga cikin 'yan siyasa na yanzu ko na baya sun kamu da cutar. "
Shugaban Iran, Hassan Rouhani, ya aika da wata wasika mai ban mamaki ga shugabannin duniya, inda ya nemi taimako a ranar 14 ga Maris, 2020, yana mai cewa kasarsa tana kokarin yaki da yaduwar cutar saboda rashin samun damar zuwa kasuwannin duniya sakamakon takunkumin Amurka a kan Iran. Wannan barkewar cutar ta bukaci Amurka ta dauki manufofin zamantakewa na sauran kasashe masu arziki, ciki har da lafiyar duniya, kula da yara a duniya, ba da izini ga iyalansu da kuma karin kudi ga lafiyar jama'a.
Masu nazarin siyasa sun yi hasashen cewa annobar cutar za ta iya shafar yiwuwar sake zabar Donald Trump a zaben shugaban kasa na 2020 da kuma dangantakar da ke tsakanin Japan da Koriya ta Kudu.
"Bayan da Japan ta sanar da cewa za ta yi wa duk fasinjojin da ke shigowa daga Koriya ta Kudu kulle-kulle na tsawon makonni biyu a wuraren da gwamnati ta tsara, Koriya ta Kudu ta soki Japan da cewa ta "san da ƙoƙarin kulle-kulle ba tare da sanin abin da ke faruwa ba".
Mutanen Koriya ta Kudu sun yi ta zama masu nuna bambanci game da yadda Shugaba Moon Jae-in ya amsa wannan rikicin.
Yawancin mutanen Koriya sun sanya hannu kan takardun shaida da suka nemi a yi wa Moon horo, ko kuma su yaba da yadda gwamnatin ta yi aiki ba tare da yin amfani da cutar ba. Wannan annoba ta ba wa ƙasashe damar yin dokar ta baci don aiwatar da amsa mai kyau.
Wasu masu sharhi sun nuna damuwa cewa wannan na iya sa gwamnatoci su ci gaba da riƙe iko.
A Hungary, majalisar dokokin kasar ta amince da cewa Firayim Minista Viktor Orbán zai iya mulki da hukuncin da ba a iyakance ba, an dakatar da majalisar dokoki da kuma zaben, kuma za a hukunta waɗanda suka yada rashin gaskiya game da cutar da kuma gwamnatin da ke kula da rikicin.
Cutar coronavirus ta faru ne saboda wasu misalai na rashin wadatar kayayyaki, wanda ya haifar da karuwar amfani da kayan aikin yaki da cutar, tsoro na sayayya da kuma rikice-rikice a cikin masana'antu da kayan aiki.
Hukumar Abinci da Magunguna ta Amurka ta yi gargadi game da karancin magunguna da kayan aikin likita saboda karuwar bukatar masu amfani da kuma rikice-rikice a cikin masu samarwa.
Yawancin yankuna sun ci gaba da ganin yawan jama'a don sayayya, wanda ya haifar da satar kayan da ake buƙata kamar abinci, kayan wanka da kwalabe na ruwa, wanda ya haifar da ƙarancin wadata.
Musamman masana'antar fasaha sun yi gargadin jinkirin aika kayayyakin lantarki.
A cewar Tedros Adhanum, babban sakataren Hukumar Lafiya ta Duniya, an ninka bukatar kayan kariya ta mutum sau 100.
Wannan bukatar ta haifar da karin farashin zuwa sau ashirin na farashin yau da kullum, wanda ya haifar da jinkiri na watanni hudu zuwa shida a samar da kayayyakin kiwon lafiya.
Wannan ya haifar da karancin kayan kariya na mutum a duniya, kuma Hukumar Lafiya ta Duniya ta yi gargadin cewa zai iya kawo hadarin lafiyar ma'aikata.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayar da kayayyakin Diego don sayar da kayayyakin Australiya a China.
Wannan aikin ya haifar da karancin nono a wasu manyan kasuwanni, wanda ya haifar da dakatar da shi daga gwamnatin Ostiraliya. Duk da yawan adadin cututtukan COVID-19 a arewacin Italiya da yankin Wuhan da kuma babban bukatar abinci, babu ɗayan yankunan da suka sami mummunan lahani.
Matakan da kasar Sin da Italiya suka dauka kan cin hanci da rashawa da kuma safarar kayayyakin da ba a yarda da doka ba sun yi nasara, kuma sun hana matsanancin karancin abinci da aka yi hasashen zai faru a Turai da kuma Arewacin Amirka.
A cikin yankunan arewacin Italiya, inda ake samar da kayayyakin gona, samar da kayayyakin gona bai ragu ba, amma a cewar wakilan yankin, farashin zai iya tashi.
Ko da a birnin Wuhan, an kafa ɗakunan ajiya na abinci na ɗan lokaci, yayin da manyan jami'an kasar Sin suka buɗe ɗakunan ajiyar naman alade don tabbatar da isasshen abinci ga yawan jama'a.
Irin wannan doka a Italiya ta bukaci masu samar da abinci su adana abinci don irin wannan lokacin.
An ji lalacewar tattalin arzikin duniya a kasar Sin: A cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na 2020 saboda matakan da gwamnati ta dauka na hana barkewar cutar, inda shagunan sayar da kayayyaki suka ragu da kashi 20.5%.
Tun da kasar Sin ta kasance daya daga cikin manyan wuraren tattalin arziki da samarwa, yaduwar cutar tana da babbar barazana ga tattalin arzikin duniya.
Agathe Demarais daga kungiyar bayanan tattalin arziki ta yi hasashen cewa kasuwanni za su kasance marasa tabbas har sai an bayyana halin da sakamakon zai iya kasancewa.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa sakamakon tattalin arzikin cutar a kan ci gaban duniya zai iya zama mafi girma fiye da yadda SARS ya barke a 2002 zuwa 2004.
Wani masanin jami'ar Washington a St. Louis ya kiyasta cewa, za a yi tasiri a kan sarkar samar da kayayyaki ta duniya har zuwa dala biliyan 300, wanda zai ci gaba har tsawon shekaru biyu.
"A cewar rahoton kungiyar kasashen da ke fitar da man fetur (OPEC), farashin man fetur ya "ƙaru sosai" saboda raguwar bukatar kasar Sin.
Kasuwancin duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar yawan kamuwa da COVID-19 a wajen kasar Sin.
A ranar 27 ga Fabrairu, karuwar damuwa game da barkewar cutar coronavirus ta haifar da raguwar da ba a taɓa gani ba a cikin NASDAQ-100, S&amp;amp;amp;, P 500 da Dow Jones Industrial Average, wanda ya kasance mafi girma a cikin rana ɗaya tun lokacin rikicin kuɗi na 2007, Dow Jones, da maki 1,191.
Dukkanin alamun sun yi kasa da 10% a karshen mako.
A ranar 28 ga watan Fabrairu, kamfanin kimantawa na GMBH Scope ya amince da kimantawar darajar China amma ya yi mummunan zato.
Kasuwancin ya sake faɗuwa saboda tsoron coronavirus, wanda ya fi yawa a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai iya zama mai yiwuwa.
Masanin tattalin arziki Muhammad Al-Arian ya yaba wa manyan bankuna da kasashe da suka dauki matakan gaggawa.
Babban bankin ya yi sauri fiye da rikicin kudi na 2008.
Kasuwancin yawon bude ido na cikin wadanda suka fi fama da cutar saboda takunkumin da aka sanya kan tafiya, hutun wuraren jama'a kamar wuraren yawon bude ido da kuma shawarar gwamnatoci na kada su yi tafiya zuwa wasu ƙasashe.
A sakamakon haka, kamfanonin jiragen sama da dama sun soke jiragen sama, ciki har da British Airways, China Eastern Airlines da Qantas, saboda rashin bukatar, yayin da jirgin saman yankin na Burtaniya Flybe ya gaza.
Wannan ya shafi masana'antar jiragen ruwa kamar yadda ba a taɓa gani ba.
An kuma rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da dama.
Aikin ya faru ne a lokacin da ake gudanar da babban biki na sabuwar shekara ta kasar Sin.
Gwamnatocin ƙasa da na yanki sun soke wasu abubuwan da suka faru kamar bikin Sabuwar Shekara da aka yi da yawa, kuma kamfanoni masu zaman kansu sun rufe shaguna da wuraren yawon buɗe ido kamar Disneyland Hong Kong da Disneyland Shanghai.
Yawancin abubuwan da suka faru na Sabuwar Shekara ta Lunar da wuraren yawon bude ido an rufe su don hana mutane tattarawa, ciki har da birnin da aka hana a Beijing da kuma wuraren nune-nunen gargajiya na haikalin.
A larduna 24 daga cikin larduna 31 na kasar Sin, hukumomin larduna da na yanki sun tsawaita hutun sabuwar shekara har zuwa 10 ga Fabrairu, kuma sun umarci yawancin wuraren aiki da kada su bude ranar.
Wadannan yankuna sun wakilci kashi 80 cikin dari na samar da kayayyakin cikin gida da kashi 90 cikin dari na fitarwa.
Hong Kong ta kara yawan matakan da ta dauka na magance cutar ta kamuwa da cuta, ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris, kuma ta soke bikin Sabuwar Shekara.
Kasuwancin da ake yi a Turai da Latin Amurka sun ragu da kashi 40 cikin dari.
Kasashen da ke Gabas ta Tsakiya da Arewacin Amirka sun samu kashi 50 zuwa 60 cikin dari na raguwar tallace-tallace.
Wannan ya haifar da raguwar cinikin da aka yi a cikin shaguna a watan Maris fiye da Fabrairu.
Masu sarrafa manyan cibiyoyin cinikayya na duniya sun ɗauki ƙarin matakai, kamar ƙara bin ƙa'idodin kiwon lafiya, shigar da na'urorin daukar hotan jiki don bincika yanayin zafin jiki na masu siye da soke abubuwan da suka faru. A cewar kimar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, bala'in da ya haifar da annobar zai haifar da talauci mai tsanani tsakanin mutane miliyan 14 zuwa 22 a Latin Amurka, wanda ya fi yawan waɗanda ba su da annobar.
A cikin watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta kai ga Wuhan, kimanin mutane miliyan 5 a kasar Sin sun rasa ayyukansu.
Yawancin ma'aikatan kasar Sin na ƙauyuka kusan miliyan 300 sun makale a gidajensu a lardunan da ke nesa da teku ko kuma a lardin Hubei. A watan Maris na 2020, fiye da Amurkawa miliyan 10 sun rasa aikinsu kuma sun nemi taimakon gwamnati.
A cewar kimantawar bankin tarayya na St. Louis, cutar coronavirus na iya shafar ayyukan yi miliyan 47 a Amurka kuma ya kara yawan rashin aikin yi zuwa 32%. Ƙuntataccen killacewa a Indiya ya haifar da rashin aikin yi na ma'aikatan Indiya miliyan goma (wanda ke aiki tare da biyan kuɗi). Sakamakon binciken da Cibiyar Angus Reed ta gudanar ya nuna cewa kashi 44 cikin dari na iyalai na Kanada sun shiga cikin rashin aikin yi. Tun lokacin da aka aiwatar da ƙuntataccen killacewa a tsakiyar Maris 2020 a Spain, kimanin ma'aikata 900,000 sun rasa ayyukansu.
A cikin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi albashi na wucin gadi na wucin gadi, kuma ma'aikata miliyan 1 na Burtaniya sun nemi takardar shaidar jama'a (Kurdish Universal). Kusan rabin kamfanoni miliyan a Jamus sun aiwatar da shirye-shiryen aiki na ɗan gajeren lokaci na ma'aikata da tallafin gwamnati da ake kira Kurzarbit.
Har ila yau, Faransa da Birtaniya sun amince da shirin ba da gudummawar gajeren lokaci na Jamus.
Sassan da ke aiki a fagen wasan kwaikwayo da al'adun gargajiya sun shafar mummunan tasirin cutar wanda ya shafi ayyukan ƙungiyoyi da mutane, ma'aikata da masu zaman kansu a duk faɗin duniya.
Kungiyoyin al'adu da fasaha sun yi ƙoƙari su tallafa wa manufofin su (sau da yawa ta hanyar kudade na jama'a) don jama'a su sami damar yin amfani da al'adun gargajiya, kiyaye lafiyar ma'aikatan su da jama'a, da kuma tallafawa masu fasaha idan ya yiwu.
Har zuwa Maris 2020, a duk faɗin duniya, a cikin bambancin, gidajen tarihi, dakunan karatu, wuraren wasan kwaikwayo da sauran cibiyoyin al'adu, tare da nune-nunen su, abubuwan da suka faru da wasan kwaikwayon da aka soke ko kuma aka jinkirta, an rufe su har abada.
A sakamakon haka, an yi ƙoƙari sosai don samar da ayyuka na madadin ta hanyar dandamali na dijital. Wani sabon abu kuma da ke hanzarta rage cutar shine soke abubuwan addini, manyan wasanni da sauran abubuwan zamantakewa kamar bukukuwa da kide kide, taro na fasaha, da kuma nunin zamani.
An kuma yi watsi da masana'antar fim. Vatican ya sanar da cewa an soke al'adar mako mai tsarki a Roma, wanda ya kamata a yi a cikin mako na azumi na Kirista.
Yawancin bishops sun ba da shawarar dattawa su zauna a gida maimakon halartar bukukuwan Lahadi; wasu majami'u sun watsa bukukuwan coci ta hanyar rediyo, watsa shirye-shirye ta kan layi ko talabijin, yayin da wasu ke ba da shawarar yin ibada ta mutum.
Yayin da bishop na Roman Katolika ya rufe majami'unsu, manya da ƙanana, kuma St. Peter's Square ya zama baƙi ga masu ziyara na Kirista, sauran cibiyoyin addini sun soke ayyukansu kuma sun ƙuntata taron jama'a a majami'u, masallatai, majami'u, haikalin ibada da wuraren ibada.
Ma'aikatar Lafiya ta Iran ta sanar da cewa za a soke gudanar da sallar Jumma'a a yankunan da ke da cutar, kuma wuraren ibada sun ci gaba da rufewa, yayin da Saudiyya ta haramta wa 'yan kasarta haikalin wuraren ibada a Makka da Madina, tare da hana masu ziyara daga kasashen waje shiga.
Wannan annoba ta haifar da babbar katsewa a gudanar da wasanni tun lokacin yakin duniya na biyu.
Yawancin manyan wasanni na wasanni an soke ko kuma an jinkirta, ciki har da gasar zakarun Turai UEFA 2019-2020, gasar Premier 2019-2020, UEFA Euro 2020, kakar NBA da kakar NHL daga 2019 zuwa 2020.
"Cutar ta kuma rushe shirye-shiryen gasar Olympics ta bazara ta 2020 wanda aka fara shirin fara daga karshen watan Yuli; kwamitin Olympics na duniya ya sanar a ranar 24 ga Maris cewa taron zai "juya zuwa wani kwanan wata banda shekarar 2020 amma ba bayan lokacin rani na 2021 ba". Gidajen caca da sauran wuraren wasan caca a duk faɗin duniya sun rufe kuma an dage ko kuma an soke gasar karta ta rayuwa. "
Wannan ya haifar da yawan masu caca da yawa zuwa caca ta kan layi, kuma yawancin shafukan caca na kan layi sun ba da rahoton ƙaruwar yawan shiga.
Yawancin manyan gidajen cinema, ciki har da na Broadway, sun dakatar da duk ayyukan su.
"Wasu masu fasaha sun gano hanyoyin ci gaba da samarwa da kuma haɗin gwiwar aikin ta hanyar Intanet a matsayin maye gurbin ayyukan rayuwa na gargajiya kamar su raye-raye na kai tsaye ko ƙirƙirar ""yanayin yanar gizo na Intanet"" don masu fasaha don yin aiki, rarrabawa da tallata ayyukansu. "
Ana yin amfani da tarho na intanet na coronavirus don yin dariya da kuma yin dariya a cikin wannan batu.
Tun lokacin da COVID-19 ya barke, an lura da nuna bambanci mai ban sha'awa, tsorata da nuna wariyar launin fata ga mutanen China da na ƙasashen Gabashin Asiya da kuma mutanen ƙasashen Turai da ke da yawan yaduwar cutar, Amurka da sauran ƙasashe.
An lura da abubuwan da suka faru kamar tsoro, shakku da tashin hankali a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya da Oceania.
Rahotanni daga watan Fabrairu (lokacin da yawancin abubuwan da suka faru a shekarar 2019 suka kasance a cikin China) sun nuna ra'ayoyin wariyar launin fata na kungiyoyi da yawa a duniya cewa mutanen China sun san cewa sun cancanci cutar da abin da ake zargi da gaskiya.
Wasu kasashen Afirka sun kuma ga karuwar rashin jin dadin kasar Sin.
Mutane da yawa daga cikin mazaunan Wuhan da Hubei sun ba da rahoton cewa an nuna musu bambanci saboda sun fito daga yankin.
Akwai taimako na kan layi da na kan layi daga yankunan da cutar ta shafa a China.
Yayin da cutar ta ci gaba a kasashen da ke da sabon ci gaban kamuwa da cutar, mutanen Italiya, kasar farko a Turai da ta fara fuskantar mummunan yaduwar COVID-19, na iya ci gaba da fuskantar mummunan tsoro da kuma tsoratar da 'yan ƙasa na sauran ƙasashe. 'Yan ƙasa a ƙasashe da suka haɗa da Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takardun hana shigowar Sinawa cikin ƙasarsu don ƙoƙarin dakatar da cutar.
A Japan, hashtag #ChineseDontComeToJapan ya tashi a Twitter.
Jama'ar Sin da sauran 'yan Asiya a Ingila da Amurka sun ba da rahoton karuwar rashin mutunci da kuma hare-haren.
"Shugaba Donald Trump ya fuskanci sukar kiransa da "Cinese virus", wani lokaci da masu sukar suka yi la'akari da nuna wariyar launin fata da kuma adawa da kasar Sin".
Masu zanga-zangar a Ukraine sun kai hari kan motocin bas da ke dauke da 'yan kasar Ukraine da na kasashen waje da suka bar Wuhan kuma suka koma Novi Sinjar.
Rahotanni sun nuna cewa dalibai daga arewa maso gabashin Indiya, wanda ke da iyaka da China, da kuma dalibai da ke karatu a manyan biranen Indiya, suna cikin damuwa da damuwa game da annobar coronavirus.
"Dilip Ghos, shugaban jam'iyyar Bharatiya Janata a jihar Bengal ta Kudu ya ce 'yan kasar Sin sun lalata yanayi kuma shi ya sa Allah ya yi musu rashawa.'"
"Sannan aka yi wa ofishin jakadancin kasar Sin a Kolkata la'akari da wannan magana kuma an ce ta "ba daidai ba". A kasar Sin, an tsananta fargaba da wariyar launin fata a kan 'yan kasashen waje bayan annobar, kuma an yi la'akari da' yan kasashen waje a matsayin "ƙazanta na kasashen waje" ko kuma an ce su jefa su cikin "ƙazanta".
Yawancin jaridu da ke da sassan kuɗi sun cire waɗannan sassan don ɗaukar labaran coronavirus.
Yawancin masu wallafa kimiyya sun ba da takardun kimiyya game da yaduwar cutar kyauta ga kowa.
Wasu masana sun yanke shawarar raba sakamakon su a kan sabobin da aka buga a baya kamar bioRxiv.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Duniya da cututtuka - Magana game da duniya da kuma yaduwar cututtuka
Jerin annoba da annoba - Jerin mutuwar cututtukan cututtuka
Cinikin dabbobi da cututtukan da ke tattare da dabbobi da kuma haɗarin kiwon lafiya da ke tattare da cinikin dabbobi a cikin namun daji na ƙasarsu
Gwajin gwaji na cutar coronavirus ta 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke da alaƙa da ita, ya ƙunshi hanyoyi biyu, hanyoyin gano cutar da hanyoyin gano maganin rigakafi da aka ƙirƙira don amsawa ga kamuwa da cuta.
Akwai ƙwayoyin cuta a cikin samfurori da aka tabbatar da RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwaji ne na musamman kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da sababbin cututtuka ko kuma masu aiki.
Ana iya amfani da gano antibodies (saurology) don gano cututtuka da kuma kula da yawan jama'a.
Gwajin rigakafin ya nuna yawan mutanen da suka kamu da cutar, ciki har da waɗanda alamun su suka yi rauni sosai da ba a buƙatar bayar da rahoto ba ko kuma waɗanda ba su da alamun cutar.
Ana iya ƙayyade ƙididdigar ƙididdigar mutuwar da mutuwar da ke tattare da cutar da kuma matakin rigakafin shanu a cikin yawan jama'a ta amfani da sakamakon wannan gwajin.
Saboda ƙarancin gwaji, babu wata ƙasa da ta sami tabbataccen bayanai game da yaduwar cutar tsakanin mutane har zuwa Maris 2020.
Har zuwa ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da 3% na yawan jama'arta, kuma akwai bambanci sosai game da yawan gwaje-gwajen da aka yi a ƙasashe daban-daban na duniya.
Hakanan, za a iya samun tasirin tasirin tasirin mutuwar da aka ruwaito, wanda zai iya zama a wasu ƙasashe an kiyasta shi da kyau.
Ta hanyar amfani da jerin polymerase reverse transcription chain reaction (rRT-PCR), ana iya yin gwaji a kan samfurori na numfashi da aka samu ta hanyoyi daban-daban, ciki har da samfurin anti-inflammatory ko samfurin analgesic.
Sakamakon yawanci ana sanar da shi bayan 'yan sa'o'i ko kuma aƙalla kwanaki 2.
Gwajin RT-PCR da aka yi ta hanyar samfurin da aka ɗauka a cikin mako na farko na cutar yana da tabbaci.
Daga nan sai cutar ta ɓace a cikin makogwaro, ko da yake tana ci gaba da ninka a cikin huhu.
Don cututtukan da aka gwada a mako na biyu, ana iya samun samfurin daga ƙananan hanyoyin numfashi ta hanyar catheter na hanci ko cire belga (kwarya).
Wani gwajin PCR na farko da aka shirya a watan Janairu na 2020 ta Charita a Berlin, inda aka yi amfani da jerin abubuwan da aka yi na polymerase transcription reverse anian (rRT-PCR) kuma ya samar da tushe don samar da kaya 250,000 da aka rarraba ta Hukumar Lafiya ta Duniya (WHO).
Birtaniya ta yi gwaji har zuwa 23 ga Janairu 2020. Kamfanin Kogenebiotech a Koriya ta Kudu ya samar da wani kit na gano SARS-CoV-2 na asibiti, wanda aka yi amfani da shi a ranar 28 ga Janairu, 2020, bisa PCR, mai suna PowerChek Coronavirus.
"Jin ""E"" wanda ke cikin dukkanin nau'ikan beta na coronavirus da kuma gano jini RdRp wanda ke cikin SARS-CoV-2 kawai. A China, BGI Group ita ce farkon kamfanin da ya sami izinin gaggawa daga Hukumar Kula da Kayan Aikin Kayan Aiki ta kasar Sin don kit ɗin gano PCR na SARS-CoV-2. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) na Amurka suna ba da kwamitin gano sabon COVID-19 (2019-nCoV) na Real-Time RT-PCR a cikin kayan aikin International Reagent Resource ga dakunan gwaje-gwaje na kiwon lafiya na jama'a. "
Daya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsofaffin sigogin gwajin gwajin bai cika ba saboda rashin daidaito a cikin ganewar asali, wanda ya haifar da gwaji a CDC Atlanta, wanda ya haifar da raguwar adadin samfurori da aka gwada a cikin dukan watan Fabrairu na 2020, a matsakaici na yau da kullum 100.
Ba a tabbatar da tabbacin gwajin da ke amfani da sassan biyu ba har zuwa 28 ga Fabrairu, 2020, kuma dakunan gwaje-gwaje na jihohi da na gida sun sami izinin fara gwajin daga wannan ranar.
Hukumar Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin gaggawa. Labs na kasuwanci na Amurka sun fara gwajin a farkon Maris 2020.
LabCorp ta sanar da cewa gwajin COVID-19 akan RT-PCR zai kasance a duk faɗin ƙasar har zuwa 5 ga Maris, 2020.
Quest Diagnostics ta kuma ba da takardun gwaji na COVID-19 a duk faɗin ƙasar daga 9 ga Maris, 2020.
Babu wani takunkumin killacewa da aka sanar; ana buƙatar tattara samfurori da kuma nazarin su bisa ga bukatun CDC.
A Rasha, Cibiyar Nazarin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwa
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Lafiya ta Tarayya ta yi rajista da gwajin. A ranar 12 ga Maris, 2020, an ruwaito cewa Mayo Clinic ta samar da gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar Hukumar Abinci da Magunguna don gwajin da za a iya yi a cikin awanni 3.5 da kuma girma, wanda zai iya haifar da injin guda ɗaya don yin gwajin kusan 4,128 a kowace 24 hours.
A ranar 19 ga Maris, 2020, Hukumar Abinci da Magunguna ta ba da izinin gaggawa (EUA) don Abbott Laboratories don gwajin tsarin Abbott's m2000; Hukumar Abinci da Magunguna ta ba da izinin kama da haka ga kamfanonin Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, kamfanin Cepheid ya karbi EUA daga Hukumar Abinci da Magunguna don gwajin da zai ɗauki minti 45.
Hukumar Abinci da Magunguna ta amince da gwajin da ke amfani da fasahar ƙarfafa nucleic acid isothermal maimakon PCR.
Tun da yake ba ya buƙatar tsarin juyawa na zafin jiki, wannan hanyar za ta iya samun sakamako mai kyau a cikin minti 5 da kuma mummunan sakamako a cikin minti 13.
Yanzu haka akwai 18,000 na waɗannan injunan a Amurka, kuma Abbott na shirin samar da gwaje-gwaje 50,000 a rana da karuwar samarwa nan ba da jimawa ba. A halin yanzu ana gudanar da gwaji a Taiwan ta amfani da antibody monoclonal, wani abu da ke haɗa sabon kwayar cutar coronavirus da ƙwayoyin nucleoacid (protein N); ana fatan wannan gwajin zai iya samar da sakamako a cikin minti 15 zuwa 20.
"Har zuwa Maris 2020, binciken bayanan ya nuna cewa ""radio-cage radiography ba shi da amfani wajen gano cutar a farkon lokacin cutar, yayin da CT na iya kasancewa kafin bayyanar cututtuka".
Daga cikin siffofin da aka saba da su, CT na iya nufin nau'ikan gilashin gilashin gilashin da ke da hanyoyi biyu tare da rarraba gefe, ba daidai ba, da kuma baya (posterior).
Ƙarƙashin rinjaye (subpleural dominance) yana faruwa ne tare da ci gaban cututtuka, tasiri, da kuma yanayin rashin fahimta (crazy paving).
Wani bincike a Wuhan, inda cutar ta kamu da cutar ta psychological ta fara, ya kwatanta PCR da CT, kuma ya bayyana cewa CT ya fi tsananin damuwa fiye da PCR, kodayake ba ta da ƙwarewa kuma tana da halaye masu yawa na hoto tare da sauran cututtukan huhu da matsalolin numfashi.
"Har zuwa Maris 2020, shawarar da Jami'ar Radiology ta Amurka ta bayar ita ce ""kada a yi amfani da CT don yin binciken cutar a matsayin layin farko na gwajin gano COVID-19"." Har zuwa Maris 2020, shawarar CDC ita ce amfani da PCR don yin bincike".
Wani ɓangare na amsawar tsarin rigakafi ga cutar shine samar da antibodies kamar IgM da IgG.
Ana iya amfani da su don gano cutar a cikin mutane, a cikin kwanaki 7 ko fiye bayan bayyanar cututtuka, don gano rigakafi, da kuma don lura da yawan jama'a. Ana iya yin gwaje-gwaje a cikin manyan dakunan gwaje-gwaje (CLT) ko kuma a cikin kayan aikin gwajin wurin kulawa (PoCT).
Tsarin sarrafa kansa mai ƙarfi a cikin dakunan gwaje-gwaje da yawa zai iya yin waɗannan kimantawa, amma samun damar su ya dogara da yawan samarwa ga kowane tsarin.
Ana amfani da samfurin jini guda ɗaya don CLT, duk da haka ana iya amfani da samfurin jini don bin tsarin rigakafi.
Ana yin samfurin jini don PoCT ta hanyar yin allurar fata.
A ranar 26 ga Maris, 2020, Hukumar Abinci da Magunguna ta gabatar da kamfanoni 29 da suka sanar da kungiyar game da bukatun kuma a sakamakon haka za su iya rarraba gwajin rigakafin su.
Tun daga ranar 7 ga Afrilu, 2020, FDA ta amince da gwajin guda ɗaya kawai don amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don kit ɗin gwajin su; waɗannan kit ɗin na iya gano IgG da IgA antibodies da cutar a cikin samfurin jini.
Ana iya gwadawa da ɗaruruwan samfurori a kowace awa, saboda haka ana yin saurin PCR na yau da kullun don RNA na kwayar cutar.
Ana iya gano rigakafin iska har zuwa kwanaki 14 bayan kamuwa da cuta. A farkon watan Afrilu, Birtaniya ta sanar da cewa babu wani daga cikin kayan gwajin rigakafin iska da aka saya da ya isa.
"Hong Kong ta kafa shirin da ke ba da izinin mutanen da ake zargi da cutar su zauna a gida, ""ma'aikatar gaggawa ta ba da samfurin bututu ga mai haƙuri", mai haƙuri ya saka shi cikin bututun, ya sake aikawa, kuma bayan wani lokaci ya sami sakamakon gwajin. Hukumar Kiwon Lafiya ta Jama'a (NHS) a Burtaniya ta sanar da cewa tana gwaji a kan shirin da za a gwada abubuwan da ake zargi da cutar a gida don kawar da haɗarin kamuwa da cutar a hanyar zuwa asibiti ko kuma bukatar yin maganin rigakafin motar motar motar asibiti. A cibiyoyin gwajin COVID-19 don abubuwan da ake zargi, ƙwararren masanin kiwon lafiya zai yi amfani da matakan tsaro don yin samfurin".
Cibiyoyin sabis na tuki (Drive-through centers) sun taimaka wa Koriya ta Kudu ta gudanar da ɗayan gwaje-gwaje mafi sauri da kuma mafi girma a duniya. A Jamus, Kungiyar Likitocin Kula da Lafiya ta Ƙasa ta sanar a ranar 2 ga Maris cewa tana da ƙarfin gudanar da gwaje-gwaje 12,000 a rana a cikin motar asibiti, kuma an gwada 10,700 a makon da ya gabata.
Idan likita ya ba da umarnin yin gwajin, inshorar lafiya za ta biya kuɗin.
A cewar shugaban cibiyar Robert Koch, Jamus na da damar gudanar da gwaji 160,000 a mako.
Har zuwa 19 ga Maris, an ba da sabis na gwaji a kan doki a wasu manyan birane.
Har zuwa 26 ga Maris, 2020, yawan gwaje-gwajen da aka yi a Jamus ba a san su ba, saboda an ba da rahoton sakamako mai kyau kawai.
"Binciken farko na dakin gwaje-gwaje ya nuna cewa a kalla samfurori 4,83,295 ne aka gwada a makon 12/2020 kuma sakamakon gwajin SARS-CoV-2 ya kasance mai kyau ga mutane 33,491 (6.9%). A Isra'ila, masu bincike a asibitin Technion da Rimbaum sun kirkiro hanyar gwaji ta hanyar yin amfani da samfurori daga marasa lafiya 64 a lokaci guda, inda aka haɗa dukkan samfurori kuma aka gwada su, kuma idan sun kasance masu kyau, ana gwada samfurori a kan mutum.
Wanda ya kafa BGI, Wang Jian, ya lura da aikin da ya ɗauki kwanaki biyar; a cikin samfurin, an gano cewa idan ba a ƙara wannan ƙarfin ba, za a sami ƙarin kamuwa da cuta a Hubei da kashi 47% kuma za a ninka farashin aiwatar da killace.
Bayan dakin gwaje-gwaje na Wuhan, an fara dakin gwaje-gwaje na Hu-Yan a Shenzhen, Tianjin, Beijing da Shanghai, a cikin birane 12 a duk faɗin China.
Har zuwa 4 ga Maris, 2020, yawan gwajin gwajin yau da kullum ya kai 50,000. An wallafa zane-zane na budewa da na al'ada da Origami Assays ya samar, wanda za a iya gwada samfurori masu girma fiye da 1,122 don cutar COVID-19, ta amfani da gwaji 93.
Har zuwa watan Maris, ƙarancin ƙididdiga da ƙarancin ƙididdiga sun kasance ɗaya daga cikin ƙarancin samar da gwaji a cikin EU, Birtaniya da Amurka.
Wannan ya sa wasu masu bincike suka fara nazarin tsarin shirya samfurori wanda ya hada da dumama samfurori zuwa zafin jiki na 98 ° C (208 ° F) na minti 5 don sakin kwayoyin RNA don gwaji na gaba. A ranar 31 ga Maris, an sanar da cewa UAE ta gwada masu cutar coronavirus fiye da kowace ƙasa a lokacin, kuma tana kan hanyar samun matakin gwaji na yawan jama'arta.
"Wannan ya faru ne ta hanyar haɗuwa da yiwuwar samar da sabis na hawa da sayen dakin gwaje-gwaje na samfurin ƙididdigar ƙididdiga daga Group 42 da BGI (bisa ga dakin gwaje-gwaje na gano gaggawa ""ho-yan"" a China)".
Wannan dakin gwaje-gwaje, wanda aka gina a cikin kwanaki 14, zai iya gudanar da gwaje-gwaje na RT-PCR da yawa a kowace rana, kuma shine farkon samfurin a wannan sikelin da aka yi aiki a waje da China.
An kirkiro hanyoyin gwaji daban-daban da ke nuna bambancin yanayin kwayoyin halitta na coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar lafiya ta duniya ta yi amfani da umarnin Jamus don samar da kaya da za a aika zuwa ƙasashen da ba su da isasshen albarkatu don samar da kaya.
An fitar da umarnin Jamus a ranar 17 ga Janairu, 2020; an ba da yarjejeniyar Cibiyar Kula da Cututtuka ta Amurka ba har zuwa ranar 28 ga Janairu, kuma an jinkirta gwajin da ke cikin Amurka. China da Amurka sun sami matsaloli game da amincin kit ɗin gwaji a farkon barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isasshen kit ɗin don biyan buƙatun da shawarwarin masana kiwon lafiya don yin gwaji ba.
A gefe guda kuma, masana sun ce samun damar yin gwaji a Koriya ta Kudu ya taimaka wajen rage yaduwar sabbin cututtukan coronavirus.
Gwamnatin Koriya ta Kudu ta kafa damar gwaji, mafi yawa a cikin dakin gwaje-gwaje na masu zaman kansu, a cikin shekaru da yawa.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta sanar da cewa, ana bukatar hanzarta shirye-shiryen gwaji a matsayin hanya mafi kyau don rage hanzarin ci gaban cutar ta COVID-19. Babban bukatar gwaji saboda yaduwar cutar ta haifar da tara dubban gwaje-gwaje a cikin dakunan gwaje-gwaje na masu zaman kansu na Amurka, kuma samar da kayan gwaji da sinadarai yana da wuya.
A watan Maris na shekarar 2020, kasar Sin ta ruwaito cewa kayan aikin gwajin kasar suna da matsala kuma basu da daidaito.
"A Amurka, CDC ta yi amfani da kit ɗin gwaji don "karatu"; sai gwamnatin ta kawar da shinge na gwamnati wanda ya hana gwaji na sirri. Spain ta sayi kit ɗin gwaji daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin amma ta gano cewa sakamakon ba daidai ba ne. "
Kamfanin ya bayyana cewa sakamakon da bai dace ba na iya kasancewa sakamakon rashin samun samfurin da ya dace ko kuma yin amfani da kit ɗin gwajin da ba daidai ba.
Ma'aikatar tsaron kasar ta Spain ta sanar da cewa za ta tattara kaya da ke dauke da sakamakon da bai dace ba, kuma za ta maye gurbin su da wani kit na gwaji daban-daban da Shenzhen Bioeasy ta bayar. Kashi 80% na kayan gwajin da Jamhuriyar Czech ta saya daga China sun bada sakamakon da bai dace ba. Slovakia ta sayi kaya miliyan 1.2 daga China wanda aka gano ba daidai ba ne.
"Prime Minister Matović ya ba da shawarar a jefa su cikin Tekun Danube. Fire Kara, wani memba na ma'aikatar lafiya ta Turkiyya, ya ce kayan gwajin da Turkiyya ta saya daga China suna da "halayen kuskure" kuma "ba a amfani da su ba". Birtaniya ta sayi kayan aikin miliyan 3.5 daga China amma a farkon watan Afrilu 2020 an bayyana cewa ba za a iya amfani da su ba. "
Gwaje-gwajen da aka yi tare da killace mutanen da suka samu sakamako mai kyau da kuma gano mutanen da suka yi hulɗa da mutanen da ke da cutar SARS-CoV-2 sun haifar da sakamako mai kyau.
Masu binciken da ke birnin Vo na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje na matakai biyu a kan mazauna 3,400 na birnin, a tsakanin kwana goma.
Kimanin rabin mutanen da suka samu sakamako mai kyau ba su da wata alama kuma an killace duk wadanda aka gano.
Ta hanyar ƙuntata tafiye-tafiye na birni, sababbin cututtuka sun ƙare.
Cutar coronavirus ta barke a Singapore a shekarar 2020 saboda rashin tuntuɓar da aka yi, takunkumin tafiye-tafiye na cikin gida, gwaji da killacewa da yawa a hankali fiye da sauran ƙasashe masu tasowa, amma babu wani takunkumin da ya shafi irin wannan izinin izinin cin abinci da wuraren sayar da kayayyaki.
An soke yawancin abubuwan da suka faru kuma Singapore ta shawarci 'yan kasar ta su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a ranar 23 ga Maris bayan an yi hutu.
Wasu kasashe kamar Iceland da Koriya ta Kudu sun gudanar da cutar ta hanyar tsauraran tsare-tsaren hana tuntuɓar, takunkumin tafiye-tafiye na cikin gida, gwaji da killacewa, amma sun sami iyakancewar izini.
Wani bincike ya nuna cewa kasashen da suka yi gwaje-gwaje masu yawa na ganewar asali fiye da mutuwar, suna da ƙananan adadin mutuwar, mai yiwuwa saboda waɗannan ƙasashe sun fi iya gano cututtukan cututtukan cututtukan da ke da alamun bayyanar cututtuka ko kuma waɗanda ba su da alamun.
Hukumar lafiya ta duniya ta ba da shawarar cewa kasashen da ba su da damar yin gwaji kuma suna da dakunan gwaje-gwaje da ke da ƙarancin gogewa game da COVID-19, su aika da alamun farko na COVID-19 guda biyar da na farko na goma don tabbatarwa zuwa ɗayan dakunan gwaje-gwaje na WHO guda 16.
A waje da dakunan gwaje-gwaje 16, akwai shari'o'i 7 a Asiya, 5 a Turai, 2 a Asiya, 1 a Arewacin Amirka, da 1 a Australia.
"A cikin teburin da ke ƙasa, "Abin da ke da kyau a cikin % na gwaje-gwaje" yana shafar jagorar gwajin kowace ƙasa. "
A daidai wannan yanayin, wata ƙasa da ke gwada asibitocin da aka yi wa gwaji kawai, tana da kashi kashi kashi 1 cikin dari na waɗanda suka yi gwajin, ba tare da la'akari da bayyanar cututtuka ba.
Wanke hannu (ko wanke hannu), wanda ake kira tsabtace hannu, wani abu ne da ake yi don kawar da ƙasa, kitse, kwayoyin cuta, ko sauran abubuwa marasa amfani a hannu.
"Tsabtace hannuwanku da sabulu a kai a kai a cikin "lokaci mai mahimmanci" a rana yana hana yaduwar cututtuka da yawa, misali, kuturta da annoba, wanda ke gudana ta hanyar hanyar hanta-hanta".
Haka kuma, mutane za su iya kamuwa da cututtukan numfashi kamar mura ko kuma faduwa ta yau da kullum idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko bakinsu (misali, gashin hanci).
Akwai lokatai biyar na wanke hannu da sabulu a rana don rage yaduwar cutar ta jiki: bayan wanka (tash da wanka), bayan wanke suturar jariri (canja sutura), kafin ciyar da jariri, kafin cin abinci, kafin da bayan shirya abinci, ko kuma lokacin da kake taɓa nama mai naman alade, kifi ko naman alade.
Idan babu sabulu da ruwa, za ka iya yin wanka da toka.
Kafin, lokacin da kuma bayan dafa abinci.
Kafin da bayan kula da mai haƙuri.
Bayan an canza sutura ko kuma an wanke yaro wanda ya yi amfani da gidan wanka.
Bayan an zubar da hanci, zafin jiki ko ƙishirwa.
Bayan ka taɓa dabbobi, ka ciyar da su, ka taɓa su.
Kula da lafiya na likita yana nufin ayyukan lafiya da suka shafi hanyoyin likita.
Yin wanke hannu kafin yin amfani da magani ko kuma maganin zai iya hana ko rage yaduwar cutar.
Babban aikin likita shine wanke hannu, tsabtace hannu daga abubuwan cutarwa (kwayoyin cuta, ƙwayoyin cuta ko sauran kwayoyin cuta waɗanda zasu iya haifar da cuta) da kuma sunadarai waɗanda zasu iya haifar da rauni ko cutar.
Wannan yana da mahimmanci ga mutanen da ke aiki da abinci ko kuma waɗanda ke aiki a fannin likita, amma yana da mahimmanci ga jama'a.
Yin wanke hannu yana da fa'idodi masu yawa, ciki har da rage kamuwa da cutar mura, coronavirus da sauran cututtuka masu yaduwa; kuma hana kamuwa da cututtukan da ke haifar da tari; da rage kamuwa da cututtukan numfashi;
Kuma rage yawan mutuwar jarirai a cikin haihuwar gida.
Wani binciken da aka gudanar a shekarar 2013 ya nuna cewa ingantaccen aikin wanke hannu na iya haifar da ƙananan ci gaba a matsakaicin ci gaban yara a ƙarƙashin shekaru biyar.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da kuma kuturta ta hanyar sauya halaye masu sauƙi kamar wanke hannu da sabulu.
Wannan aikin mai sauki zai iya rage yawan mutuwa da mutuwa a cikin wadannan cututtuka har zuwa 50%.
Hanyoyin da ke inganta wanke hannu suna iya rage yawan tari da kusan kashi ɗaya bisa uku, wanda ya yi daidai da samar da ruwa mai tsabta a yankunan da ke da karancin yawan kuɗi.
Ana iya danganta rage yawan kashi 48% na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Ciwon huhu, babban ARI, shine sanadin farko na mutuwa a cikin yara a karkashin shekaru biyar, wanda ke kashe yara miliyan 1.8 a kowace shekara.
Rashin zuciya da kuma ciwon kirji suna haifar da mutuwar kusan yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, sauya wanke hannu kafin cin abinci da bayan wanka zuwa wani al'ada mai dorewa zai iya ceton rayuka fiye da kowane irin rigakafi ko magani, ya rage mutuwar da ke haifar da asarar zuwa kusan rabin, kuma ya rage mutuwar da ke haifar da cututtukan numfashi da kashi ɗaya cikin huɗu.
Yin wanke hannu yawanci yana da sauran maganin rigakafi tare da ruwa, maganin rigakafi da shirye-shiryen kiwon lafiya na mutum (WASH).
Yin wanke hannu yana hana cutar ta jiki (impetigo) da ke gudana ta hanyar kai tsaye ta jiki.
Ƙananan sakamako mai illa na wanke hannu shine cewa wanke hannu akai-akai na iya haifar da lalacewar hanzari saboda bushewar fata.
Wani bincike a Denmark a shekarar 2012 ya nuna cewa wanke hannu sosai na iya haifar da ciwon fata da kuma fata, wanda aka sani da cututtukan fata ko eczema, kuma wannan cuta tana da yawa a tsakanin ma'aikatan kiwon lafiya.
Yin wanke hannu fiye da yadda ake so shi ne alamar rashin lafiyar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwal.
Akwai lokatai biyar na wanke hannu da sabulu a rana don rage yaduwar cutar ta jiki: bayan wanka (sanyawa da wanka), bayan wanke suturar jariri (canja sutura), kafin ciyar da jariri, kafin abinci da kuma kafin/bayan shirya abinci ko kuma lokacin da kake taɓa nama mai naman alade, kifi ko naman alade.
Sauran lokutan da za a yi amfani da fasahar wanke hannu don hana kamuwa da cutar sun haɗa da kafin da bayan maganin rauni ko rauni, bayan tari, tari, ko kuma shan iska; bayan taɓa shara ko kula da dabbobi; da kuma bayan taɓa shara.
A ƙasashe da yawa, yawan wanke hannu da sabulu ba shi da yawa.
Wani bincike game da wanke hannu a cikin kasashe 54 a shekarar 2015 ya nuna cewa matsakaicin kashi 38.7% na mutane suna wanke hannuwansu da sabulu. A shekara ta 2014, wani binciken ya nuna cewa Saudiyya tana da mafi girma a cikin yawan wanke hannu da kashi 97%, Amurka tana da kusan matsakaici da kashi 77% da kuma China tana da mafi ƙasƙanci, kashi 23%.
"Shirin kula da lafiya mai mahimmanci" wanda Ma'aikatar Ilimi ta Philippines ta kaddamar da shi, misali ne na matakan da za a yi don inganta lafiyar yara da ilimi da kuma ilimi. "
Yin wanke kirfa sau biyu a shekara, tare da wanke hannu, da kuma yin amfani da fluoride a cikin yumiya, shine babban mahimmancin shirin na kasa.
An yi nasara a Indonesia.
Ana cire kwayoyin daga fata ta hanyar ƙara sabulu ko kayan tsabtace ruwa.
Babban aikin sabulu da masu tsabtace ruwa shine rage shinge a cikin ruwa, don haɓaka solubility.
Ruwa shi kadai yana da tsabtace fata mara kyau, saboda kitse da furotin, wanda shine kayan da ke cikin ƙasa mai tsabta, ba su da sauƙi a cikin ruwa.
Duk da haka, wankewa da ruwa mai gudana yana taimakawa.
Sabulu mai ƙarfi na iya samun ƙananan ƙwayoyin cuta fiye da yadda aka yi amfani da su a baya saboda sake amfani.
Kadan daga cikin nazarin da suka yi tunanin cewa ana iya samun kwayar cutar daga sabulu mai ƙonewa, sun kammala cewa ba zai yiwu ba, saboda ana wanke kwayoyin tare da sabulu.
CDC ta kara da cewa, "Sabulu mai ruwa yana da kyau tare da amfani ba tare da buƙatar tuntuɓar hannu ba".
Ana tallata sabulu na antibacterial don inganta lafiyar jama'a.
Har zuwa yau, babu wata hujja cewa amfani da maganin rigakafi ko maganin rigakafi da aka ba da shawarar zai iya haifar da kwayoyin da ke da juriya ga maganin rigakafi a yanayi.
Duk da haka, sabulu na antibacterial sun ƙunshi abubuwa masu amfani da kwayoyin cuta kamar triclosan, wanda ke da jerin sunayen kwayoyin da ke da tsayayya.
Saboda haka, ko da an kawar da kwayoyin cutar da maganin rigakafi ta hanyar sabulu na antibacterial, bazai iya zama tasiri kamar yadda aka yi shelar a kasuwa ba.
Bugu da ƙari, surfactant da kuma kariya ga fata, wannan ingantaccen tsari na iya haɗawa da acid (stearic acid, ascorbic acid, da lactic acid) a matsayin mai daidaita pH, benzoic acid mai aiki tare da maganin rigakafi da sauran masu danshi na fata (alloys, bitamin, menthol, kayan tsami). Wani bincike mai zurfi daga Kwalejin Kiwon Lafiya ta Jami'ar Oregon ya nuna cewa sabulu masu sauƙi kamar sabulu masu maganin kwayar cuta na farko suna da tasiri a cikin triclosan, a cikin rigakafin cututtuka da kuma kawar da ƙwayoyin cuta na hannu.
Ruwan zafi wanda yake da sauƙin wanke hannu ba shi da zafi don kashe ƙwayoyin cuta.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 ° C).
Koyaya, ruwan sabulu mai zafi ya fi ruwan sabulu mai sanyi tasiri wajen kawar da ƙwayoyin cuta na halitta waɗanda ke ƙunshe da ƙura da ƙwayoyin cuta.
Duk da haka, bisa ga abin da ake imani da shi, binciken kimiyya ya nuna cewa amfani da ruwan zãfi ba ya da tasiri a kan rage yawan ƙwayoyin cuta.
Maganin hana kamuwa da cuta na hannu ko kuma man shafawa na hannu wani abu ne mai tsabtace hannu wanda ba shi da ruwa.
A ƙarshen shekarun 1990 da farkon karni na ashirin da ɗaya, an ƙara sanin kayan tsabtace hannu na ruwa (wanda aka fi sani da tsabtace hannu na giya, tsabtace hannu mai tsabtace hannu, ko kuma tsabtace hannu).
Sau da yawa suna da tushen isopropyl ko ethanol tare da wani abu mai kama da carburer (acrylic acid polymer) wanda aka canza zuwa gel, ko mai danshi kamar glycerine a cikin ruwa, ko kumfa don amfani mai sauƙi na barasa da rage tasirin bushewa na barasa.
Ƙara hydrogen peroxide mai laushi yana ƙara aikin antimicrobial. Anti-microbial na hannu, wanda ya haɗa da akalla kashi 60 zuwa 95% na barasa, yana da tasiri sosai wajen kashe ƙwayoyin cuta.
Magungunan maganin rigakafi na barasa na cutar, kwayoyin cuta, kwayoyin cuta masu tsayayya da magunguna da yawa (MRSA da VRE), masu haifar da cutar sankara da kuma wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, renovirus, allurar rigakafi, mura da cutar hanta) da kumburi.
70% na maganin hana kamuwa da cuta na barasa na iya kashe kwayar cutar a hannu har zuwa 99.97% (ragewar lagartem 3.5, daidai da ragewa 35 decibel) na tsawon dakika 30 kuma 99.99% zuwa 99.999% (ragewar lagartem 4-5) na kashe kwayar cutar a hannu a cikin minti 1.
Magungunan hana shan maganin hana shan magani na barasa ba su da tasiri kamar yadda ake amfani da su wajen magance ƙwayoyin cuta (ko Norwalk), wanda shine mafi yawan sanadin kamuwa da gastroenteritis. Ya kamata a yi amfani da maganin hana shan magani na hannu ko kuma shafa giya a fata ta hanyar yin shi sosai da kuma rufe hannuwan biyu.
Ana shafa fuska da baya na hannayen hannu biyu da kuma tsakanin da kuma ƙarshen yatsunsu na kusan dakika 30 don ya bushe ruwa, ƙasa ko fata.
Dole ne a wanke yatsunsu da kyau tare da shafawa a ƙasa. Cibiyar Kula da Cututtuka ta Amurka ta amince da wanke hannu, musamman idan hannuwan suna da tsabta sosai, fiye da maganin hana kamuwa da cuta.
Ƙara amfani da waɗannan wankewa saboda sauƙin amfani da sauri don kawar da ƙwayoyin cuta; duk da haka, kada a yi amfani da su a matsayin maye gurbin wanke hannu mai kyau, sai dai idan sabulu da ruwa ba su samuwa.
Sau da yawa amfani da maganin hana shan giya yana haifar da bushewa na hannayensu, sai dai idan an ƙara mai danshi da / ko mai laushi ga tsarin su.
Za a iya rage tasirin bushewar barasa ta hanyar ƙara glycerin da / ko sauran masu danshi zuwa ga tsari.
A cikin gwaji na asibiti, maganin kashe kwayoyin halitta na barasa wanda ya ƙunshi mai danshi ya haifar da ƙarancin ƙonewa da bushewa idan aka kwatanta da sabulu da ke dauke da maganin rigakafi.
A cikin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Yana da kyau saboda yana da ƙananan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da cututtukan hannu da kuma wankewar ruwa.
Duk da aiki mai yawa, abubuwan da ba su da ruwa ba ba ba suna cire hannayen hannu daga kwayoyin halitta, suna kashe su.
Wannan shine dalilin da ya sa maganin hana kamuwa da cuta na hannu ba shi da tasiri kamar ruwa da sabulu don hana fitowar kwayoyin cuta, saboda sun kasance a hannun masu cutar.
Ingancin maganin hana shan maganin hana shan giya ya dogara sosai da abubuwan da ke ciki da kuma tsarinsa kuma a tarihi, ya kasance ƙasa da inganci fiye da giya da kayan giya.
Kwanan nan, magungunan da ke amfani da benzodiazepine chloride sun nuna ci gaba da karuwa da kuma karuwa na antimicrobial bayan amfani, sabanin barasa, wanda bayan amfani da shi akai-akai, zai iya haifar da raguwa a cikin inganci saboda sakamakon juyin juya halin juyin juya hali.
Mutane da yawa a cikin al'ummomin da ba su da isasshen kuɗi ba ba za su iya sayen sabulu ba kuma za su yi amfani da ƙasa da toka.
Ash ko ƙasa na iya zama mafi tasiri fiye da ruwa, amma mai yiwuwa ba fiye da sabulu ba.
Wani abin damuwa shine kamuwa da ƙura ko toka da kwayoyin cuta wanda zai iya taimakawa wajen yada cutar maimakon rage ta.
Ashes, kamar sabulu, yana da maganin kashe kwayoyin cuta, saboda yana haɗuwa da ruwa, yana haifar da maganin alkaline.
Hukumar lafiya ta duniya ta bada shawarar yin amfani da sabulu, toka ko zuma a matsayin madadin sabulu a lokacin da babu sabulu.
Hanyar wanke hannu da aka ba da shawarar ta Cibiyoyin Kula da Cututtuka na Amurka don hana yaduwar cutar ta ƙunshi matakai masu zuwa:
Ka wanke hannunka da ruwa mai zafi ko sanyi.
Ana ba da shawarar ruwan da ke gudana saboda raƙuman ruwa na iya zama masu ƙazanta, kodayake zafin ruwan yana iya zama ba shi da bambanci.
Ka shafa hannunka da sabulu mai yawa, daga baya, tsakanin yatsunsu da kuma ƙarƙashin kusoshi.
Sabulu yana cire kwayoyin daga fata, kuma nazarin ya nuna cewa mutane suna wanke hannayensu sosai idan aka yi amfani da sabulu fiye da lokacin da suke amfani da ruwa mai tsabta kawai.
Ka wanke hannunka na akalla na biyu.
Yin amfani da kayan shafawa na iya haifar da rikici wanda ke taimakawa wajen kawar da ƙwayoyin cuta, yin amfani da kayan shafawa na tsawon lokaci yana kawar da ƙwayoyin cuta da yawa.
Ka yi shayarwa a ƙarƙashin ruwa.
Yin wanka a cikin sink na iya sake lalata hannu.
Ka bushe shi da tsabta ko kuma ka bar shi ya bushe a lokacin rani.
Hannun da ke da ruwa da kuma rigar hannu suna da sauƙi su sake kamuwa da cutar. Sashen da ba a wanke su da yawa sun haɗa da yatsun hannu, ƙusa, tsakanin yatsunsu da ƙarƙashin kusoshi.
Kayan aikin wucin gadi da kuma layin ƙusa da aka yanke, na iya zama masu cutar da kwayoyin cuta.
Ana bada shawarar yin amfani da cream mai danshi don hana bushewar hannu; fata mai bushewa na iya haifar da lalacewar fata, wanda zai iya ƙara haɗarin kamuwa da cuta.
" Za a iya amfani da zaɓuɓɓuka masu rahusa daban-daban idan ana buƙata a ƙasashe masu tasowa don sauƙaƙe wanke hannu a inda ruwa da/ko sabulu ba su da samuwa. Alal misali, zuba ruwa da/ko sabulu daga gallon na fansa ko fata mai bushe tare da ramuka masu dacewa da/ko amfani da toka. A cikin yanayin iyakancewar ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin da za a iya rage yawan amfani da ruwa kamar ""ƙananan tabarau"" da sauran zaɓuɓɓuka masu ƙarancin amfani. "
Tape ba tare da hannu ba, fasaha ce mai sauƙi da ake amfani da ita ta hanyar amfani da wani yanki da aka rataye ta hanyar igiya da kuma wani nauyin aiki tare da ƙafa don zuba ruwa kadan a hannayen hannu da kuma wani nau'i na sabulu.
Drying hannuwanku daidai yana da mahimmanci a cikin tsabtace jiki, amma akwai muhawara game da yadda za a bushe hannuwanku a cikin gidajen wanka na jama'a.
Ƙarin bincike ya nuna cewa wanke hannu na takarda yana da lafiya fiye da na'urorin bushewa na lantarki da ake amfani da su a yawancin wuraren wanka.
A shekara ta 2008, Jami'ar Westminster a London da kuma tallafawa ta masana'antar takarda ta Turai ta Tissue Symposium, sun gudanar da wani bincike don kwatanta matakan lafiya da takarda ta hannu, bushewar iska mai zafi da kuma bushewar hannu na Airjet suka bayar.
Bayan wanke da kuma bushe hannu da mai bushewa mai zafi, an gano cewa adadin kwayoyin ya karu da kashi 194% a kan yatsunsu da kuma 254% a kan yatsunsu.
Drying hannayen hannu tare da iska mai numfashi ya haifar da matsakaicin karuwa na kwayoyin cuta a kan yatsunsu zuwa 42% da kuma a kan yatsunsu zuwa 15%.
Bayan wanke da kuma bushe hannu da takarda mai tsabta, adadin kwayoyin ya ragu da matsakaici zuwa kashi 76 cikin dari a yatsunsu da kuma kashi 77 cikin dari a kan yatsunsu. Masana kimiyya sun ci gaba da gudanar da gwaje-gwaje don gano ko akwai yiwuwar kamuwa da juna tsakanin sauran masu amfani da gidan wanka da kuma yanayin wanka ta hanyar amfani da kowane irin bushewa.
Airjet air dryer, wanda ke fitar da iska daga mota a gudun mita 180 a dakika (kilomita 650 a awa), yana iya numfasa kwayoyin cuta daga hannu da na'ura kuma yana iya gurɓata masu amfani da gidan wanka da kuma yanayin wanka har zuwa mita 2.
Yin amfani da bushewar hannu mai zafi yana watsa microorganisms zuwa fiye da mita 0.25 na bushewa.
A shekara ta 2005, wani bincike da TÜV Produkt und Umwelt ya gudanar ya bincika hanyoyin bushewa daban-daban na hannaye.
An lura da canje-canje masu zuwa a cikin adadin kwayoyin bayan an bushe hannu:
Akwai kamfanoni daban-daban da ke samar da bushewar hannu, kuma an kwatanta bushewar hannu da wanke hannu na takarda.
Yin wanke hannu ta amfani da tawul na rigakafi yayin tafiya na iya zama madadin ruwa da sabulu.
Dole ne maganin rigakafin barasa ya ƙunshi akalla kashi 60 cikin ɗari na barasa.
An tilasta yin wanke hannu na likita fiye da yadda likitan Hungary, Ignaz Smolovis (a 1846) ya gano tasirinsa wajen hana kamuwa da cuta a cikin asibiti.
Akwai na'urori masu yawa na lantarki da ke tunatar da ma'aikatan magani ta amfani da masu ba da amsa don kada su manta da wanke hannu.
Wani binciken ya nuna cewa an rage yawan kamuwa da cuta ta amfani da su.
Yin wanke hannu na likita, tare da amfani da isasshen sabulu da ruwa ko kuma wanke hannu da kuma shafa kowane ɓangaren hannu na akalla 15 seconds.
Kuma ku yi wa hannayenku ɗamara, ku rufe su da yatsunsu.
Idan akwai sutura da kuma kayan da ke ƙarƙashin kusoshi, ya fi kyau a yi amfani da goga don tsabtace su.
Tun da kwayoyin sun kasance a cikin ruwa da kuma a kan hannayen, yana da muhimmanci a yi wanka da kyau sannan a bushe hannayen da takardar tsabta.
Bayan bushewa, dole ne a yi amfani da takarda mai tsabta don rufe ruwa (da kuma buɗe duk wani rami na fitarwa idan ya cancanta).
Wannan zai hana sake kamuwa da hannayen hannu ta hanyar waɗannan matakan.
"Manufar wanke hannu a cibiyoyin kiwon lafiya ita ce kawar da kwayoyin cuta (""kwayoyin cuta") da kuma hana yaduwar cutar".
Jaridar New England Medical Journal ta ruwaito cewa rashin wanke hannu a mafi yawan wuraren kula da lafiya yana da matakin da ba za a iya yarda da shi ba, kuma akwai likitoci da ma'aikatan jinya da yawa da ke mantawa da wanke hannu kafin su tuntubi mai haƙuri, wanda ke haifar da watsa microorganisms.
Wani bincike ya nuna cewa wanke hannu da sauran ayyuka masu sauki na iya rage yawan kamuwa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Duba rubutun jagorar lafiya ta hannu da aka shirya ta Hukumar Lafiya a shafin yanar gizon Hukumar da ke samuwa ga jama'a.
Wani bincike mai dacewa da Whiteby da abokan aiki suka gudanar.
Idan ana buƙatar tabbatar da bin ƙa'idodi, na'urorin kasuwanci na iya auna da tabbatar da tsabtace hannu.
Hukumar lafiya ta duniya ta bayyana "hannu biyar" don wanke hannu:
Bayan haɗuwa da jini / jijiyoyi
Kafin yin maganin rigakafi, kuma
"Bayan kula da mai haƙuri. Ƙara maganin rigakafi na sinadarai zuwa sabulu (sabulu na ""magunguna"" ko ""antibacterial") yana taimakawa wajen hana kamuwa da cuta na kayan wanke hannu".
" Irin wannan matakan kisa suna iya zama da kyau kafin a yi tiyata ko kuma a yanayin da kwayoyin da ke da tsayayya da kwayoyin cutar ke da yawa. Don ""tsabtace"" hannayen mutum don tiyata, dole ne a buɗe ko rufe ruwan ruwa ba tare da an taɓa shi ba, da wanke-wanke na chloroglycide ko acid, da wanke-wanke na hannu don bushewa bayan wankewa da kuma sandar sterile don yin layin da kuma wani abu na sterile don tsabtace kusoshi".
Za a bar dukan duwatsu masu daraja.
Wannan aikin ya ƙunshi wanke hannu da kuma wanke hannayen hannu na tsawon minti biyu zuwa shida.
Ba lallai ba ne a ba shi dogon lokaci (minti goma).
Idan aka wanke hannuwanku, kada ruwa da aka zuba a kan agogo ya koma hannayenku.
Bayan an gama wanke hannu, an bushe hannuwan da aka wanke da hannu mai tsabta kuma an rufe su da hannu.
Don rage yaduwar kwayoyin cuta, yana da kyau a wanke hannu kafin da bayan kula da mai haƙuri, ko kuma a yi amfani da maganin rigakafi.
A cikin kula da cututtukan staphylococcal a asibitoci, an tabbatar da cewa babban amfani na wanke hannu yana samuwa ne kawai a 20% na lokacin wankewa na farko, kuma ci gaba da wankewa har zuwa 35% ya haifar da ƙananan ƙarin amfani.
Wankewa da sabulu mai sauƙi yana haifar da sau uku na yawan kamuwa da cututtukan cuta na cuta fiye da wankewa da sabulu na cuta. Kwatanta wankewa da maganin maganin hana cuta na hannu tare da wankewa da sabulu na hannu na matsakaici na 30 seconds ya nuna cewa wankewa da giya zuwa maganin hana cuta na cuta ya rage yawan kamuwa da cuta ta cuta da kashi 26% fiye da wankewa da sabulu na cuta.
Amma sabulu da ruwa sun fi tasiri wajen rage cutar H1N1 da Clostridium difficile. Saɓo da ruwa sun fi na maganin hana hana shan shan giya. Saɓo da ruwa na iya taimakawa wajen inganta lafiyar hannu a cibiyoyin kula da lafiya, ya ƙunshi horar da ma'aikata game da wankewa, ƙara samun maganin hana shan giya, da kuma rubutaccen tunatarwa ga ma'aikata.
Ana buƙatar ƙarin bincike don gano ko wane daga cikin waɗannan hanyoyin ya fi tasiri a cikin cibiyoyin kiwon lafiya daban-daban.
A ƙasashe masu tasowa, wanke hannu da sabulu an gane shi a matsayin hanya mai araha da kuma dole don samun lafiya mai kyau har ma da abinci mai gina jiki.
Duk da haka, rashin ruwa, sabulu ko kayan wanke hannu a gidajen mutane, a makarantu da kuma wuraren aiki yana sa samun halaye na wanke hannu a duniya ya zama kalubale.
Alal misali, a yankunan karkara na Afirka, akwai ƙananan wuraren wanke hannu kusa da gidajen wanka na sirri ko na jama'a, duk da haka akwai zaɓuɓɓuka masu arha don gina wuraren wanke hannu.
Duk da haka, ƙananan yawan wanke hannu na iya zama sakamakon wasu halaye da aka kafa don rashin sabulu ko ruwa.
Ƙarfafawa da kuma tallafawa wanke hannu da sabulu na iya rinjayar yanke shawara na siyasa, ya kara wayar da kan jama'a game da amfanin wanke hannu, kuma ya haifar da sauya halaye na dogon lokaci a cikin al'umma.
Kulawa da kimantawa suna da mahimmanci don aiki mai tasiri.
"Binciken tsarin nazarin 70 ya nuna cewa hanyoyin da suka danganci al'umma sun kasance masu tasiri wajen kara wanke hannu a cikin LMICs, yayin da kamfen din talla na zamantakewa ya kasance mara tasiri. Misali na inganta wanke hannu a makarantu shine ""Taro-Star Walk"" na UNICEF wanda ya karfafa makarantu su dauki matakai masu sauki, masu rahusa, kamar tabbatar da cewa, ban da biyan sauran bukatun kiwon lafiya, ɗalibai suna wanke hannayensu da sabulu. "
Bayan samun ƙarancin maki, makarantu za su iya samun ci gaba daga tauraro ɗaya zuwa taurari uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen ɗin talla na wanke hannu wanda aka yi don rage rashin lafiya da mutuwar yara.
Ranar wanke hannu ta duniya ita ce wani misali na yakin neman wayar da kan jama'a wanda ke ƙoƙarin canza halaye. A sakamakon annobar coronavirus 2019-20, UNICEF ta tallata amfani da emojis na wanke hannu.
Kadan daga cikin nazarin sun yi la'akari da tasirin tasirin farashin wanke hannu a ƙasashe masu tasowa dangane da DALYs.
Duk da haka, wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi dacewa fiye da sauran hanyoyin ruwa da tsabtace jiki.
"Babban amfani da wanke hannu ga lafiyar mutum, musamman ga mutanen da ke da rauni kamar uwayen da suka haifi jarirai ko kuma sojojin da aka ji rauni a asibitoci, an fara gabatar da su a tsakiyar karni na 19 ta hanyar masu ba da shawara game da tsabtace hannu: likita na Hungary Iñaz Smálvíz, wanda ke aiki a Vienna, Austria, da Florence Nightingale, wanda ya kasance ""mai gina cibiyar kula da marasa lafiya ta zamani"" a Ingila. "
A lokacin, yawancin mutane sun gaskata cewa kamuwa da cuta sakamakon ƙanshin da ake kira messmas.
A cikin shekarun 1980, yaduwar cututtukan abinci da cututtukan da suka shafi kiwon lafiya ya sa Cibiyoyin Kula da Cututtuka na Amurka sun inganta tsabtace hannu a matsayin muhimmin hanyar hana kamuwa da cuta.
Cutar cutar sankarar da aka yi a shekarar 2009 da kuma annobar COVID-19 a duniya a shekarar 2020 sun sa kasashen da dama sun san muhimmancin wanke hannu wajen hana irin wannan kamuwa da cuta.
Alal misali, an sanya hotunan da ke dauke da "fasaha na wanke hannu" a kusa da wanke-wanke a cikin gidajen wanka na jama'a da kuma a cikin gidajen wanke na gine-gine da kuma filin jirgin sama na Jamus.
"Halin ""wanke mutum daga"" wani abu, yana nufin sanar da rashin son mutum ya dauki alhakin ko ya shiga cikinsa. "
Ya samo asali ne daga wani ɓangare na Linjila na Matiyu inda Pontius Pilate ya ƙi yanke shawarar giciye Yesu Kristi, amma ya sami amfani da shi a wasu maganganun Turanci.
"A cikin ""Macbeth"" na Shakespeare, Lady Macbeth ta yi ta yi wa hannuwanta sau da yawa ba tare da saninsa ba don kawar da tabo na rashin adalci wanda ya nuna lamirinta game da laifuffuka da ta aikata kuma ta tilasta mijinta ya aikata".
An kuma nuna cewa mutane suna wanke hannayensu fiye da wasu bayan tunawa ko tunani game da ayyukan da ba su da kyau, kuma suna da ƙarin kulawa ga wanka da wanke hannu.
"Bugu da kari, mutanen da aka ba da izinin wanke hannu bayan irin wannan kulawar, suna iya zama kasa da yawa a cikin sauran ayyukan tilasta ""sakewa"", kamar aikin sa kai".
Addinai suna ba da umarnin wanke hannu don dalilai na kiwon lafiya da alama. Yin wanke hannu na alama, amfani da ruwa ba tare da sabulu ba don wanke hannu, wani ɓangare ne na wanke hannu na addini wanda aka nuna a yawancin addinai, ciki har da Baha'u'u'llah, Hinduism, Twellah, da kuma Nitalai na Tunawa a cikin Yahudanci, Labawa a cikin Kiristanci, da kuma al'ada a cikin Musulunci. Addinai suna ba da shawarar wanke hannu musamman bayan wasu ayyuka.
Hindu, Yahudanci da Musulunci sun ba da umarnin wanke hannu bayan wanka.
Hindu, Buddha, Sikh, Yahudawa, da Musulunci sun umarci wanke hannu kafin da bayan kowane abinci.
Kula da haɗarin yanayin aiki don COVID-19
Gudanar da haɗarin a cikin yanayin aiki don COVID-19 yana nufin amfani da hanyoyin lafiya da aminci na aiki don sarrafa haɗari da hana barkewar cutar coronavirus 2019 (COVID-19).
Gudanar da haɗari a wurin aiki ya dogara da yanayin aiki da aikin da ake yi, kuma yana canzawa dangane da kimanta haɗarin daga hanyoyin samun cutar, yadda cutar take a cikin al'umma, da kuma abubuwan haɗari ga kowane ma'aikaci wanda zai iya zama mai rauni ga kamuwa da COVID-19.
A cewar sanarwar Hukumar Lafiya da Tsaro da Yanayi ta Amurka (OSHA), ƙananan kamfanoni masu haɗari suna da ƙarancin lamba ta aiki tare da jama'a da sauran abokan aiki, ana ba da shawarar waɗannan kamfanoni su ɗauki matakan da suka dace don hana kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna da rashin lafiya, yin amfani da abin rufe fuska da tsabta da kuma rigakafin aikin yau da kullun.
Kasuwancin matsakaici na iya zama waɗanda ba sa buƙatar tuntuɓar mutane masu shakka ko waɗanda ke da cutar COVID-19 ko kuma waɗanda ke da haɗari, amma suna iya zama masu haɗari saboda haɗuwa kai tsaye da jama'a ko tafiya ta duniya.
Wannan ya shafi ma'aikata da ke hulɗa da jama'a a wurare kamar makarantu, wuraren aiki masu yawan jama'a da wasu manyan shagunan sayar da kayayyaki.
Kula da haɗarin ga wannan rukuni, ban da matakan farko na rigakafin kamuwa da cuta, ya haɗa da iska ta iska ta amfani da matattarar iska masu inganci, kiyaye ƙishirwa da samun damar yin amfani da kayan kariya na mutum don magance COVID-19.
OSHA tana ɗaukar ma'aikatan kiwon lafiya da kiwon lafiya da ke fuskantar haɗari tare da waɗanda ake zargi da COVID-19 a matsayin masu aiki a cikin ayyukan haɗari, wanda zai iya zama haɗari sosai idan aka yi amfani da hanyoyin samar da Aerosol ko ɗaukar samfurori daga waɗanda ake zargi da COVID-19.
Ƙunƙusawa na aikin haɗari da suka dace da waɗannan ma'aikatan za a iya ambata su ne na aikin injiniya kamar ɗakunan da ke da iska mai ƙarancin iska da kuma kayan aikin kariya na mutum da suka dace da aikin.
Yaduwar COVID-19 na iya haifar da tasiri mai yawa a wurin aiki.
Ma'aikata na iya kasancewa a wurin aiki saboda rashin lafiya, buƙatar kula da wasu, ko tsoron rashin lafiya.
Hanyoyin kasuwanci na iya canzawa, duka dangane da kayan da ake buƙata da kuma hanyar karɓar waɗannan kaya (kamar sayayya a cikin sa'o'i na waje ko hanyar sabis na isar da kaya ko sabis na hawa).
A ƙarshe, jigilar kaya daga yankunan da COVID-19 ya fi tasiri zai iya zama matsala. Za a iya amfani da shirin shiri da amsawa don gudanar da matakan kariya.
A cikin tsare-tsaren, an yi la'akari da matakan haɗari da ke tattare da wuraren aiki da ayyuka daban-daban, ciki har da hanyoyin tuntuɓar cututtuka, abubuwan haɗari a cikin zamantakewa da gida da abubuwan haɗari ga kowane ma'aikaci daban, ciki har da rashin lafiya ko rashin lafiya na yau da kullun.
Har ila yau, an bayyana hanyoyin da za a iya amfani da su wajen hana wadannan haɗarin da kuma tsarin maye gurbin yanayi da zai iya haifar da yaduwar cutar.
Shirye-shiryen shirye-shirye da amsawa ga cututtukan cututtuka na iya aiwatar da su ta hanyar la'akari da shawarwarin ƙasa ko na gida.
Manufofin da ake da su na magance yaduwar cutar sun hada da rage yawan yaduwar tsakanin ma'aikata, kare mutanen da ke da haɗarin kamuwa da cututtuka masu zuwa, kula da ayyukan kasuwanci da kuma rage tasirin da ba a so a kan sauran cibiyoyin da ke cikin sarkar samar da kayayyaki.
Matsayin cutar yana shafar amsawar da ake samu a cikin al'umma, inda kasuwancin ke.
Tsarin tsarin kula da haɗari shine tsarin da aka yi amfani dashi a cikin ci gaba da lafiya da lafiya a wurin aiki don tsara haɗari bisa ga tasirin tasiri.
Inda babu yiwuwar kawar da haɗarin COVID-19, sarrafa injiniya, sannan na gudanarwa, da kuma na'urorin kariya na mutum, sune mafi inganci na sarrafawa.
Gudanar da aikin injiniya yana nufin kawar da ma'aikata daga haɗarin aiki ba tare da dogaro da halayyar ma'aikaci ba, wannan zai iya zama mafi arha.
Gudanar da gudanarwa shine sauyawa da aka ba a cikin umarni ko hanyoyin aiki kuma dole ne ma'aikata ko ma'aikata suyi aiki akan su.
Kayan kare mutum (PPE) ba su da tasiri sosai a kan gudanarwa da aikin injiniya, amma suna iya hana wasu haɗari.
Dukkanin PPE dole ne a zabi su bisa ga haɗarin da ke tattare da ma'aikata, a sanya su yadda ya kamata (misali masks na likita), a yi amfani da su a kai a kai, a bincika su, a yi musu hidima, a maye gurbin su, a buɗe su, a tsabtace su, kuma a sake shigar da su idan ya cancanta, ko a jefa su don hana kamuwa da cuta.
A cewar Hukumar Lafiya da Tsaro ta Amurka (OSHA), ma'aikata masu haɗari da ke da ƙarancin hulɗa da jama'a ko sauran abokan aiki suna da ƙarancin haɗari.
Ya ce, akwai matakan kariya da za a ba wa mutane a duk fannonin aiki, kamar wanke hannu da kuma wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna da rashin lafiya, yin amfani da abin rufe fuska na numfashi da kuma rufe bakinsu a lokacin da suke tari ko kuma suna jin zafi, samun takarda da kwandon shara, shirya don sadarwa daga nesa ko sa'o'i na aiki mara kyau idan ya cancanta, ƙarfafa ma'aikata su yi amfani da wasu kayan aiki da kuma yin shiri na yau da kullum don tsabtace da kuma hana kamuwa da cuta a wurin aiki.
Ganowa da kuma cire mutane da sauri waɗanda za su iya kamuwa da cutar yana da mahimmanci a cikin kare ma'aikata, abokan ciniki, abokan ciniki da sauran mutane a cikin yanayin aiki.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) sun ba da shawarar cewa ma'aikatan da ke da alamun cututtukan numfashi mai tsanani su zauna a gida har sai zazzabi, alamun zazzabi da wasu alamun sun tafi, aƙalla awanni 24 bayan sun daina shan maganin maganin zazzabi ko na sauya alamun cutar, kuma a sami ƙarin sassauƙa a cikin layin amfani da izinin izinin kulawa don ba ma'aikatan damar zama a gida don kula da marasa lafiya na iyali, kuma duk ma'aikatan su san sabon layin.
A cewar OSHA, ayyukan da ke da haɗari na matsakaici sun haɗa da ayyukan da ke buƙatar haɗari mai yawa da kuma nesa da juna a cikin zangon ƙafa shida (mita 1.8) kuma ba a san ko masu amfani suna da cutar COVID-19, amma saboda yawan shiga cikin al'umma ko tafiya ta duniya zuwa wurin da cutar COVID-19 ta barke ba, za su iya kamuwa da SARS-CoV-2.
Waɗannan sun haɗa da ma'aikata da ke hulɗa da jama'a, kamar waɗanda ke aiki a makarantu, wuraren aiki masu yawa da wasu manyan wuraren sayar da kayayyaki. Ƙididdigar injiniya ga waɗannan ƙungiyoyi da ƙungiyoyin da ke da haɗari sun haɗa da shigar da matatun iska masu inganci, haɓaka farashin iska, shigar da shinge na jiki kamar su rigakafin ruwan sha na filastik da kuma shigar da kayan aikin hawa don sabis na abokin ciniki. Ƙididdigar aiki ga waɗannan ƙungiyoyi da ƙungiyoyin da ke da haɗari mafi yawa sun haɗa da sakin layi masu zuwa: ƙarfafa ma'aikatan marasa lafiya su zauna a gida, ƙarfafa ma'aikatan marasa lafiya su maye gurbin tarurruka na yau da kullun, ƙirƙirar sa'o'i masu canji, soke balaguron da ba dole ba zuwa wuraren da ke fuskantar COVID-19, daidaita haɗarin haɗarin haɗari na mutum-mutumin da kuma sanya kayan aikin hawa don sabis na abokin ciniki. Dole ne ma'aikatan su yi amfani da kayan aiki da kayan aiki da ke da mahimmanci, ƙayyade matakan da suka dace don kula da yanayin COVID-19 da kuma kula da yanayin aiki, kula da ma'aikatan da ke da amfani da kayan aiki, ƙarancin matakan da ke da kyau don kula da kayan aiki, kula da kuma kula da kayan aiki, kula da kula da kayan aiki, kula da kula da kula da kayan aiki, da kuma kula da kayan aiki, da kuma kula da kayan aiki.
Ma'aikatan wannan rukunin haɗari ba sa buƙatar injunan numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, ana iya amfani da hanyoyin sarrafawa masu kyau don kare ma'aikata da sauran fasinjoji, ta hanyar ware mai haƙuri daga wasu, ta hanyar kafa nesa da ya zama aƙalla ƙafa 6, ta hanyar sanya ma'aikatan da za su iya ba da masks ga mai haƙuri, da kuma buƙatar shi ya rufe bakinsa da hanci da tawul yayin da yake tari ko kuma ya yi tururuwa.
Ma'aikatan jirgin dole ne su sa sa safofin hannu na likita na sau ɗaya lokacin da suke ba da sabis ga wani mai haƙuri ko taɓawa da takarda ko matakan da ke da haɗari, kuma idan mai haƙuri yana da zazzabi, yawan zazzabi ko rashin numfashi, yi amfani da wasu kayan kariya idan ya yiwu.
Dole ne a ajiye safofin hannu da sauran kayan aiki na sau ɗaya a cikin jakar shara ta asibiti, dole ne a tsabtace matakan da aka kamu da su bayan aiki. Don aikawa na kasuwanci, gami da jigilar jiragen ruwa da sauran jiragen ruwa, kula da haɗari ya ƙunshi abubuwa kamar hana tafiya idan kana rashin lafiya, cirewa da kuma sanar da asibitin jirgin nan take idan ka lura da zazzabi ko wasu alamomi a lokacin da kake cikin jirgin.
A mafi kyawun yanayin, dole ne a bi hanyar magani a cikin ɗakin ɗakin mutumin da aka kwantar. CDC ta ba da shawarar rufe makarantu da cibiyoyin kula da yara na ɗan gajeren lokaci don yin tsabtace da maganin rigakafi, ba tare da la'akari da yadda cutar ta yadu a cikin al'umma ba, saboda mai yiwuwa mutum mai cutar ya kasance a cikin ginin makaranta.
Lokacin da yawan watsawa na zamantakewa ya kasance ƙasa ko matsakaici, ana iya taimakawa ta hanyar dabarun nesa da zamantakewa kamar soke tarurruka, tarurruka da sauran tarurruka kamar koyar da halarta ko ajiyar waƙa ko ciyar da abinci a cikin cafe, ƙara nesa tsakanin tebur, sauya lokacin farawa da ƙarshen, iyakance halartar baƙi marasa mahimmanci da amfani da ofishin kiwon lafiya na musamman don yara waɗanda ke da alamun cutar mura.
Lokacin da akwai canji mai mahimmanci a cikin al'umma, ban da dabarun nesa da zamantakewa, dole ne a yi la'akari da hutu na dogon lokaci na makaranta. CDC ta yi imanin cewa akwai ƙananan haɗarin kai tsaye ga lafiyar ma'aikatan doka waɗanda ke gudanar da ayyukan yau da kullun.
Jami'an tsaro da ke da alaka da mutanen da ke fama da cutar ko kuma waɗanda ake zargi da cutar COVID-19 suna da shawarar bin irin wannan tsari na masu aikin gaggawa na gaggawa, ciki har da yin amfani da kayan kariya na mutum.
Idan akwai kusanci a lokacin da ake jin tsoro, ma'aikata za su yi tsabta da kuma tsabtace belinsu da kayan aiki kafin su sake amfani da su tare da fesa ko tawul, kuma su bi ka'idodin aiki game da riƙewa da kawar da PPE da aka yi amfani da su da kuma kiyayewa da wanke tufafi masu datti.
OSHA ta yi imanin cewa wasu ma'aikata a cikin kiwon lafiya da kuma gidajen sanyi suna cikin haɗari ko manyan haɗari.
Ayyukan haɗari kamar samar da sabis na kiwon lafiya, tallafi, dakunan gwaje-gwaje da ma'aikatan sufuri na likita waɗanda ke fuskantar kamuwa da cutar COVID-19.
Idan ma'aikata suka yi amfani da hanyoyin samar da Aerosol, ko kuma suka ɗauki samfurori daga marasa lafiya masu shakka ko waɗanda ke da cutar COVID-19, waɗannan suna da haɗarin watsawa mai yawa.
Abubuwan da ake amfani da su a cikin tsarin samar da iskar shaka sun haɗa da bututun ruwa, matakan rage yawan hawan jini, bronchoscopy, wasu bincike da tiyata na hakori ko kuma daukar samfurin da ya shafi.
Ayyukan sanyi na haɗari suna ɗaukar aiki mai haɗari inda mutum zai shirya gawawwakin waɗanda ake zargi da cutar COVID-19 bayan mutuwa; idan aka yi autopsy, waɗannan ayyukan suna cikin nau'in aiki mai haɗari. Don waɗannan rukunin haɗari, ƙarin kulawar injiniya dole ne a yi la'akari, gami da ɗakunan kwantar da hankali don marasa lafiya masu shakka ko masu kamuwa da COVID-19, musamman lokacin da ake aiwatar da hanyoyin samar da cutar.
A wasu yanayi masu tsabta da kuma yanayin sanyi, iska mai ƙarancin matsa lamba na musamman na iya zama mai dacewa.
Dole ne a ɗauki samfurori bisa ga matakan tsaro na matakin kariya ta 3 na rayuwa.
Hukumar lafiya ta duniya (WHO) ta ba da shawarar cewa sababbin marasa lafiya su kasance a cikin sassan jiran da aka keɓe don gano ko suna da cutar COVID-19. OSHA ta ba da shawarar cewa waɗanda ke aiki a nesa da ƙafa 6 daga marasa lafiya ko waɗanda ake zargi da SARS-CoV-2 da kuma waɗanda ke yin hanyoyin samar da Aerosol, su yi amfani da masks na likita, ban da sauran kayan kariya na mutum.
A Amurka, a cikin tsarin shirin kariya na numfashi mai zurfi da takarda wanda ya haɗa da gwajin fuska, motsa jiki da bincike na likita, dole ne a yi amfani da masks masu numfashi na N95 waɗanda suka sami amincewar NIOSH ko samfurori mafi kyau.
Sauran nau'ikan kayan numfashi na iya samar da ƙarin kariya da inganta kwanciyar hankali ga ma'aikata. Hukumar Lafiya ta Duniya ba ta ba da shawarar yin amfani da ƙarin murfin ba, saboda COVID-19 cuta ce ta numfashi kuma ba ta yaduwa ta hanyar fitsari.
Hukumar lafiya ta duniya ta ba da shawarar cewa ma'aikatan da ke wurin fara binciken su saka abin rufe fuska.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa duk wanda ya karɓi, ya riƙe, ko ya ba da samfurin numfashi daga marasa lafiya na COVID-19 ba tare da wani tsari na samar da Aerosol ba, ya yi amfani da masks na tiyata, tabarau masu kariya, rigar fuska, rigar rigar, da safofin hannu.
Idan an yi amfani da hanyar samar da aerosol, ana maye gurbin abin rufe fuska na tiyata da abin rufe fuska na N95 ko FFP2.
Ganin cewa samar da PPE a duniya bai isa ba, Hukumar Lafiya ta Duniya ta ba da shawarar rage bukatar kayan kariya ta mutum ta hanyar wadannan matakan: yin amfani da tarkon magani (ta hanyar nesa), sanya shinge na jiki kamar su tsabtace jiki, ba da izinin shiga dakin marasa lafiya na COVID-19 ga waɗanda ke shiga cikin kulawa kai tsaye, amfani da PPE kawai don ayyuka na gaggawa, amfani da abin rufe fuska na likita da rashin shi yayin kula da marasa lafiya da yawa waɗanda ke da irin wannan cuta, kula da sarkar samar da PPE da daidaita shi, kuma a ƙarshe ƙarfafa talakawa marasa alamar amfani da abin rufe fuska.
Daga: Katherine Maher, Darakta Darakta na Gidauniyar Wikimedia
Ga: Duk ma'aikatan Wikimedia Foundation
Rubutun: [Covid-19] Sauƙaƙe nauyi da shirye-shirye don gaba
Ranar / Lokaci: 14 ga Maris, 2020, a 00: 24 na duniya daidaitaccen lokaci
CC0: Wanne haƙƙin ba shi da haƙƙin mallaka
Muna ganin kanmu a cikin yanayi mai ban sha'awa a wannan watan.
Cutar COVID-19 ita ce abin da ke nuna haɗin kai na duniya da kuma nauyinmu ga juna.
Wannan ƙalubale ne mai ban mamaki, amma mun tabbata cewa amsarmu mafi kyau ita ce ga haɗin kai, haɗin kai da kuma dogaro da alhakin zamantakewar da ke cikin zuciyar wannan ƙungiyar.
Jinƙai da kulawa da muka samu ta hanyar imel, kira da hira tsakanin dukkan abokan aikinmu sun nuna yadda muke farin cikin yin aiki tare da irin waɗannan mutane masu ban mamaki.
Ina godiya ƙwarai da yake ina da irin waɗannan abokan aiki.
A makon da ya gabata, wani mutum ya yi ta gode mini don aikinmu.
Sun tunatar da ni yadda yake da muhimmanci a duniya ta koma Wikipedia, da kuma yadda kasancewa a kan layi da kuma samun dama ga kowa yana da tasiri ga waɗannan albarkatun masu mahimmanci.
Wannan shine abin da kuke yi, ko don taimakawa ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci.
Yanzu fiye da kowane lokaci, duniya tana buƙatar bayanin da Wikipedia ke bayarwa.
Yanzu ne lokacin da ba kawai abin da muke yi ba, amma yadda muke yi zai iya yin tasiri ga duniya.
Saboda muhimmancin wannan manufa da kuma rawar da kuke takawa a ciki, za a kawo canje-canje masu yawa a cikin yadda muke aiki tare daga mako mai zuwa.
Abubuwan da muke yi da kuma tsarinmu
Kamar yadda Robin ya ambata a baya, membobin tawagar C sun taru a daren jiya don tattaunawa da tattaunawa game da tsarinmu da kuma tsarinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun tattauna batutuwa da muka yi tunanin cewa amsar da ta dace ga matsalar da muke fuskanta ita ce hanya mafi kyau don kiyaye inganci da dorewar kamfani.
Muna so mu kawar da tashin hankali da kuma tallafa wa aikinmu a cikin dogon lokaci.
Idan kana bukatar ka sake kira, babu abin da ya faru.
Ga dukan ma'aikata, kwangila da ma'aikatan alkawari:
Har zuwa sanarwar ta biyu, aikinmu na yau da kullum zai kasance kimanin sa'o'i 4 a rana ko 20 a mako.
Ba za mu sanar da dokar hana fita ba - idan za ku iya yin aiki na tsawon sa'o'i kamar yadda kuka saba, za ku iya taimaka wa aikin.
Duk da haka, duniya ba ta da tabbas a yanzu, kuma ko kuna buƙatar kula da ƙaunatattunku da abinci ko ku nemi likita, lafiyarku ita ce fifiko a gare mu.
Ba mu rubuta lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ba lallai ba ne a ambaci wannan, amma za mu ambace shi.
Ba a buƙatar izinin yin aiki ko PTO - kawai gaya wa manajan ku kuma taimaka wa ƙungiyar ku duba kalandarku da rarraba lokaci don tabbatar da cewa an rufe mahimman wuraren aiki.
(Idan an tabbatar da gwajin COVID-19 naka, ka sanar da Brian a T&amp;C Ops don T&amp;C ta iya taimaka maka da samar da tallafi da kuma tabbatar da cewa gudanarwa tana kula da yanayinka sosai).
Za a biya albashi ga mutanen da ke aiki a kowane lokaci.
Mun riga mun bayyana kuma mun sake yin alkawarin kiyaye alkawuran da muke da su ga masu kwangila da abokan aikinmu.
Dukkansu dole ne su sami albashi bisa ga sa'o'i na aiki a cikin yanayi na yau da kullum.
Idan kana rashin lafiya kuma ba za ka iya yin aiki ba, wannan ya haɗa da kai.
Idan kana son yin aiki, za mu goyi bayan ka.
Mutane da yawa suna amfani da aiki a matsayin hanya don kalubalanci damuwa da duniya.
Abin da muke yi na iya zama mai matukar muhimmanci, musamman a lokutan da muke ciki.
Bari mu sake tuna cewa wannan yana da alaƙa da kula da kanka.
Muna rokon ku ku tuntuɓi manajan ku, don haka za mu san abin da kuke tsammani kuma za mu iya daidaita kanmu bisa ga hakan.
Wasu ayyuka suna da muhimmanci.
Akwai abubuwa da za mu ci gaba da yi.
Kamfanonin SRE, HR Ops, Trust & Safety da kungiyoyin karbar kudi (a tsakanin wasu) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin tallafi.
Za mu fara aiki a dukkan raka'a don tantance manufofin yanzu da kuma mayar da hankali kan tallafawa duk abin da ake bukata don aiwatar da wannan manufa.
Akwai aiki mai yawa da za a yi, za mu mai da hankali kan ayyukan da suka fi muhimmanci.
Saukewa a yanzu ba zai haifar da lalacewar gaba ba.
"Ba mu da niyyar ninka lokaci" don biyan kuɗin jinkiri lokacin da annobar ta ƙare.
Ba za a sa ran ku yi aiki mai yawa ba don ku isa ga lokacin da aka ƙayyade, wanda yanzu ba shi da ma'ana.
Mun yarda cewa yanayin ya canza kuma za mu yi aiki idan ya cancanta don kafa sababbin manufofi da jadawalin lokaci.
Menene zai faru da APP?
Don daidaitawa da gaskiyar da ake tsammani a sabon aikin, muna shirin canza lokacin don isar da shirinmu na 2020-2021.
Muna shirin fadada shirin 2019-2020 don mu iya ba da karin lokaci don kasafin kuɗi kuma mu ba ma'aikata damar sanya ayyuka na asali, kula da kansu da kula da ƙaunatattun su a matsayin fifiko, yayin da waɗanda suke buƙatar ko son aiki za su sami tsarin aiki mai sauƙi a cikin makonni masu zuwa.
Wannan tsawaita jadawalin zai rage matsin lamba na yanzu don tsarawa da kuma matsin lamba ga dukan kungiyar.
Za mu gabatar da shawarwarinmu ga kwamitin a mako mai zuwa kuma za mu sanar da wakilan da kungiyoyin a kan matakai na gaba da zarar an amince da su.
Muna godiya ga tawagar APP saboda jagorancin da suka bayar.
Yanayin aiki, haɗari da tsabta
A makon da ya gabata, mun gano cewa wani ma'aikacinmu a SF na iya kamuwa da cutar COVID-19.
Duk da haka, saboda kiyaye matakan tsaro, mun sanya ƙungiyar ma'aikatan tsabtace rigakafin cutar don hana allurar rigakafi a duk matakan ofishin San Francisco.
Sun yi amfani da maganin rigakafi na asibiti don kashe dukkan farfajiyar da kuma lobbies da ɗakunan da ke kan bene.
Ginin yana aiwatar da tsarin kula da shi ta amfani da kayayyakin da ke kare lafiyar mazauninsa.
Muna jin dadi cewa ofishin zai kasance a shirye don dawowarmu.
Ofishinmu na DC yana cikin WeWork, wanda ya raba yarjejeniyar COVID-19 tare da mu da duk ma'aikatan DC.
A makon da ya gabata, ofishinmu na DC ya zama mai aiki sosai, bisa ga jagororin da aka raba tare da San Francisco.
Kamar yadda wasu abokan aikinmu na birnin New York suka sani, muna tattaunawa game da haya a Brooklyn.
Wadannan tattaunawa suna ci gaba amma suna iya jinkirta.
Wasu abokan aikinmu suna fuskantar rashin jin daɗi a karon farko.
Abokanmu na dogon lokaci suna bukatar su san cewa za a iya samun canji, kuma ina bukatar in ba da wasu shawarwari:
Za a iyakance tsawon zaman ga iyakar sa'a daya ko biyu.
Idan kana bukatar zaman lokaci mai tsawo, ka yi tunani game da raba taron da kuma gudanar da shi a cikin 'yan kwanaki.
Ka bayyana taron a fili, ka shirya jadawalin taron, kuma ka aika da abin da za a karanta a gaba.
Ka sa kiran bidiyo ya zama dole don sauƙaƙe haɗin kai da sadarwa ta hanyar amfani da Google Docs da Zoom.
A duk zaman shugaban, mutum yana lura da tattaunawar da ke da alaƙa da tambayoyi, yana bin jerin masu magana, kuma yana da mutum ɗaya don yin rubutu (ko kuma yin aiki tare don yin rubutu).
Idan kana buƙatar madaidaicin kai, tuntuɓi sashen tallafi na fasaha ta imel.
Yi amfani da kuɗin kuɗin ku don siyan abincin dare.
Ka shiga tashar #remoties a Slack kuma ka yi magana da abokan aikinka game da rarraba aiki
Ƙungiyar Ayyukan Gudanar da Ayyukan Mutum za ta yi nazarin jagororin ergonomics da kuma taron tattaunawa don tallafawa karuwar rarraba aiki a duk faɗin tushe.
A makon da ya gabata, mun nemi duk masu karɓar tallafin zamantakewa su soke taron jama'a da aka tallafawa ta hanyar tallafin Wikimedia, kamar gudanar da ayyukan ATMs har sai an sanar da ƙarshen annobar ta Hukumar Lafiya ta Duniya.
Muna sanar da su cewa mun fahimci cewa buƙatarka don sokewa da sauran ƙuntatawa na iya sa kammala ayyukan bayarwa da aka amince da su ya zama ba zai yiwu ba kuma ba za a yi wa kowa hukunci ba don jinkirta ko sauya manufofin.
A mako mai zuwa, za mu ba da ƙarin bayani game da Wikimania da sauran taron jama'a na gida da na al'ada.
A wasu lokuta, jama'a na duniya suna jin dadi saboda wannan katsewa, amma suna jin dadi saboda suna iya mayar da hankali ga ayyukan zamantakewar su, Wikimedia Media da sauran hanyoyin.
CRT na ci gaba da aiki don ƙirƙirar shafi a kan Meta-Wiki don samar da sarari ga al'umma don lura da tasirin da kuma kula da mu.
Ka kasance a kan layi game da COVID-19
Za mu aika da gayyatar zuwa ranar Alhamis mai zuwa da karfe 14:00 na yamma, tare da daidaitaccen lokaci na duniya na 07:00 PT, don gudanar da taron ma'aikata na musamman.
Za mu yi amfani da wannan damar don raba shawarwari na gaba, amsa tambayoyinku da tuntuɓar juna.
Mun kasance a cikin wannan halin kuma muna shirye mu taimaka.
A wannan lokacin, za ka iya samun bayanai ta hanyar imel ɗin nan kuma ka duba Office Wiki don duk sauran bayanan da ake bukata game da COVID-19.
CRT yana taimakawa wajen daidaita waɗannan shafuka da kuma adana duk bayanan.
Muna yin iyakar kokarinmu don sadarwa tare da ma'aikatan da ke zaune a kasashen da suka fi fama da cutar.
Idan kana da wata tambaya game da tafiya, abubuwan da suka faru, babban aiki, ko ƙalubalen ɗaukar hoto, ko kuma duk wani abu da kake buƙatar taimako don warwarewa, don Allah ka sanar da CRT da sauri kuma ka yi aiki tare da shi.
Muna ba da sabis don taimakawa wajen samar da tallafi da sadarwa, idan ya cancanta.
Idan kana da wani abu mai mahimmanci ko mai mahimmanci, tuntuɓi Bryan Judan, darektan ayyukan HR na duniya.
Babu wani daga cikin waɗannan canje-canje da za a iya ɗauka a matsayin watsi da aiki da alhakin.
A akasin haka, yanzu suna nuna cewa aikinmu da alkawuranmu dole ne su daidaita a wani sabon tsari wanda ba a taɓa gani ba.
Waɗannan su ne matakan da muke ganin suna da muhimmanci don tallafawa juna, don ci gaba da aiki, don ba da gudummawa ga motsin motsin da yake buƙatar tallafawa da kuma tallafawa duniyar da ta dogara.
Ayyukanmu da aka tsara suna jiranmu a lokacin da ya dace.
Yanzu lokaci ya yi da za mu goyi bayan juna kuma mu samar da sarari don ayyukan da za mu yi a cikin makonni masu zuwa, kuma wataƙila watanni masu zuwa.
Muna bukatar ku duka don yin wannan, kuma saboda haka muna bukatar ku kula da kanku da iyalanku don ku kasance cikin mafi kyawun yanayi a lokacin da ake buƙata.
Yanzu, don Allah -- ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, sashen CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S) da sauran mambobin ƙungiyar gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
Anjeocanthin-2B (ACE2) shine enzyme wanda ke haɗe zuwa waje (ƙwayoyin halitta) na ƙwayoyin huhu, jijiyoyin jini, zuciya, hanci da jini.
ACE2 yana magance aikin enzyme mai canza angiotensin ta hanyar rage adadin angiotensin 2 da kuma ƙara angiotensin (da 1-7) kuma ya sanya shi kyakkyawan magani don magance cututtukan zuciya. ACE2 har yanzu yana aiki a matsayin hanyar shiga cikin kwayoyin halitta ga wasu coronavirus.
An kira wani nau'in na mutum na enzyme hACE2 sau da yawa.
Anjeotancin-2 mai canzawa yana dauke da wani metalanzyme wanda ke dauke da wani abu mai mahimmanci wanda yake a saman kwayoyin ciki da sauran kwayoyin.
Protein ACE2 yana dauke da yankin M2 na ne-terminal peptidease da kuma yankin karɓar ƙananan amino acid cholesterol C-terminal.
ACE2 wani nau'i ne na furotin na gland na nau'i guda daya wanda ke da tasirin enzymatic wanda ke samuwa a saman kwayoyin a cikin huhu da sauran kayan.
Ƙarfin waje na kwayar ACE2 yana ƙunshe da wani enzyme da ake kira shadase na glandular translucent, kuma furotin mai narkewa da aka samu yana fitowa cikin jini kuma a ƙarshe yana fitarwa cikin urine.
ACE2 yana samuwa a mafi yawan sassan jiki: ACE2 yana haɗuwa da membrane na ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta na ƙananan hanji, ƙwayoyin cuta na ciki da ƙwayoyin jijiyoyin jijiyoyin jiki a mafi yawan sassan.
Ana samun ACE2 mRNA a cikin kwakwalwa, tsarin tsarin, hypothalamus, da ƙwaƙwalwar kwakwalwa.
Babban aikin ACE2 shine aiki a matsayin ACE antibody.
ACE hormone ya raba angiotensin daya zuwa angiotensin biyu, wanda shine mai hana jijiyoyi.
ACE2 a maimakon haka, yana raba aminonin carboxylic-terminal alanyl-alanyl daga angiotensin-du (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolyzing shi zuwa angiotensin mai faɗaɗa jijiya (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya haifar da rabuwa daga wasu peptides, ciki har da /DS-Arg9)-Bridkinin, Neurotensin, Dinorphine A, da Grelin.
ACE2 yana daidaita wucewar masu ɗaukar amino acid SLC6A19 na tsaka tsaki daga gland, kuma yana taka rawa a cikin cututtukan zuciya.
ACE2 a matsayin furotin na membrane, yana taka rawa a matsayin babban shigarwa zuwa kwayar cutar don wasu ƙwayoyin cuta, ciki har da HCoV-NL63 (virus da ke haifar da SARS) da SARS-CoV-2 (virus da ke haifar da COVID-19).
Musamman, haɗuwa da furotin S1 na Spike a cikin SARS-CoV da SARS-CoV2 tare da yankin ACE2 a saman sel, yana haifar da endocytosis da kuma watsa duka ƙwayoyin cuta da enzymes zuwa endosomes a cikin sel.
Wannan tsari na shigarwa yana buƙatar shirya furotin S na TMPRSS2 mai karɓar bakuncin protease, wanda ke da kariya a matsayin magani mai yuwuwa. Wannan ya haifar da zato cewa rage matakan ACE2 a cikin kwayoyin zai iya taimakawa wajen magance kamuwa da cuta.
Duk da haka, kungiyoyi da yawa da kuma cibiyoyin kulawa sun bada shawarar ci gaba da maganin ACE da maganin ARB.
"Binciken farko da kuma nazarin meta da aka buga a ranar 11 ga Yuli, 2012 ya nuna cewa ""amfani da masu hana ACEs ya haifar da raguwa mai mahimmanci na 34% na hadarin huhu (pneumonia) idan aka kwatanta da masu kulawa".
Bugu da ƙari, "haɗarin ƙirjin ya rage a cikin marasa lafiya da aka yi wa maganin hana maganin angiotensin mai canzawa, marasa lafiya da suka fi haɗari ga ƙirjin, musamman marasa lafiya da bugun jini da rashin lafiyar zuciya".
"Amfani da masu hana ACEs ya kuma haifar da raguwar mutuwar fata daga ƙirjin, ko da yake sakamakon ya kasance da ƙananan tasiri a kan hadarin ƙirjin gaba ɗaya. """
An gano cewa ACE2 na mutum, nootropic (rhACE2), wani sabon magani ne don mummunan rauni na huhu kuma yana haifar da ingantaccen tsarin hanci da kuma iskar oxygen a cikin aladu da ke fama da cutar cututtukan numfashi mai tsanani na lipopolysaccharide.
Rayuwar rabi na rhACE2 a cikin mutane yana da kimanin sa'o'i 10 kuma farawa yana da minti 30 da kuma tsawon lokacin tasiri na awanni 24.
Binciken ya nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga waɗanda ke da tsayayya ga masu hana tsarin rhinin-angiotensin (RAS inhibitors) na gargajiya ko a cikin asibiti tare da dogon lokaci na angiotensin II. An yi nazarin allurar rhACE2 a cikin nazarin asibiti don magance cututtukan cututtukan numfashi na numfashi.
"Shirin COVID-19 B shine software na wayar hannu wanda aka tsara don taimakawa wajen bin diddigin kira a cikin martani ga cutar ta coronavirus 2019-20, wato, tsarin gano mutane ("taɓawa") waɗanda zasu iya kasancewa a cikin tuntuɓar mutum".
An samar da ko kuma an haɓaka aikace-aikace da yawa tare da tallafin gwamnati a wasu yankuna da yankuna.
An kirkiro wasu tsarin don ƙirƙirar shirye-shiryen bin diddigin sadarwa.
Akwai damuwa game da tsare sirri, musamman game da tsarin da ke aiki bisa ga bin diddigin yanayin masu amfani da aikace-aikacen hannu.
Zaɓuɓɓukan da ba su da matsala sosai sun haɗa da amfani da siginar Bluetooth don yin rikodin kusanci ga mai amfani zuwa sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa damar tallafawa waɗannan aikace-aikacen da ke kan Bluetooth kai tsaye a kan tsarin aiki na Android da iOS.
A kasar Sin, gwamnatin kasar ta yi aiki tare da Alipay, ta kafa wani shiri da zai ba 'yan kasar damar duba ko sun kasance a cikin tuntuɓar mutane da suka kamu da cutar COVID-19.
Ana amfani da shi a cikin birane fiye da 200 na kasar Sin. A Singapore, ana amfani da software mai suna Tris Togder.
"An kirkiro wannan shirin ne ta hanyar kungiyar fasaha ta bayanai ta gida, an wallafa shi a matsayin rubutu mai budewa kuma ana bayar da shi ga gwamnati. Arewacin Macedonia ta kaddamar da wani shiri mai suna "" StopKorona! "", wanda ke da tushen Bluetooth don bin diddigin tuntuɓar mutanen da ke da cutar da ke iya kamuwa da cutar, wanda ke ba da damar amsawa da sauri ga hukumomin lafiya".
Ma'aikatar sadarwa da fasaha da kuma ma'aikatar lafiya ne suka kirkiro wannan software.
Tun daga 14 ga Afrilu, 2020, ana jiran amincewar Google Play da Apple App Store.
"A ranar 12 ga watan Afrilu, gwamnati ta bayyana cewa shirin bin diddigin masu sauraro yana cikin ci gaba da ci gaba kuma zai kasance a cikin 'yan makonni don yin amfani da shi. An shirya shirin kama da wannan a Ireland da Faransa (""StopCovid"")."
Ostiraliya da New Zealand na tunanin samar da software ta hanyar amfani da siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar siginar sig
Ross Anderson, Farfesa a Jami'ar Cambridge, ya lissafa wasu matsaloli masu yuwuwa a aikace-aikacen tsarin, ciki har da rashin inganci da rashin inganci idan an yi amfani da shirin ne kawai ga karamin ɓangare na yawan jama'a.
"Apple ta ba da takunkumi game da yaduwar ɓatarwa ko kuma cutarwa ta "Coronavirus", ta sanya takunkumi ga kungiyoyi da za su iya ƙara shirye-shiryen da suka shafi coronavirus zuwa App Store, kuma ta iyakance wannan ga kawai ""asasa"" ko masu izini".
Google da Amazon sun sanya irin wannan takunkumi.
Masu fafutukar kare hakkin bil'adama sun nuna damuwarsu game da amfani da sa ido na jama'a ta amfani da shirye-shiryen coronavirus, musamman game da soke kayan aikin sa ido da aka gina don magance cutar ta coronavirus bayan an kawar da barazanar cutar.
Amnesty International da fiye da kungiyoyi 100 sun fitar da sanarwa, suna neman a takaita irin wannan sa ido.
Hukumomi sun bayyana sharuɗɗa guda takwas ga ayyukan gwamnati:
"Sauye-sauyen dole ne ya zama ""doka, dole, da kuma dacewa"";
Dole ne a kammala aikin kula da tsaro a cikin tarihi;
Dole ne a iyakance amfani da bayanai ga manufar COVID-19.
Dole ne a kiyaye tsaro na bayanai da rashin sani, kuma dole ne a tabbatar da wannan kariya bisa ga hujjoji.
Kada a yi amfani da sa ido na dijital don ƙara nuna bambanci da kuma warewa.
Duk wani ɓangare na raba bayanai tare da wasu kamfanoni dole ne a bayyana shi a cikin doka;
Dole ne a sami kariya daga zalunci da kuma hakkin ɗan ƙasa don amsa zalunci.
"Za a bukaci haɗin kai mai ma'ana daga dukkan 'yan kasuwa masu ruwa da tsaki,' ciki har da masana kiwon lafiya da kungiyoyin da aka ware. Kungiyar Kwamfuta ta Jamus (CCC) da 'Yan Jarida ba tare da iyaka ba (RASF) sun kuma wallafa jerin abubuwan da suka dace".
Shirin Google/Apple na nufin magance matsalar ci gaba da saka idanu ta hanyar cire tsarin bin diddigin daga tsarin aiki na na'urar su, lokacin da ba a buƙatar su ba.
Wasu ƙasashe suna amfani da bin diddigin cibiyar sadarwa maimakon aikace-aikace, suna kawar da buƙatar sauke aikace-aikace da kuma yiwuwar kauce wa bin diddigin.
An tabbatar da bin diddigin da aka yi a Isra'ila.
Hanyoyin sadarwa na cibiyar sadarwa da ke samun damar samun bayanai na wuri mai tsabta suna haifar da matsalolin sirri.
Duk da haka, ba duk tsarin da ke da sabobin cibiyar ba ne ke buƙatar samun damar bayanan wuri na sirri. An kirkiro wasu tsarin tsare sirri da ke amfani da sabobin cibiyar kawai don sadarwa ta biyu (duba sashe na gaba).
A Koriya ta Kudu, an yi amfani da tsarin da ba a dogara da shirin ba don bin diddigin kira.
Maimakon amfani da wani shirin sadaukarwa, tsarin yana tattara bayanan bin sawu daga tushe daban-daban, ciki har da bayanan bin sawu na wayar hannu da bayanan ma'amala na katin, yana haɗa su don samar da faɗakarwa ta hanyar saƙonnin rubutu ga mutanen da ake zargi da kamuwa da cutar.
Baya ga amfani da wannan bayanin don gargadi ga masu sauraro, gwamnati ta ba da bayanan wuri ga jama'a, wanda aka ba da izini saboda canje-canje masu yawa a cikin dokokin tsare sirri bayan barkewar cutar MERS a kasar.
Wannan bayanin yana samuwa ta hanyar wasu aikace-aikace da kuma shafukan yanar gizo. Kasashe kamar Jamus sun yi la'akari da amfani da tsarin tsare sirri da tsare sirri.
Har zuwa 6 ga Afrilu, 2020, ba a bayyana cikakken bayani game da bikin ba.
Bayanin tuntuɓar sirri shine ra'ayin da aka amince da shi wanda ya ba da bincike mai yawa tun aƙalla daga 2013. Tun daga ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyi masu ƙwarewa suna aiki akan hanyoyin da suka dace don kiyaye sirri, kamar amfani da Bluetooth mai ƙarancin kuzari (BLE) don yin rikodin kusanci ga mai amfani zuwa sauran wayoyin hannu.
Duk da haka, PEPP-PT ƙoƙari ne na daidaitawa wanda ya ƙunshi duka biyu ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci.
A cikin waɗannan ladabi, bayanan sirri masu ganowa ba su taɓa barin motar ba kuma duk abubuwan da aka gano suna faruwa a cikin motar.
Kungiyar tsare sirri a dakin gwaje-gwaje na MIT ta ci gaba da SafePaths, dandamali wanda ke amfani da fasahar tsare sirri yayin tattara da amfani da bayanan wuri ko hanyar hawan hanya don bin diddigin watsa COVID-19.
"Wannan ya dogara ne da bincike daga takardun farar fata ""Apps Gone Rogue: Tsaron tsare sirri a lokacin annobar"" da aka buga a watan Maris na 2020. Wani irin wannan ƙoƙari, dandamali na SafeTrace na Enigma MPC ne, wani kamfani da ke haɓaka fasahar tsare sirri wanda aka fara a cikin dakin gwaje-gwaje na MIT Media".
SafeTrace yana ba masu amfani damar raba bayanai masu mahimmanci game da wurin su da kuma amincin su tare da sauran masu amfani da hukumomi ba tare da yin hadarin tsare sirrin su ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN Global Alliance ta ƙungiyoyi da ke kewaye da abin da ke da mahimmanci a cikin wannan tsarin da kuma cikakkun hanyoyin sadarwa, tare da manufar rage haɗin kai da samar da haɗin gwiwar duniya a cikin sa ido da shirye-shiryen gargadi - wani muhimmin abu don cimma karbuwa mai yawa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta sanya yarjejeniyar BlueTrace ta bude tushen da aka yi amfani da ita a cikin software ta gwamnati.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa wayoyin hannu na Android da iOS, sun ba da sanarwar wani sabon abu don bin diddigin masu sauraro, wanda suka yi ikirarin cewa yana kiyaye tsare sirri, dangane da haɗin fasaha na Bluetooth mai ƙarancin kuzari da ɓoye sirrin.
Sun kuma wallafa bayanan da suka shafi manyan fasahohin da aka yi amfani da su a cikin tsarin.
A cewar Apple da Google, an tsara tsarin ne don bunkasa shi a matakai uku:
Bayyana sabbin hanyoyin da za su ba gwamnatoci damar kafa shirye-shiryen gano cutar coronavirus tare da kiyaye tsare sirri.
Haɗa wannan aikin kai tsaye zuwa iOS da Android; Google da Apple suna shirin rarraba tsarin ta hanyar tsarin sarrafawa na farko, sannan su cire shi a cikin wannan hanyar bayan an sami haɗari.
Sake amfani da magani na b (wanda aka fi sani da magani mai amfani, sake amfani, sake amfani ko sake amfani da magani) shine sake amfani da magani da aka amince da shi don magance wata cuta ko yanayin likita daban da abin da aka fara yin magani don.
Wannan shi ne wani bangare na bincike na kimiyya da ake neman a yanzu don bunkasa hanyoyin magance COVID-19 marasa lahani da tasiri.
Sauran bincike sun hada da ci gaban allurar rigakafin COVID-19 da kuma ingantaccen allurar plasma. SARS-CoV-2 yana da sunadarai 66 da ke da damar ci gaba da maganin su, kowannensu yana da wurare masu alaƙa da ligand.
Binciken waɗannan wuraren haɗin zai ba da damar samar da ingantaccen shiri na samar da maganin rigakafin cutar da ke da tasiri ga furotin COVID-19.
Daga cikin manyan sunadarai masu mahimmanci na SARS-CoV-2, proteases kamar papine, RNA-duty RNA polymerases, helicazes, proteins S (S) da ribophosphatase ADP.
Hussain A.A da abokan aikinsa sun yi nazarin samfurori da yawa kuma sun inganta su da kuma nazarin su don kamanceceniya da su da irin wannan magani tare da mafi girman ƙimar amincewa don hanzarta ci gaban maganin SARS-CoV-2 a cikin binciken su na farko, wanda aka ba da shawarar a cikin ƙirar binciken asibiti.
Chlorokine magani ne na maganin malaria wanda ake amfani dashi wajen magance wasu cututtukan rashin lafiyar kai.
A ranar 18 ga Maris, Hukumar Lafiya ta Duniya ta sanar da cewa chlorokine da hydroxychloroquine sun dace, ciki har da magunguna hudu da aka yi nazari a matsayin wani ɓangare na binciken asibiti na yau da kullum.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York akan chlorine da hydroxychloroquine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chlorine phosphate a ƙarƙashin izinin amfani na gaggawa (EUA).
Ba a amince da wannan magani ba ta hanyar nazarin asibiti na FDA kuma an yarda da shi ne kawai a matsayin magani na gwaji don maganin gaggawa a cikin marasa lafiya da ke asibiti kuma ba su iya samun magani a cikin binciken asibiti ba.
Cibiyar Kula da Cututtuka ta ce, "Ba a tabbatar da amfani da su, sashi ko tsawon lokacin da ake amfani da su don hana ko magance kamuwa da cutar SARS-CoV-2 ba".
"Kwararrun likitoci sun ce za su yi amfani da wannan magani ne a lokacin da ""babu wani zaɓi""".
Ƙungiyar bincike ta Turkiyya a Vlaietbol ta gudanar da bincike kan amfani da chloroquine a hade da ruwan inabi, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da Jami'ar Oxford.
Jami'ar Likitoci ta NYU Langone tana gudanar da gwaji kan rashin haɗari da ingancin amfani da hydroxychloroquine a hanyar rigakafi.
"Binciken asibiti na kasar Sin a Wuhan da Shenzhen ya yi ikirarin cewa Fawai Piravir yana da ""cikakken tasiri""".
A matsakaici na kwanaki 4, sakamakon gwajin ya kasance mummunan ga marasa lafiya 35 yayin da tsawon lokacin cutar ya kasance kwanaki 11 ga marasa lafiya 45 da ba su karɓa ba.
A wani bincike da aka gudanar a Wuhan, a kan marasa lafiya 240 da ke fama da cututtukan ƙirjin, rabin mutane sun karɓi Favipiravir da rabi na omefenovir.
Hukumar Kula da Magunguna ta Italiya ta tunatar da mutane cewa akwai karancin shaidu da ke tallafawa wannan magani.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don ajiya kuma za ta sami taimakon soja don isar da maganin zuwa asibitocin jami'a inda za a yi amfani da shi don magance marasa lafiya na COVID-19.
"A cewar jaridar South China Morning Post, Shinzo Abe ya ba gwamnatin Trump shawarar sayen magani wanda zai iya yin tasiri sosai a cikin mummunan cututtukan da cutar ta riga ta ninka".
Yana iya zama cewa ba shi da haɗari ga mata masu ciki ko waɗanda suke ƙoƙarin haihuwa.
"Bincike game da Lupinvir/Retinavir (Caltra), haɗuwa da maganin maganin Lupinvir da Retinavir, ya kammala cewa ""ba a sami amfani ba".""
An tsara wadannan magunguna don hana yaduwar HIV ta hanyar haɗuwa da protease.
Wani rukuni na masu bincike daga Jami'ar Colorado suna ƙoƙarin gyara magani da kuma gano wani nau'i wanda zai dace da SARS-CoV-2 protease. Akwai zargi a cikin masana kimiyya game da jagorantar albarkatu zuwa sauya amfani da magungunan psychoactive, musamman magungunan da aka samar don cutar AIDS.
Hukumar lafiya ta duniya ta haɗa da maganin Lupinvir/Retinavir a cikin gwaji na duniya.
Gilead Sciences ta samar da kuma ci gaba da samar da Remdesivir a matsayin magani ga cutar Ebola da cutar Marburg. Daga baya Gilead Sciences ta gano cewa Remdesivir yana da aikin anti-virus a cikin yanayin gonar da ke cikin gida don yin yaki da yawancin ƙwayoyin cutar Filo, Nomo, Paramexo, da Corona.
Wata matsala game da maganin rigakafi na ƙwayoyin cuta ita ce samar da juriya ta hanyar motsi wanda zai iya haifar da kamuwa da cutar da kuma wucewa mai tsanani.
Wasu bincike na farko kafin gwaji sun nuna cewa Ramsayver na iya samun babban hanawar kwayoyin halitta don juriya. Yawancin nazarin asibiti suna gudana, ciki har da biyu da asibitocin Jami'ar Cleveland suka gudanar; ɗaya ga mutanen da ke da ƙananan matakan cutar da wani ga marasa lafiya masu tsanani.
Akwai nazarin asibiti guda uku da ake gudanarwa don yin allurar bitamin C ga mutanen da ke asibiti da kuma waɗanda ke fama da cutar COVID-19 sosai; gwaje-gwaje biyu da aka sarrafa tare da placebo (China, Kanada) da gwaji guda ɗaya ba tare da kulawa ba (Italiya).
Jihar New York ta fara gwajin maganin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya ta Japan (NCGM) tana shirin gudanar da wani bincike na asibiti na aluscotigen (cyclosonide), wani corticosteroid mai tsaftacewa don asma, don magance marasa lafiya masu cutar coronavirus.
Wani nau'i na enzyme mai canza angiotensin 2 yana gudana a matsayin gwajin mataki na 2 tare da marasa lafiya 200 da aka zaɓa daga cikin manyan cututtuka da aka yi a cikin asibiti a Denmark, Jamus da Austria don ƙayyade tasirin magani.
Masu binciken cibiyar zuciya ta Montreal a Kanada a yanzu suna nazarin rawar da calcinin ke takawa wajen rage kumburi da cututtukan huhu a cikin marasa lafiya da ke fama da bayyanar cututtuka na COVID-19.
Wannan binciken, wanda ake kira Colcorona (COLCORONA), ya shafi mutane 6,000 da suka kai shekaru 40 da haihuwa da suka kamu da COVID-19, waɗanda ke da alamun rashin lafiya masu sauƙi waɗanda ba sa bukatar yin asibiti.
Mata masu ciki ko masu shayarwa ko waɗanda ba su yi amfani da wata hanyar hana haihuwa mai tasiri ba ba su cancanci cancanta.
An gwada wasu anti-sandari a Italiya.
Ana amfani da heparin a cikin maganin marasa lafiya saboda ƙananan nauyin kwayoyin halitta, kuma ya sa Hukumar Magunguna da Likitoci ta Italiya ta ba da umarni game da amfani da shi.
An sanar da wani bincike mai zurfi a kan marasa lafiya 300 da ke nazarin amfani da sodium anoxaparin a allurai na rigakafi da magani a Italiya a ranar 14 ga Afrilu.
Tun da cutar coronavirus ta SARS (SARS-CoV-2) ita ce kwayar cutar, an ba da kulawa mai mahimmanci ga ilimin kimiyya game da amfani da magungunan rigakafin cutar da aka tabbatar da cutar ta riga ta barke kamar cutar MERS, SARS da West Nile.
Ribavirin: Ana ba da shawarar ribavirin a cikin takarda ta bakwai na jagorar kasar Sin don maganin COVID-19
Omfenowirus: An bada shawarar Omfenowirus don maganin COVID-19 bisa ga gyare-gyare na bakwai na jagororin kasar Sin
Wasu maganin rigakafi da aka sani da yiwuwar maganin COVID-19 sun haɗa da:
Tocilizomb (mai karɓar IL-6): An tabbatar da shi a China.
An kuma gudanar da gwaje-gwaje a Italiya da China, kuma za ku iya ganin Tosilizomab #COVID-19.
Allurar rigakafin COVID-19 allurar rigakafi ce da aka yi amfani da ita don magance cutar coronavirus 2019 (COVID-19).
Ko da yake babu wani rigakafin da ya kammala nazarin asibiti, ana yin ƙoƙari da yawa don samar da irin wannan rigakafin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta sanar da cewa ba ta tsammanin za a sami allurar rigakafin SARS-CoV-2 a cikin ƙasa da watanni 18 ba.
Alurar riga kafi guda biyar da aka gabatar a watan Afrilu sun kasance a cikin nazarin rigakafin lokaci na farko.
An gano COVID-19 a watan Disamba na 2019.
Wani babban yaduwar cutar a duniya a shekarar 2020, wanda ya haifar da babban zuba jari da bincike don samar da allurar rigakafi.
Yawancin kungiyoyi suna amfani da kwayoyin halitta da aka buga don haɓaka alluran rigakafi don magance SARS-CoV-2.
Kamar yadda aka bayyana a watan Afrilu, jagororin CEPI na ci gaban alluran rigakafi sun haɗa da: saurin, ƙarfin samarwa, fadadawa a sikelin, da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa an gudanar da bincike da samar da dandamali daban-daban na fasaha 10 a farkon shekarar 2020 don samar da allurar rigakafin COVID-19.
Babban burin dandamali wanda ya ci gaba a cikin nazarin rigakafi na farko ya haɗa da:
Nucleic acid (DNA da RNA) (wanda ke fadada mataki na farko da kuma candidate na allurar rigakafi: Moderna, mRNA-1273)
Mai ɗaukar hoto (lokacin mai haɓakawa da allurar da aka bayar: CanSino Biologics, mai ɗaukar hoto na adenovirus na nau'i 5)
A cewar masana kimiyya na Coalition for Epidemic Preparedness Innovation (CEPI) a watan Afrilu, akwai samfurin rigakafi 115 a farkon ci gaba, inda an amince da samfurin 78 a matsayin aikin aiki (ya zuwa 79, a cewar Cibiyar Milken) da kuma wasu rigakafi 37, amma akwai bayanai kaɗan a cikin jama'a (an ɗauka cewa suna cikin tsari ko zane).
Mataki na I-II na gwaji yana gwada rigakafin farko da kuma ci gaban rigakafi kuma yana da bazuwar da kuma sarrafawa ta hanyar placebo kuma ana gudanar da shi a wurare da yawa, yayin da yake ƙayyade mafi inganci da kuma ƙayyadaddun sashi.
Gwaje-gwaje na 3 yawanci sun ƙunshi ƙarin mahalarta, ciki har da daga ƙungiyar kulawa da ingancin gwajin rigakafin cutar, da kuma kula da haɗuwa da sashi a cikin sashi mai kyau.
"Daga cikin alluran da aka gabatar da su 79 da ke ci gaba da aiki (wanda aka amince da su a farkon Afrilu 2020), 74 ba su shiga matakin kimantawar mutum ba tukuna (suna cikin binciken ""preclinical""".
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana nazarin yiwuwar allurar kwayar cuta ta kwayar cuta wacce ke canza kwayoyin cutar ta hanyar kwayoyin halitta don tayar da tsarin rigakafi.
A ranar 24 ga Janairu, 2020, Cibiyar Hoto ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin allurar rigakafi a Kanada, wanda ya shirya fara gwajin kan mutum a shekara ta 2021.
An sanar da ayyukan samar da allurar rigakafi a Cibiyar Kula da Cututtuka ta China a ranar 26 ga Janairu, 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, kamfanonin Johnson Pharmaceuticals, karkashin jagorancin Hank Shweitmaker, sun sanar da cewa sun fara aiki kan samar da allurar rigakafi.
Janssen na samar da wani allurar rigakafi tare da abokin aikinsa na biotechnology, Vaxart.
A ranar 18 ga Maris, 2020, BioSolutions Emergent ta sanar da haɗin gwiwa tare da Vaxart don samar da wannan allurar.
A ranar 8 ga Fabrairu, 2020, Cibiyar Labaran Incogene ta wallafa wani labarin a cikin Romania game da tsara allurar rigakafi tare da irin wannan fasaha don maganin cutar kansa, ta hanyar sabon maganin rigakafi.
A ranar 25 ga Maris, shugaban cibiyar ya sanar da cewa sun kammala sintiri na allurar kuma sun fara gwaji.
A ranar 27 ga Fabrairu, 2020, ɗaya daga cikin kamfanonin Generex, NuGenerex Immuno-Oncology, ya sanar da cewa sun fara aikin yin allurar rigakafi don samar da allurar peptide Ii-Key na COVID-19.
"Suna so su samar da allurar rigakafi da za a iya gwadawa a kan mutane a cikin ""kwanaki 90"."
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da ayyukanta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Nazarin Kayan Aikin Likita da Na'urorin Sojan Amurka a Fort Detrick da Cibiyar Nazarin Sojan Walter Reed a Silver Spring, duka biyu a yammacin Maryland, sun sanar da cewa suna aiki a kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa tana aiki tare da Novavax.
A cikin samar da allurar rigakafi.
Abokan hulɗa sun sanar da shirye-shirye don gwajin farko da nazarin asibiti na farko har zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki akan karin abubuwa 11 kuma ko da tare da saurin bin hanyoyin, samar da allurar zai ɗauki aƙalla shekara ɗaya da rabi zuwa biyu.
A ranar 12 ga Maris, 2020, kamfanin Medicago, wani kamfanin kere kere na rayuwa a birnin Quebec, ya sanar da cewa zai samar da wani kwayar cutar coronavirus-kamar-ta hanyar samar da wani ɓangare na kudade daga cibiyoyin kiwon lafiya na Kanada.
Wannan samfurin na allurar yana cikin gwajin gwaji na dakin gwaje-gwaje kuma ana shirin gwada shi akan mutane a watan Yuli ko Agusta 2020.
A makon da ya gabata, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba da "damar samun dama ga allurar COVID-19" ga CureVac kuma ya fuskanci zanga-zangar gwamnatin Jamus.
A ranar 17 ga Maris, 2020, kamfanin Pharmaceutical na AmurkaPfizer ya sanar da haɗin gwiwarsa da kamfanin BioNTech na Jamus don samar da allurar rigakafi ta mRNA.
Ana sa ran a fara yin allurar rigakafin aikin sa kai ta mRNA, mai suna BNT162, wanda a halin yanzu yana cikin pre-kayan gwaji na asibiti, a watan Afrilu na 2020.
A Italiya a ranar 17 ga Maris, 2020, Taxis Biotek, wani kamfanin kimiyyar halittu na Italiya ya sanar da cewa za su sami sakamakon gwajin gwaji na farko a watan Afrilu na 2020, kuma za a iya gwada samfurin maganin su na ƙarshe a cikin babban adadi na mutum.
A Faransa, a ranar 19 ga Maris, 2020, ƙungiyar shirye-shiryen annoba ta CEPI ta ba da dala miliyan 4.9 ga wata kungiya ta bincike kan allurar COVID-19, wadda ta haɗa da Cibiyar Pastor, Temis Biosciences (Win Austria) da Jami'ar Pittsburgh, wanda a hade zai kawo dala miliyan 29 ga saka hannun jari a kan samar da allurar COVID-19.
Sauran abokan haɗin gwiwar CEPI don samar da allurar COVID-19 sun haɗa da: Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
Hukumomin lafiya na Rasha sun sanar a ranar 20 ga Maris, 2020 cewa masana sun fara gwaji a kan samfurori daban-daban na allurar rigakafi guda shida.
Masu binciken Kwalejin Imperial na London sun sanar a ranar 20 ga Maris, 2020 cewa suna samar da allurar RNA mai karfafa kai don COVID-19.
An samar da samfurin allurar a cikin kwanaki 14 daga lokacin da aka karɓi jerin daga China.
A karshen watan Maris, gwamnatin Kanada ta sanar da cewa ta ba da tallafin dala miliyan 275 na Kanada don gudanar da bincike 96 kan matakan rigakafin COVID-19, wanda ya haɗa da samfurori masu yawa na allurar rigakafi a kamfanoni da jami'o'in Kanada kamar su Medical College da Jami'ar Saskatchewan.
"A lokaci guda, gwamnatin Kanada ta ba da sanarwar bayar da dala miliyan 192 don samar da allurar COVID-19 tare da shirye-shiryen samar da ""bank na allurar rigakafi"" tare da sababbin alluran rigakafi da za a iya amfani da su a yayin da sauran cututtukan coronavirus suka barke".
"A ranar 2 ga Afrilu, 2020, masu binciken Jami'ar Pittsburgh na Likita sun sanar da gwajin PittCoVacc, wanda zai iya zama allurar COVID-19 a cikin beraye, kuma sun bayyana cewa ""MNA da aka karɓa na allurar SARS-CoV-2 S1 ya haifar da amsawar antibody na musamman na antigen mai ƙarfi [a cikin beraye] wanda ya bayyana makonni 2 bayan rigakafin. """
A ranar 16 ga Afrilu, 2020, Jami'ar Farfasa ta Waterloo ta sanar da samfurin allurar rigakafi na DNA a matsayin yiwuwar maganin saurin jini.
Ta amfani da kwayoyin cuta, ana tsara DNA don yin kwayar a cikin kwayoyin mutum don samar da ƙwayoyin cuta-kamar cutar, wanda zai iya motsa tsarin garkuwar jiki don samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na 2020, gwamnati, masana'antu da jami'o'i uku na Amurka sun haɗa kan albarkatun da ake buƙata don samun damar zuwa kwamfutocin IBM, tare da albarkatun girgije na kamfanin Holt Packard, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako na musamman, wanda ake kira sakamako na musamman.
Wannan yana nufin cewa zasu iya samun fa'idodi fiye da rigakafin cutar.
Wani gwaji na rashin daidaito a Ostiraliya yana neman yin rajista da 4,170 na aikin kiwon lafiya.
Akwai yiwuwar cewa alluran rigakafi da ake ci gaba ba su da haɗari ko kuma ba su da tasiri.
Binciken farko na kimanta ingancin allurar rigakafi ta amfani da samfurin dabba na COVID-19, musamman daga berayen transgenic-ACE2, sauran dabbobi na dakin gwaje-gwaje da dabbobi masu shayarwa ba mutane, ya nuna bukatar matakan kariya ta jiki na matakin 3 don sarrafa ƙwayoyin cuta masu rai da kuma daidaitaccen tsarin duniya don tabbatar da daidaitattun hanyoyin kariya.
An gwada alluran SARS da MS a kan samfurin dabba.
Har zuwa shekarar 2020, babu wani magani ko allurar rigakafi ga cutar ta SARS da ta tabbatar da cewa tana da lafiya da tasiri a kan mutane.
A cewar takardun da aka buga a shekara ta 2005 ko 2006, gabatar da sababbin alluran rigakafi da magunguna don magance SARS sun kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya. Har yanzu babu wani allurar da aka amince da ita a kan Mars.
Lokacin da cutar ta bazu, an yi imanin cewa binciken da aka yi akan SARS na iya samar da samfurin da zai taimaka wajen samar da allurar rigakafi da maganin kamuwa da cutar MERS-CoV.
Tun daga watan Maris na 2020, akwai rigakafin MERS (DNA-based) wanda ya kammala karatun farko na asibiti, kuma akwai wasu rigakafi uku da ake gudanarwa, dukansu rigakafin cutar ne, adenoviral vectors (ChAdOx1-MERS, BVRS-GamVac) biyu da MVA vector (MVA-MERS-S).
Shafukan sada zumunta sun inganta ka'idar ta'addanci da ke da'awar cewa an gano cutar da ke haifar da COVID-19 kuma riga an sami allurar rigakafinta.
Patent na daban-daban na kafofin watsa labarun sun koma zuwa ga takardun shaida na jinsin kwayoyin halitta da kuma alluran rigakafi don sauran nau'ikan coronavirus kamar SARS.
Cutar Coronavirus 2019 (COVID-19) cuta ce mai kamuwa da cuta da cutar ta SARS-CoV-2 (SARS-CoV-2).
Alamomin da aka saba da su sun hada da zazzabi, tari da kuma numfashi.
Sauran alamun na iya zama gajiya, ciwon tsoka, tari, rashin numfashi, rashin jin ƙanshi, da ciwon ciki.
Ana ɗaukar kwanaki 5 daga lokacin da aka fara kamuwa da cutar zuwa lokacin bayyanar cututtuka, amma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
Ko da yake mafi yawan cututtuka suna da alamun bayyanar cututtuka, wasu suna fama da cututtukan kirji da hanci da kuma rashin aiki na gabobin jiki.
Tun daga ranar 17 ga Afrilu, 2020, an samu fiye da miliyan 2.24 na kamuwa da cutar a cikin kasashe 210 da yankuna, wanda ya haifar da mutuwar mutane fiye da 153,000.
Fiye da mutane 568,000 sun warke. An fara yada cutar ta hanyar tuntuɓar kai tsaye, yawanci ta hanyar saukad da ruwa daga tari, ƙishirwa ko magana.
Lokacin da aka samar da waɗannan saukad da a lokacin safa, yawanci suna manne a ƙasa ko a saman maimakon motsawa a nesa.
Mutane na iya kamuwa da cutar ta hanyar taɓa wani shafi mai cutar sannan ta taɓa idanu, hanci ko baki.
Kwayar cutar na iya rayuwa har tsawon awanni 72 a saman.
Cutar ta fi kamuwa da ita a cikin kwanaki uku na farko bayan bayyanar cututtuka, ko da yake akwai yiwuwar bayyanar cututtuka kafin bayyanar cututtuka da kuma a matakai na gaba.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ake zargi da kamuwa da cutar da kuma masu kula da su.
Shawarwari game da amfani da abin rufe fuska a cikin jama'a sun bambanta, wasu hukumomi sun ƙi yin amfani da abin rufe fuska, wasu sun ba da shawarar, wasu kuma sun tilasta shi.
A halin yanzu, babu wani maganin rigakafi ko maganin rigakafi na musamman don COVID-19.
An samu karuwar cutar a cikin gida a mafi yawan ƙasashe a duk yankuna shida na WHO.
Mutane da suka kamu da cutar za su iya ba da alamun cutar ko nuna alamun da suka yi kama da mura kamar zazzabi, tari, gajiya ko kuma numfashi mai wuya.
Alamomin gaggawa sun haɗa da rashin numfashi, ciwo ko ciwon kirji, tashin hankali, wahalar farkawa da kuma launin toka a fuska ko lebe; idan akwai waɗannan alamun, ana ba da shawarar samun gaggawa na likita.
Wani lokaci, ana iya ganin alamun bayyanar cututtukan numfashi kamar tari, zubar da hanci ko ciwon wuya.
Alamun da ke tattare da narkewa kamar naƙuda, zubar da jini da kuma tari sun kasance a cikin kashi daban-daban.
Wasu daga cikin marasa lafiya a China suna da ƙananan ƙirjin da kuma yanayin da ba su da kyau.
A wasu mutane, cutar na iya haifar da ciwon kirji da hanci, rashin aiki da yawa da mutuwa.
Wannan lokaci ne ake kira lokacin haihuwa ko lokacin incubation.
Lokacin haihuwa na COVID-19 yawanci kwanaki biyar zuwa shida ne, amma yanayin canji na iya bambanta daga kwana biyu zuwa 14.
Kashi 97.5% na mutane suna nuna alamun cutar a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa duk abubuwan da suka faru ba dole ba ne su nuna alamun cutar.
Ba a san cikakken rawar da waɗannan masu ɗaukar hoto marasa alamun ke takawa wajen watsa cutar ta coronavirus ba, ko da yake akwai shaidu na farko da ke nuna cewa suna iya taka rawa wajen yada cutar.
A halin yanzu ba a san adadin wadanda suka kamu da cutar ba, kuma ana nazarin su, a cewar rahoton Cibiyoyin Kula da Cututtuka na Koriya (KCDC), kashi 20 cikin dari na dukkan wadanda aka tabbatar da cutar sun kasance marasa alamun cutar yayin da suke asibiti.
Hukumar lafiya ta kasar Sin ta fara shigar da marasa alamun cututtuka a cikin kididdigar cututtukan yau da kullum daga ranar 1 ga Afrilu. Daga cikin mutane 166 da suka kamu da cutar a wannan ranar, mutane 130 (78%) ba su da alamun cutar a lokacin gwajin.
Ƙarƙashin ƙaho da kumburi na bakin suna da dalilai masu yawa na cutar.
Magana da ƙarfi yana haifar da ƙarin ƙarancin ƙira idan aka kwatanta da magana ta yau da kullun.
Wani binciken da aka gudanar a Singapore ya nuna cewa wani kwance ba tare da kariya ba zai iya haifar da zubar da numfashi har zuwa nesa na mita 4.5.
Ko da yake cutar ba ta rataye a cikin iska ba, National Academy of Sciences ta ce za a iya watsa ta wannan hanyar kuma samfurin daga iska na waje na mutane ya nuna RNA mai kyau.
Wasu hanyoyin likita kamar bututun jini da kuma CPR na iya haifar da yaduwar iska ta numfashi, wanda zai haifar da fitar da iska.
Akwai damuwa cewa cutar za ta iya kamuwa da cutar ta hanyar kwayoyin halitta, amma rashin yiwuwar hakan ba shi da yawa. Mafi yawan cututtuka shine lokacin da mutum ke da alamun bayyanar cututtuka, yayin da za a iya kamuwa da cutar kafin bayyanar bayyanar cututtuka, amma ba shi da tabbas.
Cibiyar Tsaro da Kula da Cututtuka ta Turai ta ce, yayin da ba a san yadda cutar ta yadu ba, mutum ɗaya yana kamuwa da wasu mutane biyu zuwa uku.
A musamman, an lura cewa cutar tana iya ganowa har zuwa kwana ɗaya a kan kwalba, fiye da kwana talatin a kan filastik (polypropylene) da bakin karfe (AISI 304) da kuma fiye da sa'o'i huɗu a kan tagulla.
Duk da haka, wannan yana canzawa dangane da zafi da zafin jiki.
Sabulu da kuma tsabtace-kayan aiki suna da amfani idan an yi amfani da su yadda ya kamata: samfurori masu tsabta suna kawar da ƙwayar cutar daga ƙwayar cutar, suna cire ƙwayar daga fata da sauran farfajiyar.
Sauran hanyoyin, kamar benzalkonium chloride da chloride gluconate (abin da ke hana kamuwa da cuta na tiyata) sun fi tasiri. A cikin wani binciken da aka yi a Hong Kong, an dauki samfurin saliva a matsakaici na kwana biyu bayan shiga asibiti.
A cikin 5 daga cikin marasa lafiya shida, samfurin farko ya kasance mafi yawan lokutan kamuwa da cutar kuma mai haƙuri na shida ya kasance mafi yawan lokutan kamuwa da cutar a rana ta biyu.
Coronavirus 2 acute respiratory syndrome (SARS-CoV-2) wani sabon cutar coronavirus ce da aka fara ganowa a cikin mutane uku da ke fama da cututtukan kirji da gwiwoyi a cikin jini waɗanda suka rasa matakin oxygen a cikin jini da kuma matsalolin numfashi.
Dukkanin siffofin sabon SARS-CoV-2 suna faruwa a cikin coronavirus na dangi a cikin yanayi.
A waje da jikin mutum, ana kashe kwayar da sabulu na yau da kullum, wanda ke kawar da kumfa mai riƙewa a cikin ƙasa da aka samar. COVID-19 yana da alaƙa da SARS-CoV-2.
Fuskokin su ne kwayoyin da suka fi tasiri a kan COVID-19, saboda cutar ta hanyar ƙwayoyin cuta na angiotensin 2 (ACE2) tana shiga cikin ƙwayoyin mai masaukin baki, wanda shine mai karɓar mafi yawan kwayoyin cuta na alveolar na nau'i biyu.
"Cutar ta yi amfani da wani glycoprotein (pollomer) don haɗuwa da ACE2 kuma shiga cikin kwayar mai masaukin baki, wanda ake kira ""spike"" (spike)".
A cikin kashi 12 cikin dari na cututtukan zuciya na asibiti a Wuhan, China, an sami mummunan rauni na zuciya, wanda ya fi yawa a cikin mummunan cuta.
Yawan cututtukan zuciya da jijiyoyin jini yana da yawa saboda amsawar kumburi da kuma rikice-rikice na tsarin rigakafi yayin ci gaban cutar, amma lalacewar ƙwayar zuciya na iya kasancewa dangane da masu karɓar ACE2 a cikin zuciya.
Ana bayyana masu karɓar ACE2 a cikin zuciya kuma suna da ma'ana ga aikin zuciya.
An lura da yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Ko da yake SARS-CoV-2 yana da halayyar ƙwayoyin cuta na ACE2, marasa lafiya da ke fama da COVID-19 suna nuna alamun bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Musamman, an nuna cewa kwayoyin T na GM-CM suna da alaƙa da amfani da kwayoyin cuta na IL-6 da kuma cututtukan huhu masu tsanani a cikin marasa lafiya na COVID-19.
An kuma bayar da rahoton cewa an yi amfani da maganin lymphocytic a cikin autopsy.
Hukumar lafiya ta duniya ta wallafa wasu ka'idojin gwaji don cutar.
Hanyar gwaji ta yau da kullum ita ce ta hanyar jerin polymerase reverse transcription chain (rRT-PCR).
Ana yin gwaji a kan samfurori na numfashi da aka samu daga cikin hanci na hanci; amma ana iya amfani da samfurori na hanci ko kuma daga hanci.
Sakamakon zai kasance a cikin sa'o'i da yawa zuwa kwanaki biyu.
Ana iya yin gwajin jini, amma ana buƙatar samfurin jini biyu da aka ɗauka a tsakanin makonni biyu kuma sakamakon yana da ƙarancin ƙimar lokaci.
Masana kimiyya na kasar Sin sun sami damar ware wani nau'in coronavirus kuma su bayyana jerin kwayoyin halitta, don haka dakunan gwaje-gwaje a duniya zasu iya samar da polymerase chain reaction (PCR) da kansa don gano kamuwa da cuta bisa ga cutar.
Har zuwa 4 ga Afrilu, 2020, ana ci gaba da gwajin rigakafin iska (wanda zai iya gano kamuwa da cuta mai aiki da ko mutum ya kamu da cutar a baya) amma ba a amfani da shi sosai ba.
Gwajin da 'yan kasar Sin suka yi ya nuna cewa an yi amfani da daidaito na kashi 60 zuwa 70 cikin 100.
Hukumar Abinci da Magunguna ta Amurka ta amince da gwajin farko na wurin kulawa a Amurka a ranar 21 ga Maris, 2020, don amfani a ƙarshen wannan watan. Tsarin ganewa da asibitin mata na Jami'ar Wuhan ya wallafa ya ba da shawarar hanyoyin gano kamuwa da cuta bisa ga halaye na asibiti da cututtukan cututtuka.
Abubuwan da ke faruwa a cikin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin gilashin da gilashin gilashin da da ke faruwa a cikin gida.
Cutar huhu, tsarin da ba a sani ba (mai ƙonewa na hanci da kuma cikawa na al'ada na airbags) da kuma ƙarancin ƙwayar cuta sune alamun ci gaban cutar.
Akwai bayanai kadan game da cutar COVID-19 ta hanyar microscopic da pathophysiology.
Babban binciken ilimin halayyar mutum daga autopsy ya hada da:
Macroscopy: Fluoride, Ames na zuciya, kwantar da hanci da jijiyoyin jini
Akwai nau'i hudu na cutar ta kirji da hanci:
Ƙarƙashin ƙirjin da ƙuƙwalwa: kumburi na jijiya, hyperplasia na pneumocyte, manyan pneumocytes na atypical, ƙwayar gani tare da ƙwayar lymphocyte da kuma samar da kwayar cuta mai girma
Cutar huhu mai tsanani: lalacewar alveolar da aka yada (DAD) tare da exodate na alveolar.
DAD shine dalilin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Maganin kirji da gwiwoyi: samar da matattarar a cikin ramin jaka na iska da kuma fibrosis na gani na jijiya
Jini: Ƙarƙashin jini mai zurfi (DIC); amsawar lucoeuroblastic
Abubuwan da za a iya ɗauka don rage yiwuwar kamuwa da cuta sun haɗa da kasancewa a gida, gujewa zuwa wurare masu yawa, wanke hannuwanka da sabulu da ruwa a kai a kai, kiyaye numfashi mai kyau, da kuma guje wa taɓa idanu, hanci ko baki da hannuwanka na akalla na biyu.
Cibiyar Kula da Cututtuka ta CDC ta ba da shawarar rufe bakinka da hanci da tawul idan kana tari ko kuma ka yi tari ko kuma ka yi tari idan babu wani daga cikin tawul ɗin.
Ana bada shawara a kiyaye tsabtace hannu bayan tari ko kuma tari.
Don hana kamuwa da cutar ta hanyar masu dauke da cutar ba tare da alamun bayyanar cututtuka ba, CDC ta ba da shawarar yin amfani da suturar rufe fuska a wuraren jama'a. Dabarun nesa da zamantakewa suna nufin rage yawan jama'a ta hanyar rufe makarantu da wuraren aiki, ƙuntata tafiye-tafiye da soke manyan tarurrukan jama'a.
Tsarin nesa ya kuma haɗa da kiyaye mutane aƙalla ƙafa 6 (mita 1.8).
"Babu magani da aka sani da zai iya hana kamuwa da cutar COVID-19". Tun da ba za a sami lokaci mafi guntu ba kafin shekara ta 2021, akwai babban batun da ake tattaunawa a kan kula da COVID-19, wato, ƙoƙarin rage cutar, ko kuma "sake tsabtace kurkuku".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu na tsawon dakika 20, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun kasance da tsabta, kafin su ci abinci ko bayan sun wanke hanci, bayan sun ji tari da kuma tari.
Bugu da ƙari, ana ba da shawarar cewa masu amfani da giya su yi amfani da akalla kashi 60 cikin ɗari na giya, amma kawai idan sabulu da ruwa ba su da sauƙi. WHO ta ba da takardun biyu don samar da gida don yankunan da ba a samun maganin hana hana kamuwa da cuta na hannu.
A cikin wannan tsari, aikin antimicrobial ya samo asali ne daga ethanol ko isopropanol.
"Ana amfani da hydrogen peroxide don taimakawa wajen kawar da spores na kwayoyin a cikin barasa. ""Ba abu ne mai aiki ba ne mai hana kamuwa da cuta na hannu"."
An ƙara glycerol a matsayin mai ɗaukar danshi.
Mutane suna kula da kulawa mai taimako, wanda zai iya haɗawa da magani na ruwa, taimako na oxygen, da kuma goyon bayan sauran kwayoyin halitta masu mahimmanci.
CDC ta ba da shawarar cewa mutanen da ake zargi da kasancewa masu ɗaukar hoto su yi amfani da abin rufe fuska mai sauƙi.
Ana amfani da iskar oxygen na waje (ECMO) don magance matsalar rashin numfashi, amma ana nazarin amfanin shi a yanzu.
Ana ba da shawarar kiyaye lafiyar mutum da kuma salon rayuwa mai kyau da kuma cin abinci mai gina jiki don inganta tsarin rigakafi.
Magungunan karewa na iya zama da tasiri ga mutanen da ke da alamun cutar mai sauƙi da kuma farkon kamuwa da cuta. Hukumar Lafiya ta Duniya (WHO) da Hukumar Lafiya ta Kasa ta kasar Sin (Chinese National Health Commission) sun wallafa shawarwari don kula da mutanen da ke asibitoci saboda COVID-19.
Masana kula da lafiya na musamman da kuma masana shida a Amurka sun tattara shawarwarin masu kula da cututtuka daga hukumomi daban-daban a cikin wani tushen kyauta, IBCC.
Har zuwa watan Afrilu 2020, babu wani magani na musamman don COVID-19.
Wasu masana sun fi son yin amfani da paracetamol don magance bayyanar cututtuka fiye da ibuprofen don magani na farko.
Don rage haɗarin watsa kwayar cutar, dole ne a yi hankali, musamman a cikin yanayin magani inda za a iya samar da ƙwayoyin cuta yayin aiwatar da ayyukan, kamar bututun ruwa da amfani da tsarin numfashi na hannu.
Ga masu kula da lafiya da ke kula da mutanen da ke dauke da COVID-19, CDC ta ba da shawarar yin amfani da kayan aiki na mutum (PPE) a lokacin annobar, ban da yin amfani da matakan tsaro, kulawa da tuntuɓar da kuma sarrafa kamuwa da cutar ta iska, sanya mutum a cikin dakin hana kamuwa da cutar ta iska (AIIR).
Abubuwan da aka ba da shawarar sun haɗa da: PPE, tsarin numfashi ko mask, kariya ga idanu da safofin hannu na likita. Idan akwai, ana fifita injunan numfashi (maimakon mask).
An amince da matattarar numfashi na N95 don wuraren masana'antu, amma FDA ta ba da izinin amfani da waɗannan masks kawai don yanayin amfani da gaggawa (EUA).
An tsara su don kare ƙwayoyin da ke rataye a cikin iska kamar ƙura, amma ba a tabbatar da ingancin su ga wani takamaiman halittar halitta don amfani da ba a ambata a kan lakabin ba.
CDC ta bada shawarar yin amfani da kariya ta fuska, ko kuma a matsayin wata hanya ta ƙarshe, yin amfani da abin rufe fuska a gida lokacin da ba a samun abin rufe fuska.
Yawancin cututtukan COVID-19 ba su da tsanani sosai don buƙatar numfashi ko makamancin haka, amma kashi na marasa lafiya suna buƙatar waɗannan sassan.
Ana nazarin nau'in taimakon numfashi da marasa lafiya da ke fama da rashin numfashi na COVID-19 ke buƙata a yanzu a kan mutane a asibiti, kuma akwai shaidu da ke nuna cewa ana iya hana yin numfashi ko kuma yin amfani da bututun da ke da matsin lamba mai yawa ko kuma matsin iska mai tasiri a rabi.
Ba a san ko wanne daga cikin waɗannan zai haifar da irin wannan fa'ida ga mutanen da ke fama da rashin lafiya ba.
Wasu likitoci sun fi son ci gaba da amfani da injunan iska masu iska a lokacin da aka samu damar, saboda wannan fasaha ta iyakance yaduwar kwayoyin cutar a cikin hanci fiye da maganin oxygen na hanci mai tsawo. Abubuwan da suka fi muni a cikin cututtuka suna da yawa (mutanen da suka wuce shekaru 60 da kuma musamman waɗanda suka wuce shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isasshen asibitoci, wanda ke iyakance ikon tsarin kiwon lafiya don magance ƙaruwar yawan mutanen da ke fama da COVID-19 da ake buƙata sosai don shiga asibiti.
Wani bincike a kasar Sin ya nuna cewa kashi 5% na masu karɓar kulawa ta musamman sun shiga, kashi 2.3% na bukatar taimakon tsarin numfashi na wucin gadi, kuma kashi 1.4% sun rasa rayukansu.
A kasar Sin, kimanin kashi 30 cikin dari na mutanen da aka kai asibiti saboda COVID-19 an kwantar da su a ICU.
Tsarin iska yana da wuya yayin da cutar ta rikitarwa ta numfashi (ARDS) ta ci gaba a cikin COVID-19 kuma ta zama da wuya a samar da iskar oxygen.
Ana amfani da ventilators, ciki har da yanayin kula da matsa lamba da PEEP mai tsawo, don haɓaka iskar oxygen yayin rage haɗarin lalacewar huhu da ke tattare da tsarin numfashi da na pneumothorax.
Ƙarin sabuntawa (PEEP) na iya kasancewa ba a cikin tsofaffin masu iska ba.
An fara bincike kan yiwuwar warkarwa a watan Janairun 2020 kuma ana ganin magungunan rigakafin cutar a cikin nazarin asibiti.
Ramsayver ya kasance mafi tasiri a wannan lokacin.
Ko da yake zai iya ɗaukar lokaci kafin a yi sabon magani a shekara ta 2021, yawancin magungunan da ake gwadawa sun tabbatar da amfani da su a wasu lokuta ko kuma an riga an tabbatar da su a cikin gwaji na ci gaba.
Ana iya gwada maganin rigakafi akan mutane masu rashin lafiya mai tsanani.
Hukumar lafiya ta duniya ta ba da shawarar cewa masu sa kai su shiga cikin gwaje-gwajen don ƙayyade inganci da rigakafin magani. Hukumar Abinci da Magunguna ta Amurka ta ba da izinin wucin gadi na amfani da plasma mai sauƙi a matsayin magani na gwaji a lokuta inda rayuwar mutum ke da haɗari ko kai tsaye.
Ba a gudanar da bincike na asibiti ba don tabbatar da rigakafi da ingancin cutar.
A watan Fabrairun 2020, kasar Sin ta gabatar da wani software mai amfani da wayar hannu don magance barkewar cutar.
Masu amfani sun nemi su shigar da sunayensu da lambar su.
"Wannan shirin yana amfani da bayanan sa ido don ganewa da ""taɓawa ta kusa"" kuma sakamakon haka yana da haɗarin kamuwa da cutar".
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan aka gano wata barazana mai yuwuwa, shirin ba kawai yana ba da shawarar yin keɓewa ba, amma yana kuma sanar da jami'an lafiya na gida. Ana amfani da nazarin manyan bayanai a kan bayanan wayar hannu, fasahar gano fuska, bin diddigin wayar hannu da kuma ilimin kere kere don bin diddigin cututtukan da suka kamu da cutar da mutanen da suka yi hulɗa da Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da izinin hukumomin tsaro su gano bayanan wayar mutanen da ake zargi da kamuwa da cutar korona.
Ana yin wannan ne don yin killacewa da kare mutanen da suke iya tuntuɓar 'yan ƙasa da suka kamu da cutar.
A watan Maris na shekarar 2020, Deutsche Telekom ta raba bayanan wuri tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch (Robert Koch Institute) don gudanar da bincike da hana yaduwar cutar.
Rasha ta aiwatar da fasahar gano fuska don gano masu keta dokar killacewa.
"Julio Galera, memba na hukumar kula da lafiyar Italiya ta ce an sanar da masu amfani da wayar hannu cewa ""kashi 40% na mutane suna zuwa da kuma zuwa da kuma zuwa da ko ta yaya"."
Gwamnatin Jamus ta gudanar da wani hackathon na tsawon sa'o'i 48 a makon da ya gabata tare da fiye da mutane 42,000.
Shugaban Estonia, Kristi Kaljulaid, ya yi kira ga duniya ta samar da hanyoyin magance yaduwar cutar coronavirus.
Mutane a cikin killace na iya fuskantar damuwa, ƙuntatawa na tafiya, rikicewar magani ko tsoron kamuwa da cuta.
"BBC ta yi bayanin cewa, Rory O'Connor ya ce: ""Hotunan zamantakewa, kadaici, damuwa game da lafiya, damuwa da kuma rikicin tattalin arziki, guguwa ne a duk ma'anar cutar da lafiyar mutum da kuma lafiyar mutum".""
Cutar na iya kasancewa da bayyanar cututtuka masu sauƙi ko ma ba tare da bayyanar ba kuma yana kama da cututtuka na yau da kullum na rashin numfashi kamar faduwa na yau da kullum.
Sauƙaƙe cututtuka sukan ƙare a cikin makonni biyu, yayin da a cikin mutane masu tsanani da cututtuka masu tsanani, zai iya ɗaukar makonni uku zuwa shida don warkewa.
Bisa ga bayanai daga wasu irin wannan ƙwayoyin cuta kamar SARS da MS, mata masu juna biyu na iya samun hadarin kamuwa da COVID-19, sai dai idan babu bayanan COVID-19 a cikin mutane. A cikin mutane da yawa, COVID-19 na iya shafar huhu kuma yana haifar da ƙirji da makogwaro.
COVID-19 a cikin mutane masu kamuwa da cutar mai tsanani, na iya ci gaba da sauri zuwa cututtukan numfashi mai tsanani (ards), wanda ke haifar da rashin numfashi, bugun jini ko rashin aiki na gabobin jiki.
Matsalolin da suka shafi COVID-19 sun haɗa da cutar ta narkewa, kumburi na halitta, da kuma lalacewar zuciya, hanci da hanta.
Rashin hawan jini, ko kuma ƙara yawan lokaci a cikin prothrombin, an lura da shi a cikin kashi 6% na waɗanda aka karɓa a asibiti tare da COVID-19, yayin da ƙananan aiki na yau da kullun ya kasance a cikin kashi 4% na wannan rukuni.
A tsakanin kashi 20 zuwa 30% na mutanen da ke kamuwa da COVID-19, suna da manyan enzymes na hanta (aminoases).
A cewar wannan rahoton, matsakaicin lokaci tsakanin bayyanar cututtuka da mutuwa ya kasance kwanaki goma, daga cikin kwanaki biyar da aka yi a asibiti.
Koyaya, a cikin marasa lafiya da aka kwantar a ICU, matsakaicin matsakaicin lokaci tsakanin lokacin shiga asibiti da lokacin mutuwa ya kasance kwanaki 7.
A cikin binciken da aka gudanar da karin cututtuka na farko, matsakaicin lokaci daga bayyanar cututtuka na farko zuwa mutuwa ya kasance kwanaki 14, tare da zangon yanayin juyin halitta daga kwanaki shida zuwa 41.
A cikin wani binciken da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta gudanar, maza sun samu kashi 2.8 cikin dari na mutuwar yayin da mata suka samu kashi 1.7 cikin dari.
Binciken ilimin halayyar jiki na samfurori na huhu na mutuwa ya nuna lalacewar alveolar da aka warwatsa da exodates na fibromycin sel a cikin huhu biyu.
An lura da gyare-gyare na cytopathic na cutar a cikin ponomusites.
Hoton shida ya yi kama da cututtukan cututtukan numfashi mai tsanani (ARDS).
A cikin kashi 11.8 cikin dari na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an lura da yawan lalacewar zuciya saboda yawan yawan maganin troponin ko bugun zuciya.
A cikin watan Maris a Amurka, kashi 89% na mutanen da ke asibitoci suna da cututtuka masu saurin kamuwa da cutar.
Bayani game da mutuwar da waɗannan yanayin suka haifar sun bambanta saboda bambance-bambance na yanki da kuma matsalolin da aka yi.
Ƙananan ƙididdigar ƙananan lokuta suna haifar da ƙididdigar mutuwar da aka yi la'akari da su.
Koyaya, gaskiyar cewa mutuwar ta haifar da waɗanda suka kamu da cutar a baya na iya nufin cewa an kiyasta ƙimar mutuwar a yanzu.
Masu shan sigari suna da alamun bayyanar cututtukan COVID-19 sau 1.4 kuma suna buƙatar kulawa ta musamman sau 2.4 fiye da waɗanda ba su shan sigari.
Jami'in asibitin Hong Kong ya gano raguwar kashi 20% zuwa 30% a cikin ƙarfin huhu a cikin yawan mutanen da suka warke daga cutar kuma an gano cewa an yi wa hanta na hanta na jiki.
Wannan kuma na iya haifar da ciwon bayan kulawa ta musamman.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar ta baya zai haifar da rigakafi mai tasiri da tsawo a cikin mutanen da suka warke daga cutar ba.
Ana ganin cewa rigakafin mutum zai yiwu saboda halayyar sauran cututtukan coronavirus, amma an ruwaito cewa mutane da suka warke daga COVID-19 sun sake kamuwa da cutar.
An yi imanin cewa waɗannan za su sa kamuwa da cuta ta dogon lokaci ta zama muni maimakon sake kamuwa da ita.
Ana ganin cewa wannan kwayar halitta ce kuma ta samo asali ne daga dabba ta hanyar hanyar kamuwa da cutar.
Ba a san ainihin asalinsa ba, amma yaduwar kamuwa da cuta har zuwa Disamba 2019 ta kasance hanyar da za ta dace da hanyar watsawa daga mutum zuwa mutum.
Nazarin farko na mutane 41 da aka tabbatar da COVID-19, wanda aka buga a cikin The Lancet a watan Janairun 2020, ya sanar da ranar farko da bayyanar cututtuka ta fara a ranar 1 ga Disamba, 2019.
Rahotanni na Hukumar Lafiya ta Duniya sun ruwaito cewa alamun farko na cutar sun kasance a ranar 8 ga Disamba, 2019.
Yawancin lokaci ana amfani da ma'auni da yawa don ƙididdige ƙimar mutuwa.
Wadannan kididdigar sun bambanta dangane da yankin da tsawon lokaci kuma suna canzawa dangane da yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da ya wuce tun farkon yaduwar cutar, da kuma halaye na yawan jama'a kamar shekaru, jinsi, da overall health.
A ƙarshen 2019, Hukumar Lafiya ta Duniya ta ba da lambar gaggawa ta ICD-10 cutar U07.1 ga ɓangarorin da suka kamu da cutar SARS-CoV-2 wanda aka tabbatar da su a cikin dakin gwaje-gwaje, kuma lambar U07.2 ga marasa lafiya waɗanda suka mutu ba tare da cutar SARS-CoV-2 da aka tabbatar da su a cikin dakin gwaje-gwaje ba waɗanda suka kamu da COVID-19.
A cewar bayanan Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai kashi 6.9% (ya zuwa 17 ga Afrilu 2020), 153,822/22,40191.
Ƙididdiga sun bambanta dangane da yanki. Sauran ma'auni sun haɗa da CFR, wanda ke nuna mutanen da suka kamu da cutar kuma suka mutu, da kuma Inflammatory Inflammatory Rate (IFR), wanda ke nuna yawan adadin kamuwa da cutar (wanda aka gano ko ba a gano ba) da suka mutu daga cutar.
Wadannan kididdigar ba su da iyaka ga lokaci kuma suna bin wani yanki na al'umma daga kamuwa da cuta zuwa warwarewa.
Ko da yake ba dukan marasa lafiya ne ke samar da maganin rigakafi ba, kasancewar waɗannan maganin rigakafi a cikin mutane yana nuna yawan waɗanda suka kamu da cutar.
A tsakiyar cutar a Italiya, a wani ƙauye mai suna Castiglione d'Adda, 80 (kashi 1.7) na yawan mutane 4,600 sun mutu.
A Ganglet, cutar ta bazu ne ta hanyar bukukuwa na Carnival kuma ta yadu tsakanin matasa, wanda ya rage yawan mutuwar. Duk da haka, ba duk mutuwar COVID-19 za su iya zama irin wannan ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai yi nasara ba a kan karɓar marasa lafiya da kuma kula da su.
A Netherlands, kimanin kashi 3% na mutane na iya samun rigakafin iska daga masu ba da jini.
Mutane 69 (kashi 0.004% na yawan jama'a) sun rasa rayukansu saboda COVID-19.
Tasirin cutar da yawan mutuwar da ke tattare da ita sun bambanta ga maza da mata.
Yawan mutuwar maza sun fi girma a cikin nazarin da aka gudanar a China da Italiya.
Mafi yawan haɗarin ya kasance ga maza a cikin shekarunsu na 50, kuma kawai a cikin 90 na bambancin tsakanin maza da mata.
A kasar Sin, yawan mutuwar maza ya kai kashi 8.2 cikin 100 da mata 7.1 cikin 100.
Ba a san dalilin wannan bambancin jinsi ba, amma dalilai na hali da na halitta na iya zama dalili.
Bambance-bambance na rigakafi dangane da jinsi, rashin yawan shan taba a cikin mata da kuma rashin lafiyar maza ga cututtuka iri ɗaya, kamar hawan jini a cikin ƙarami fiye da mata, na iya zama sanadiyyar mutuwar dogon lokaci a cikin maza.
A Turai, maza sun kai kashi 57% na mutanen da suka kamu da cutar, kuma sun kai kashi 72% na mutanen da suka mutu daga COVID-19.
Tun daga watan Afrilu 2020, gwamnatin Amurka ba ta sake bin diddigin bayanan da ke kan cutar COVID-19 ta hanyar jima'i.
Bincike ya nuna cewa cututtukan cututtuka kamar cutar Ebola, AIDS, kamuwa da cuta da SARS suna shafar mata da maza daban-daban.
Mafi yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne da ke da mafi yawan yiwuwar kamuwa da cutar.
"Hukumar lafiya ta duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar zai zama "COVID-19" (COVID-19)".
Shugaban Hukumar Lafiya ta Duniya, Tedros Adhanum Gabrisos, ya bayyana cewa CO shine farkon kalmar coronavirus, VI shine farkon kalmar virus, kuma D shine farkon kalmar cutar a cikin harshen Ingilishi, kuma shekaru 19 na farkon kamuwa da cutar sun nuna: 31 ga Disamba, 2019.
An zabi sunan cutar ne bisa ga jagororin duniya na hana yin la'akari da la'akari da cewa ba a ambaci wani yanki na musamman ba (misali China), ko wani nau'in dabbobi, ko kuma wani rukuni na mutane. An kira cutar da ke haifar da cutar COVID-19 cutar coronavirus 2 (SARS-CoV-2).
"Bugu da kari, an yi amfani da kalmar ""COVID-19 virus"" ko ""COVID-19-causing virus"" a cikin sanarwa na duniya na WHO.
"Kusan", coronavirus "yana nufin duka cutar da kuma cutar".
"A lokacin da cutar ta fara barkewa a Wuhan, China, an san cutar da cutar a matsayin ""Coronavirus"" da ""Wuhan Coronavirus""".
A watan Janairun 2020, Hukumar Lafiya ta Duniya ta sanya sunan cutar 2019-nCoV da kuma cutar huhu mai tsanani 2019-nCoV, bisa ga bayanan da aka fitar a shekarar 2015 don gano cutar ta wucin gadi da kuma ƙwayoyin cuta bisa ga wuri.
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iyawa a cikin sarkar samar da sabis na yau da kullun, wasu masana'antun dijital suna samar da kayayyakin likita kamar su na'urorin hawan hanci ko sassan iska.
Alal misali, a lokacin da asibiti a Italiya ke buƙatar fanfo mai sauri kuma mai samar da shi ba shi da ikon samar da shi, wani farawa na gida tare da injin reverse ya samar da bawul 100 a dare ɗaya.
Bayan barkewar cutar COVID-19, ka'idodin makirci, da kuma rashin gaskiya game da asalin, sikelin, rigakafi, magani da sauran fannoni na cutar sun bayyana da sauri a Intanet.
An gano cewa mutane suna iya watsa cutar daga wasu dabbobi.
Bincike ya kasa gano shaidar karuwar cutar a cikin alade, duck, da beraye.
Babu wani magani ko allurar rigakafi da aka amince da ita don magance cutar.
An gudanar da bincike na kasa da kasa kan alluran rigakafi da magunguna don COVID-19 ta hukumomin gwamnati, kungiyoyin kimiyya da masu bincike a masana'antu.
"A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da "Taraitaccen Gwajin" (SOLIDARITY Trial) don tantance tasirin maganin kwayoyin cutar guda hudu da ke da mafi girman fata na tasiri".
Babu wani rigakafin da ake samu, amma cibiyoyi daban-daban suna aiki a kan samfurori na rigakafi.
Saboda SARS-CoV da SARS-CoV-2 suna amfani da masu karɓar ACE2 don shiga cikin ƙwayoyin mutum, binciken da aka yi a baya akan SARS-CoV yana da amfani.
An yi nazarin dabarun allurar rigakafi guda uku a wannan fannin.
A farko, manufar masu bincike ita ce samar da ƙarin allurar rigakafin cutar.
Ana amfani da irin wannan kwayar cutar, ko dai ta kashe ko ta mutu, don motsa hanzarin amsawar garkuwar mutum ga sabon kamuwa da COVID-19.
Hanyar ta biyu, alluran rigakafi, shine don ƙirƙirar allurar rigakafi wanda ke sa tsarin rigakafi ya zama mai saurin kamuwa da wasu ƙananan kwayoyin cutar.
A cikin SARS-CoV-2, bincike ya kasance game da furotin S-spike wanda ke taimakawa kwayar cutar ta haɗa kanta zuwa mai karɓar ACE2.
Hanyar ta uku ita ce alluran nucleic acid (kayan RNA ko DNA, sabuwar fasaha don inganta allurar).
Dole ne a gwada alluran rigakafi na kowane ɗayan waɗannan dabarun don rigakafi da inganci. A ranar 16 ga Maris, 2020, an fara binciken farko na asibiti na allurar tare da masu sa kai hudu a Seattle.
Allurar ta ƙunshi kwafin kwayoyin halitta mara lahani na kwayar cutar da ke haifar da cutar. An ba da shawarar ingantawa dangane da rigakafi a matsayin ƙalubale mai yuwuwa don samar da allurar rigakafi don SARS-COV-2, amma wannan abu ne mai ban mamaki.
Akwai fiye da 300 nazarin asibiti masu aiki a cikin Afrilu 2020.
A halin yanzu ana nazarin gwaje-gwaje bakwai don maganin zazzabin cizon sauro, ciki har da hudu akan hydroxychloroquine ko chloroquine.
Sabbin magungunan rigakafin cutar suna ba da babban ɓangare na binciken kasar Sin, inda aka gudanar da gwaji tara na asibiti a mataki na uku akan RMS a kasashe daban-daban a ƙarshen Afrilu.
Tun daga watan Afrilu 2020, an gudanar da wani tsari na asibiti mai zurfi don samar da allurar COVID-19 tare da magungunan da aka zaba don yin haka. Ana nazarin magungunan riga-kafi da yawa don maganin COVID-19, ciki har da RMS, chloroquine da hydroxychloroquine, Lupinavir/Retinavir da Lupinavir/Retinavir tare da interferon beta.
Tun daga Maris 2020, akwai hujja na gwaji game da tasirin Ramschever.
An lura da ingantaccen asibiti a cikin marasa lafiya da aka yi amfani da su ta hanyar amfani da rahamar rahamar rahamar rahamar.
Ana gudanar da nazarin asibiti na mataki na uku a Amurka, China da Italiya. An yi nazarin chloroquine wanda aka yi amfani da shi don maganin zazzabin cizon sauro tare da sakamakon farko a watan Fabrairun 2020 a kasar Sin.
Duk da haka, akwai kira ga sauran masu bincike su sake nazarin binciken.
Hukumomin kiwon lafiya na Koriya da na kasar Sin sun bada shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayar cutar Wuhan ta ce, yayin da ta ba da shawarar kashi na gram ɗaya na yumiya, yana nuna cewa sau biyu na wannan kashi yana da haɗari sosai kuma yana iya zama mai haɗari.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa na hydorxylchloroquine da chloroquine don maganin mutane da ke fama da COVID-19. Tsarin gyara na bakwai na kasar Sin ya haɗa da interferon (interferon), ribavirin (ribavirin) ko umfenovir (umifenovir) don amfani da COVID-19.
Bayanai na farko sun nuna cewa babban sashi na ribavirin yana da mahimmanci don hana SARS-CoV-2 a cikin yanayin dakin gwaje-gwaje.
Bayan an nuna cewa yana hana ƙananan ƙwayar SARS-CoV-2, an ba da shawarar ƙarin nazarin nitasoxynide a cikin jiki. Nazarin ya nuna cewa haɗuwa na farko na protein Spike da serum interglandular protease 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa da mai karɓar ACE2.
Nazarin da aka yi na chlorine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da iyakancewar da ke hana al'umma ta likita karɓar da gwada waɗannan hanyoyin magani ba tare da ƙarin nazarin ba. Selthavivir ba ya hana SARS-CoV-2 a cikin yanayin dakin gwaje-gwaje kuma ba shi da wani aiki a cikin maganin COVID-19.
Taurari na cytokine na iya zama matsala a cikin matakan COVID-19 na gaba.
Akwai shaidu cewa hydroxychloroquine na iya samun tasirin cytochrome cytoskeine. Tocilizumab an haɗa shi a cikin takardun magani bayan kammala wani ɗan gajeren bincike na Hukumar Lafiya ta China.
Bayan da ya nuna sakamako mai kyau a cikin mutanen da ke da mummunan cutar, yana ƙarƙashin gwajin gwaji na 2 na ƙasa a ƙasar Italiya.
Ana amfani da gwajin jini tare da gwajin serum fretin don gano abubuwan da ke faruwa na cytocin (cytokine storm) don magance irin wannan ci gaban da ake cewa yana haifar da mutuwar mutane da yawa.
An amince da maganin antiretroviral na interleukin 6 don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan
Har zuwa yau, babu wata hujja ta bazuwar ko kuma ta sarrafawa da ta nuna cewa toshilizumab magani ne mai tasiri ga CRS.
Ana gudanar da bincike kan yadda za a iya amfani da maganin rigakafi da kuma maganin rigakafi da aka tattara daga tsarin rigakafin mutanen da suka warke daga COVID-19 don gano wadanda suka kamu da cutar a matsayin hanyar da ba ta da allurar rigakafi.
An gwada wannan dabarar don SARS ba tare da sakamako ba.
Kwayar cutar ta zama tsarin aiki wanda aka yi hasashen cewa maganin antibody mai aiki zai iya haifar da kariya ga SARS-CoV-2.
Duk da haka, wasu hanyoyin kamar cytotoxicity da / ko cellular phagocytosis na tushen antibody suna iya faruwa.
Ana ci gaba da wasu nau'ikan maganin rigakafi na antibody, misali, amfani da maganin rigakafi na monoclonal.
Samun magani daga mutane masu lafiya, wanda ya ƙunshi sashi na jini na marasa lafiya da suka warke kuma ya ƙunshi wasu magungunan rigakafi na cutar, zai iya ƙaruwa don amfani da sauri.
Cutar coronavirus, rukuni ne na cututtukan da ke da alaƙa sosai
Li Wenliang, likita a babban asibitin Wuhan, ya kamu da cutar kuma ya mutu bayan ya sanar da cewa cutar ta ɓace.
